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Fatigue is a common symptom in adults worldwide, varying in 
length (acute to chronic) and severity [1]. Occurrence of fatigue 
can be medically explained (e.g. related to chronic disease), but in 
some cases fatigue (physical and mental) symptoms are medically 
unexplained, i.e. cannot be adequately explained by organic causes. 
Unexplained fatigue is considered to be chronic (chronic fatigue - 
CF) if it lasts for at least 6 months. 
Persistent and severe unexplained fatigue is not alleviated by rest, 
is debilitating, and leads to functional and social impairment (e.g. 
inability to work). Commonly, these patients experience additional 
rheumatologic and neuropsychiatric symptoms, namely pain and 
cognitive impairment [2, 3]. When at least four of these symptoms 
are present it is diagnosed as Chronic Fatigue Syndrome (CFS), 
according to the US Centres for Disease Control and Prevention 
(CDC) criteria [4], which is the most widespread criteria in 
research and clinical practice. Another case-definition commonly 
used is based upon the Oxford Criteria [5], a less restricted set of 
criteria not requiring the presence of additional somatic symptoms. 
Table 1 presents the characteristics of these case definitions. 
A panel of experts has recently proposed a new international 
consensus case definition [6], which does not establish a 
timeframe for the presence of fatigue, but requires the presence 
of postexertional malaise (i.e. increase in fatigue following intense 
effort) as well as additional clusters of  symptoms related to 
neurological, immune, gastro-intestinal, genitourinary, and energy 
production/transportation impairments.  One of the problems 
with diagnosing CF or CFS is that the primary symptom, fatigue, is 
difficult to define and to measure due to its subjective nature; there 
is no biological marker for CF(S) [7, 8]. The diagnosis of CF or CFS 
is thus exclusionary [9]. In terms of terminology, another name also 
used for CFS is Myalgic Encephalomyelitis/ Encephalopathy (ME). 
Some researchers consider this term to be more appropriate to 
characterize the complex nature of the disease [8].
CFS is considered to be a heterogeneous clinical condition. 









Table 1  Criteria of the main CFS case definitions
Oxford
Fatigue is the principal symptom.
Definite onset that is not lifelong.
Fatigue is severe, disabling, affects 
physical and mental functioning.
Fatigue should have been present  
for a minimum of 6 months during 
which it was present for more than 
50% of the time.
Other symptoms may be present,
particularly myalgia, mood and   
sleep disturbance.
CDC (1994)
Medically unexplained, persistent 
fatigue lasting for at least 6 
months, of new onset, not due 
to ongoing exertion or organic 
disease, not substantially relieved 
by rest, and leading to a significant 
reduction in activity levels.1 
Presence of four or more of the 
following symptoms:
1If symptoms do not fulfil the criteria for CFS, the condition is referred to as idiopathic chronic fatigue (ICF)
Medical conditions known to 
produce chronic fatigue. 
Patients with a current diagnosis 
of schizophrenia, manic 
depressive illness, substance 
abuse, eating disorder, proven 
organic brain disease. 
Medical conditions known to 
produce chronic fatigue.
Patients with a current diagnosis 
of  Major depressive or bipolar 
disorder, psychotic disorder, 
dementia, eating disorders, 
alcohol and substance abuse, and 
severe obesity.
fatigue, psychological distress, additional somatic symptoms, 
impairment and disability [3, 10]. Co-morbidity between CFS 
and psychological distress (depression and anxiety) was found in 
several studies, although the relationship remains unclear [3, 11]. 
Patients with CFS also experience a great number of other somatic 
complaints [8, 12]. In addition, studies report a percentage between 
35% to 70% of CFS patients that present with both CFS and 
Fibromyalgia [8, 13].
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Chronic fatigue is reported by about 6% of the general population 
[14]. Prevalence of CFS has been reported to be in between 0.007% 
and 2.6% in community and primary care samples. Prevalence 
rates vary according to several factors such as the setting, country 
and diagnostic criteria used [14]. Most studies on the prevalence 
and clinical characteristics of CF and CFS have been conducted 
in North-Western Europe, North America and Oceania [15], and 
there are very few international studies that compare patient 
populations from different countries [16, 17]. It is more prevalent 
in younger adults (less than 40 years of age) and among women [2, 
3, 8].  In terms of prognosis, full recovery rates are low; it is more 
common for patients to experience improvements in symptom 
severity [18]. Chronic fatigue is associated with a high use of 
health care resources and represents an important socioeconomic 
burden [2, 19].
The aetiology of CF(S) remains unclear. Still, research points 
towards a multifactorial nature that consists of a combination 
of biological/physical and psychosocial factors (biopsychosocial 
model) operating as predisposing, precipitating and perpetuating 
factors of chronic fatigue [3, 8, 9, 20]. 
Predisposing factors are those that make the person more 
vulnerable to develop chronic fatigue, such as genetics, 
personality factors, prior psychiatric disorder, and overactive 
lifestyles, among others [3, 8, 9]. Precipitating factors are those 
that trigger fatigue, such as acute or chronic physical (e.g. viral 
infection, surgery) and psychological stress (e.g. serious life 
events) [3]. Perpetuating factors contribute to the chronicity of 
fatigue, and can impede recovery from CF(S) [21]. Research has 
identified several perpetuating factors, such as biological changes 
(e.g., changes in the hypothalamic-pituitary-adrenal axis), 
presence of additional somatic symptoms (e.g. pain), social factors 
(e.g. lack of social support), psychological distress (depression 
and anxiety), as well as cognitive and behavioral factors, which 
Aetiology of Chronic Fatigue
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are considered to play a major role in the maintenance of fatigue 
[9, 20, 21]. Regarding cognitive factors, negative or maladaptive 
illness perceptions (e.g. poor sense of control over symptoms 
or somatic attributions of symptoms), and coping strategies 
(e.g. catastrophizing, passive coping) have been identified as 
perpetuating factors of fatigue [20, 22]. 
Prolonged physical inactivity (rest) and decreased physiological 
exercise capacity are considered major perpetuating behavioral 
factors of symptoms in CF(S) [23, 24]. It has been suggested that 
prolonged inactivity can result in physical deconditioning as well 
as in other physiological and psychosocial consequences that may 
perpetuate fatigue severity and physical disability [23, 25, 26]. On 
the other hand, high levels of physical activity that exceed personal 
physical capacity can cause overexertion and perpetuate fatigue 
symptoms [23, 27-29]. It is therefore common to find a “all-or-
nothing” (or “ boom-and-bust”) behavior pattern in these patients, 
which is the systematic alternation between periods of over-activity 
(when feeling good) and, as a consequence of that, feeling extremely 
fatigued and having to rest for longer periods of time [9, 23, 30]. 
Some patients continue to perform their daily activities even when 
symptoms get worse (overactive pattern), but most patients present 
reduced levels of daily activity [23, 31].  Patients’ perceptions 
and expectations with respect to symptom exacerbation as a 
consequence of physical exertion (postexertional malaise) can also 
lead to an avoidance and fear of physical activity [3, 26, 27] that does 
not correspond to the actual level of physical disability.
 Available research shows that patients with CFS have at 
average lower levels of physical activity, less muscle strength 
and a worse physiological exercise capacity [24, 25, 31], than 
healthy sedentary control subjects. It has therefore been 
recommended that patients with chronic fatigue engage in 
(balanced) physical activity instead of refraining from it.
Research is still limited with respect to the most appropriate 
type of physical activity for chronic fatigue management but 
recent literature points at the beneficial effect of aerobic 
activities (e.g. walking), performed at mild and moderate levels  
of intensity [23].
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Current behavioral and 
psychological treatments
Treatment approaches for CF(S) focus on perpetuating factors, 
especially on behavioral (physical activity) and psychological 
factors, in view of reducing severity of fatigue and other symptoms 
as well as improving functioning and quality of life. Graded 
Exercise Therapy (GET) and Cognitive Behavioral Therapy (CBT) 
are the current recommended non-pharmacological treatments 
for chronic fatigue management [3, 8, 32]. Based on a physiological 
model of deconditioning, GET is an aerobic exercise therapy, 
consisting of supervised exercise sessions and/or home-based 
exercise prescription (e.g. walking). In GET, physical activity is 
initiated at a level that (a) takes into consideration patients’ initial 
level of exercise capacity and (b) doesn’t exacerbate symptoms. 
Exercise is then gradually increased in frequency and intensity 
until patients reach an optimal level of activity. GET focuses 
on avoiding overexertion by advising patients not to exceed the 
recommended levels of physical activity/exercise. At the same 
time, patients are encouraged not to reduce or stop doing physical 
activity when symptoms get worse. Graded exercise programs 
follow the exercise prescription guidelines from the American 
College of Sports Medicine [33], tailored to each patient’s level of 
physical capacity [34]. GET has shown to have moderate beneficial 
effects upon chronic fatigue management [35-37].
CBT and other psychological approaches consider not only 
behavioural factors, but also cognitive and affective factors that 
may contribute to the maintenance of fatigue symptoms. The 
primary focus of CBT for these patients is on challenging cognitions 
related to the perpetuation of symptoms and distress (e.g. somatic 
illness attributions, perceived lack of personal control, focusing 
on physical sensations) as well as on planning work and functional 
recovery [38, 39]. Because of the empirically established benefits of 
physical activity in CFS, a large number of Cognitive Behavioural 
Therapy (CBT) trials have incorporated a graded physical activity/
exercise component. Focusing on a cognitive model of avoidance 
of physical activity, patients are encouraged to engage in a gradual 
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increase of physical activities and balance daily activities [3]. Some 
CBT approaches distinguish between relatively-active (characterized 
by an alternation of over-activity and rest) and low-active patients 
[3, 39]. In the first case patients are initially encouraged to balance 
their daily activities and rest, but for both groups of patients the 
intervention focuses on a gradual increase of physical activity levels. 
Cognitive-behavioral therapy (CBT) has also demonstrated to have 
beneficial effects on chronic fatigue management [36, 37, 40]. 
Some recent GET, CBT and combined approaches (e.g. 
multidisciplinary rehabilitation treatments) [41] also use pacing 
strategies, either by allowing flexibility in graded exercise goals or 
programs (e.g. duration of session) according to individual tolerance 
levels (e.g. stop if symptoms get worse) [27, 42] or by promoting 
a balance between physical daily activities and rest according to 
patients own symptoms and capability [27, 41]. 
Two meta-analyses comparing GET and CBT have not found 
differential effects between both treatments on fatigue management 
[36, 37]. Despite the fact that physical activity seems to be an 
important component of both treatment approaches, there is little 
research on the effects of GET and CBT on physical activity, with 
some studies showing only marginal or trivial effects [43, 44]. One 
of the problems with both GET and CBT is that both interventions 
are resource-intensive [36, 37]. Recent randomised controlled 
trials have tried to overcome this limitation by conducting minimal 
contact interventions based on self-guided instruction manuals 
and remote contact showing promising results [45-47]. These brief 
interventions have the advantage that they can be more easily 
implemented in standard health care, e.g. in a primary care setting. 
Other non-pharmacological treatments such as complementary and 
alternative therapies, as well as pharmacological immunological 
treatments have been developed but results from these trials are 
inconclusive [48]. 
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Promoting ( balanced) physical activity: 
The Role of Self-Regulation
Adopting a health behavior change framework can contribute to 
the understanding and long-last promotion of physical activity in 
chronic fatigue patients. One of the most prominent perspectives 
on health behavior change is Self-Regulation (SR) theory [49-52]. 
According to this theory, behavior is a goal driven process [50]. 
SR can thus be defined as a “sequence of actions and/or steering 
processes intended to attain a personal goal”[49]. This dynamic-
goal guided process occurs in phases, consisting of a goal selection 
and goal setting phase, an active goal pursuit or action phase, and 
a goal attainment and maintenance or disengagement phase, in 
which motivational and volitional aspects interact [49] 
A central aspect in SR is that individuals set personal important 
and meaningful goals [49, 52]. Research points out that formulating 
self-chosen and personally important goals to guide behavior (goal 
ownership), as well as autonomously regulate one’s own behavior, 
increases the likelihood of goal achievement and maintenance [49, 
53]. Goals are hierarchically structured and interconnected, with 
more abstract long-term goals (e.g. be healthy), generating input 
for the formulation of short-term concrete goals such as specific 
actions (e.g. exercise three times a week) [52].  This hierarchical 
goal structure is important for health behaviour change 
interventions as it considers that specific actions or concrete goals 
such as doing physical activity will only be formulated and pursued 
by individuals if they are linked to higher hierarchical goals such 
as being healthy. At the same time it stresses the importance 
of increasing the personal relevance of health goals in order to 
increase the likelihood of adopting physical activity goals. One 
of the triggers of motivation and intention to change behavior is 
the perceived discrepancy between an individual’s current state 
(input value) and a desired state (the reference value), leading to 
the formulation of a specific goal [52]. The significance of these SR 
processes for interventions in chronic fatigue is that they cannot 
only contribute to our understanding of the influence of life goals 
on chronic fatigue patients’ behavior and treatment adherence [54], 
but interventions based upon these models may also contribute to 
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change the reference value from symptom avoidance to well-being 
and encourage patients to change their personal goals to more 
active and positive goals [54, 55].
Additional SR cognitions and skills are considered to play an 
important role in the phases of the goal guiding process, and 
thus in promoting long-lasting health behaviour change [49]. 
Goal self-efficacy, formulation of self-chosen and personally 
important goals (goal ownership), planning, control over 
competing goals, self-monitoring, feedback and anticipatory 
coping, as well as attention and emotion control, are considered 
to add great value to the transition from a motivational phase 
(goal selection) to action phases of goal pursuit. Relapse 
prevention strategies such as coping planning, as well as 
satisfaction and ownership of the changed behaviour or goal 
reformulation are additional SR factors that can contribute to 
long-lasting health behaviour change [49].
Self-regulation based interventions have demonstrated to be 
effective in promoting long-lasting health behaviour change 
in chronic disease populations [56-59]. In a recent meta-
analysis, Michie et al. [60] found that interventions combining 
self-monitoring with other skills derived from Self-regulation 
theory (i.e. Control Theory [52]), such as goal setting, provision 
of feedback, planning and goal revisiting, were more effective 
in promoting changes in PA and healthy eating in the general 
population than other intervention not using these techniques. 
The moderation effect of SR-skills in interventions effect 
were also found in other meta-analysis of trials conducted 
with chronic diseases patients [61-63]. For that reason, a self-
regulation perspective was adopted to develop an intervention 
for CF(S) patients.
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Aims of the thesis
Several behavioral and psychological treatments have been 
developed for chronic fatigue patients, focusing on physical 
activity, which is considered a key factor in chronic fatigue 
management. Research is however limited with respect to the 
effects of these interventions on physical activity. Furthermore, 
many of these interventions focus on establishing/prescribing 
structured exercise plans and less on the role of motivational 
and self-regulatory factors in the successful adoption and 
regulation of physical activity and other behaviours that can 
lead to a reduction of fatigue severity and improvement of 
patients’ functioning and quality of life. 
The objectives of this thesis are to:
1. Adapt the Checklist of Individual Strength (CIS20), a valid and 
reliable measure of fatigue severity, for a Portuguese population in 
order to measure fatigue according to international standards.
2. Investigate the differences in clinical characteristics and 
behavioral and cognitive determinants on chronic fatigue in a 
Dutch and a Portuguese patient sample.
3. Examine the effects of behavioral and psychological treatments 
containing a graded exercise component in chronic fatigue 
management as well as to examine potential moderator effects of 
trial characteristics.
4. Develop and evaluate post treatment and medium-term effects 
of a self-regulation based intervention (4-STEPS), combining 
motivational interviewing and self-regulation skills training, on 
physical activity and chronic fatigue management.
5. Analyze whether changes in physical activity and use of 
self-regulation skills explain observed effects of the 4-STEPS 
intervention on fatigue severity. 
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Outline of the thesis
This thesis consists of eight chapters. This first chapter (Chapter 1) 
provided a general introduction on chronic fatigue, its management 
and the contribution of a self-regulation perspective to available 
behavioural and psychological treatments targeting physical 
activity. The following six chapters (Chapters 2 to 7) correspond 
to empirical studies either published or submitted to peer-review 
journals in the field of psychology and health.  
The first of these studies (Chapter 2) describes the psychometric 
properties of the Portuguese version of the Checklist of 
Individual Strength (CIS20-P;[64]). The CIS20 is a well-validated 
multidimensional measure assessing fatigue severity that has been 
used in several observational and intervention studies conducted 
in chronic fatigue patients [45, 65]. Fatigue severity is the primary 
endpoint in many interventions conducted in chronic fatigue 
patients, including the trial presented in this thesis. Hence, in 
research studies conducted in Portuguese speaking populations 
it is crucial to use a Portuguese validated measure to assess 
fatigue severity.
Chapter 3 explores cross-cultural similarities and differences 
in clinical characteristics and behavioral and psychological 
determinants of CFS between a Portuguese and a Dutch CFS 
patient sample. Due to the fact that there is no published research 
conducted with CFS patients in Portugal, and that most trials 
targeting these patients are done in Northern European countries, 
this comparison is important in view of developing culture  
relevant behavioral and psychological treatments  for CFS.  
Chapter 4 presents an updated systematic review and 
meta-analysis of the effects of behavioral and psychological 
interventions with a graded physical activity component on 
fatigue severity, physical functioning, physical activity, and 
psychological distress, among patients with ICF/CFS. Potential 
moderator effects of trial characteristics were examined 
in order to identify factors of success that can improve 
interventions’ design and effectiveness.
Chapters 5, 6 and 7 describe the development, implementation 
and evaluation of a randomized controlled trial (RCT) for 
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patients suffering from chronic fatigue, the “Four steps to 
control your fatigue (4-STEPS)” trial.  This RCT, conducted 
in Portugal, compared a brief self-regulation based physical 
activity program consisting of motivational interviewing and 
self-regulatory skills training (4-STEPS) to a control condition 
(usual care + general information on physical activity). 
 Chapter 5 presents the protocol of the 4-STEPS trial.  The 
protocol describes in detail the trial rationale, study design 
and procedures, description of the intervention content and 
materials, as well as the outcomes assessed. 
Two studies (Chapter 6 and 7) present the results of the 
4-STEPS implementation.  Chapter 6 reports the post-
treatment (3-months) effects of the 4-STEPS intervention on 
fatigue severity (primary outcome) and impact on daily life, 
physical activity, health-related quality of life, psychological 
distress and somatic complaints. Intervention effects at follow-up 
(12-months) are reported in Chapter 7. In addition, this last study 
examines the mediation effects of the intermediate targets of 
the intervention (physical activity and use of self-regulatory 
skills) on medium-term changes in fatigue. 
The last chapter (Chapter 8) integrates and discusses the 
findings from the different empirical studies. Directions for 
future research and practical implications are formulated.
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Aim: The Checklist of Individual Strength (CIS20) is a well 
validated measure of fatigue severity, which has been adapted 
in several languages. As Portuguese is one of the most widely 
spoken languages in the world it is important to have a Portuguese 
adaptation of the CIS20. 
Method: Four hundred and thirty healthy Portuguese adults and 
89 patients with chronic fatigue (CF) filled out the Portuguese 
version of the CIS20 (CIS20-P). The CF patients and a subsample 
of the healthy adults also filled out the SF-12v2 assessing health-
related quality of life. 
Results: The CIS20 four-factor structure was confirmed 
(subjective experience of fatigue, concentration, motivation 
and physical activity scales). In general, internal consistency 
estimates were satisfactory, with the exception of the motivation 
scale. Moreover, a higher degree of fatigue severity was 
significantly associated with lower vitality and physical and 
psychological health-related quality of life. 
Conclusion: Our results indicate that the CIS20-P is a reliable and 
valid measure of fatigue severity. Future studies should establish 
Portuguese cut-off points for (sub)clinical levels of fatigue.   
Keywords: chronic fatigue, Checklist of Individual Strength 




Fatigue is a common symptom reported worldwide, that can 
vary in length (acute or chronic) and severity (Torres-Harding & 
Jason, 2005). Persistent and severe fatigue can lead to functional 
impairment (Beurskens, Bültmann, Kant, Vercoulen, Bleijenberg, 
& Swaen, 2000). Fatigue is present in several clinical conditions 
(e.g. cancer) and is called unexplained or idiopathic chronic fatigue 
(ICF) if it lasts for at least six months, is debilitating and is not 
explained by an organic disease (Fukuda, Straus, Hickie, Sharpe, 
Dobbins, & Komaroff, 1994). If additional somatic symptoms 
established by the Centers for Disease Control and Prevention 
(CDC) are present, it is classified as Chronic Fatigue Syndrome 
(CFS) (Fukuda et al., 1994).
Due to its subjective nature, fatigue is difficult to define and 
measure (Wessely, 2005). Several self-report unidimensional and 
multidimensional measures of fatigue have been developed in the 
past two decades. Multidimensional assessment has the advantage 
of providing more detail on fatigue dimensions, such as physical 
and mental fatigue (Christodolou, 2005; Dittner, Wessely, & Brown, 
2004). The Checklist of Individual Strength (CIS-20) developed 
by Vercoulen and colleagues (Vercoulen, Alberets, & Bleijenberg, 
1999; Vercoulen et al., 1994) is a well validated and widely used 
multidimensional self-report measure assessing subjective 
experience of fatigue, concentration, motivation and physical 
activity level (for a detailed review on fatigue measurement see 
Christodolou, 2005; Dittner et al., 2004).
The CIS20 was developed for CFS patients and is extensively used 
within this population (e.g. Knoop, Van der Meer, & Bleijenberg, 
2008; Vercoulen et al., 1996a), within other clinical conditions (e.g. 
Ergin & Yildirim, 2012; Vercoulen et al., 1996b) as well as within 
healthy and working groups (e.g. Beurskens et al., 2000; Bültmann, 
Vries, Beurskens, Bleijenberg, & Vercoulen, 2000). The CIS20 
was demonstrated to have good internal consistency and validity 
across studies. In addition, it has been shown to discriminate 
between non-fatigued and fatigued groups (e.g. Beurskens et al., 




This research included two samples: 430 healthy adults and 89 
CF patients. Table 1 presents the demographic characteristics of 
the samples. In both groups, inclusion criteria were: 18 - 65 years 
old; fluency in Portuguese and capacity to provide an informed 
consent. In the CF group, participants were also required to meet 
the CDC criteria for ICF/CFS (Fukuda et al., 1994). Exclusion 
criteria were: the presence of a concurrent somatic condition 
that could explain the fatigue symptoms and/or the presence of a 
severe psychiatric disorder.
Measures
Checklist of Individual Strength (CIS20-P)
The CIS20 items represent four dimensions of fatigue: 
Subjective experience of fatigue (e.g. “I feel weak” – eight items), 
Concentration (e.g. “I have trouble concentrating”– five items), 
Motivation (e.g. “I feel no desire to do anything” – four items) 
and Physical activity (e.g. “I have a low output” – three items). 
Respondents indicate, on a seven-point Likert scale ranging from 
“Yes, that is true” to “No, that is not true”, the extent to which 
each statement applied to them in the past two weeks. Scores are 
calculated by adding up the results from the items of each scale. 
Higher scores indicate higher levels of subjective experience of 
fatigue (ranging from 8 to 56), reduced concentration (5-35), 
Method
fatigue have been developed (Bültmann et al., 2000; De Vree et al., 
2002). The CIS20 has been adapted in several languages, including 
Japanese (Aratake et al., 2007), Polish (Makowiec-Dabrowska & 
Koszada-Wlodarczyk, 2006) and Turkish (Ergin & Yildirim, 2012), 
presenting good cross-cultural reliability and validity.
Since Portuguese is one of the most widely spoken languages in 
the world the development of a Portuguese version of the CIS20 is 
needed. Therefore, the aim of this study is to examine the reliability 
and validity of the CIS20-P across two different groups: a healthy 
population and a population suffering from CF.
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reduced motivation (4-28) and lower levels of physical activity 
(3-21). Furthermore, a total CIS20 score (fatigue severity) can be 
calculated by adding up the scores from each dimension (20 -140).
Procedure
Two different procedures were followed for each group. The CF 
participants were recruited through several Portuguese health 
care institutions and the Portuguese Fibromyalgia and Chronic 
Fatigue Patient Association. Questionnaires were filled out during 
individual face-to-face sessions with the principal investigator, 
as part of a larger study on CF (Marques, De Gucht, Maes, & Leal, 
2012). Participants from the healthy group are a convenience 
sample (recruited in organizational and academic settings). 
Participants were asked to complete the questionnaires and return 
them by prepaid mail or email. For both samples, informed consent 
was obtained and confidentiality of the data was guaranteed by the 
research team.
Cross Cultural Translation of the CIS20
For the Portuguese adaptation of the CIS20, the English version 
presented by Beurskens (Beurskens et al., 2000) was used following 
the recommended procedure translate-translate back (Hill & Hill, 
2005).  
Data Analysis 
Confirmatory Factor Analysis (CFA) (Arbuckle, 2005) using a 
maximum likelihood (ML) estimation method was used to test 
the validity of the four-factor structure of the CIS20-P in both the 
healthy and CF samples. Comparative Fit Index (CFI), Nonnormed 
Fit Index (NNFI), Goodness of Fit Index (GFI), Root-Mean Square 
Error of Approximation (RMSEA) fit indices and χ2 statistics were 
used to determine the adequacy of the models. A CFI >.90, GFI >.90, 
NNFI>.90 and RMSEA<.05 with 90% CI < .10 are acceptable indices 
of fit for the model and χ2/df <5 is considered to be reasonable 
(Byrne, 2001). Multivariate normal distributions of the responses 
were examined by means of the standardized Mardia’s coefficient 
(Mardia, 1974). Cronbach’s coefficient alphas were calculated for 
internal consistency. To assess the discriminant validity of the 
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CIS20-P, samples were matched on age, gender and educational 
level (healthy sample: n= 157; CF sample: n=89). There were no 
significant differences between both groups on these demographic 
variables. In order to explore differences on the CIS20, 
independent samples t-tests were conducted. The convergent and 
concurrent validity of the CIS20-P was analyzed using bivariate 
Pearson correlation coefficients with the Vitality scale and Physical 
and Psychological health-related quality of life dimensions 
(HRQoL) of the SF-12v2 (Ware, Kosinski, Turner-Bowker, & 
Gandek, 2002), that were completed by the CF population (n=89) 
and a subgroup of the healthy sample (n = 176). 
All analyses were performed with SPSS v.19 and AMOS v.20 
statistical packages.
Descriptive Statistics and Reliability of the CIS20-P 
Tables 2 and 3 present descriptive data and internal consistency 
data for each CIS20-P scale in the healthy and CF sample, 
respectively. In the healthy group, internal consistency coefficients 
were satisfactory and above α = .78 for the Subjective experience 
of fatigue, Concentration and Physical activity scales. Slightly 
inferior Cronbach’s alphas were observed in the CF sample (> .69). 
In both groups, the Motivation scale proved to have poor internal 
consistency (α = .51 for the healthy group and α = .58 for the CF 
group, respectively). Yet, all items contributed to the internal 
consistency of this scale.
Factorial validity of the CIS20-P 
Multivariate kurtosis was observed in the healthy (Kurtosis/c.r. 
= 2.86) and CF samples (Kurtosis/c.r. = 6.29). Nevertheless, the 
maximum likelihood estimation method used in CFA is robust 
even in the presence of a non-normal distribution of the data 
(Maroco, 2010).
The CFA adjustment fit indices of the four-structure model were 
reasonable for the healthy sample (χ2/df = 4.731; CFI = .85; NNFI = 
.82; GFI = .82; RMSEA = .093; 90% CI [.087 - .100]). All items loaded 
Results
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significantly on their respective factor (see Table 2). In the CF 
sample, the adjustment fit indices of the model were poorer (χ2/df = 
1.739; CFI = .76, NNFI = .72; GFI = .75; RMSEA = .092, 90%; CI [.074 
- .107]). The path coefficients were smaller in the CF group (Table 
3), in which items four (“Physically I feel exhausted” - Subjective 
experience of fatigue scale) and five (“I feel like doing all kinds 
of nice things” - Motivation scale) had very low loadings on their 
respective factor (.13 and .15, respectively).  
The inter-correlations among the CIS20-P scales ranged from 
.33 (Subjective fatigue and Concentration) to .80 (Physical activity 
and Concentration). The correlation coefficients were equivalent 
in both groups, with the exception of the relation between 
Concentration and Subjective experience of fatigue, which was 
higher in the healthy population (.62).
Discriminant Validity of the CIS20-P
The results presented in Table 4 show that in comparison with a 
matched healthy group, the CF participants scored systematically 
higher on all CIS20-P dimensions. All differences were statistically 
significant (p < .001).
Convergent and Concurrent Validity of the CIS20-P
The Pearson correlation coefficients between the total CIS20-P 
score and the SF-12v2 indicators (Vitality, Physical and 
Psychological HRQoL) are presented in Table 5. All correlations 
were negative and statistically significant (p < .01) in both groups. 
The largest correlations emerged in the healthy sub-sample.
This study aimed at analyzing the reliability and validity of the 
Portuguese Version of the CIS20 in a healthy adult population and a 
sample of CF patients. 
Overall, the CIS20-P dimensions and the total scale presented 
satisfactory internal consistency estimates, similar to those found 
in previous validation studies (Aratake et al., 2007; Makowiec-
Dabrowska & Koszada-Wlodarczyk, 2006). For the CF population, 
Discussion
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the Cronbach’s alphas within the present study were lower than 
those presented in the Dutch studies (Dittner et al., 2004). In 
addition, the motivation scale presented a very low internal 
consistency in both samples, which is in line with the findings of 
the Polish version of the CIS20 (α = .61) (Makowiec-Dabrowska 
& Koszada-Wlodarczyk, 2006). More in particular, item five 
(“I feel like doing all kinds of nice things”) presented a lower 
correlation with the factor motivation and a lower factor loading 
in comparison to the other items. One explanation may be that 
there are cross-cultural differences in the expression of reduced 
motivation. Future studies should further explore this hypothesis 
and, eventually, changes should be made to the Portuguese version 
of the motivation scale (e.g. by adding new items).
Although we found support for the four-factor structure of the 
CIS-20P in both samples, the adjustment indices of fit were worse 
in the CF sample. The small size of this group (n = 89) may partly 
explain this difference. In addition, differences in the procedure 
used for data collection in each sample, may also have contributed 
to the differences found. Few studies have analyzed the factorial 
structure of the CIS20. The Japanese version presents similar 
factorial validity estimates (Aratake et al., 2007). 
The CIS20-P proves to discriminate well between a matched 
healthy and the CF sample. CF patients demonstrated significantly 
higher levels of subjective fatigue, lower motivation, lower 
concentration, reduced physical activity and a worse fatigue 
severity, which is in line with previous studies (Beurskens et al., 
2000; Bültmann et al., 2000; Vercoulen et al., 1996b).
Finally, the convergent and concurrent validity of the CIS20-P 
was examined in both samples. Higher fatigue severity was 
significantly associated with lower vitality and physical and 
psychological HRQoL, in both groups. These results confirm 
previous research (Ergin & Yildirim, 2012).
We recommend that future studies explore other psychometric 
properties of the CIS20-P (e.g. sensitivity to change), establish 
Portuguese cut-off points for (sub)clinical levels of fatigue, and 
examine the discriminant validity of the CIS20-P in other clinical 
(e.g. cancer, diabetes) and non-clinical samples (e.g. organizational 
settings).  In addition, validation studies should be conducted in 
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other Portuguese speaking countries that are culturally different 
(e.g. Brazil).
Our findings indicate that the CIS20-P is a useful tool to assess 
fatigue severity.  
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aMatched healthy subsample for discriminant validity analysis. 
Female patients (%) 
Age, years (Mean±SD)




Table 2 Descriptives, Chronbach’s alphas and factor loadings for the Portuguese  
version of the CIS-20P for the healthy population (N=430)
Subjective fatigue  8-56
CIS1    1-7 
CIS4    1-7 
CIS6    1-7 
CIS9    1-7 
CIS12    1-7 
CIS14    1-7 
CIS16    1-7 
CIS20    1-7 
Concentration   5-35 
CIS3    1-7 
CIS8    1-7 
CIS11    1-7 
CIS13    1-7 
CIS19    1-7 
Motivation   4-25 
CIS2    1-7 
CIS5    1-7 
CIS15    1-7 
CIS18    1-7 
Physical activity   3-21 
CIS7    1-7 
CIS10    1-7 
CIS17    1-7 
CIS-20P total   21-122
28.97     12.09
4.47     2.11 
3.34     2.01 
3.83     1.90
2.94     1.92
3.77    1.90
3.59    2.13
3.10    1.93
3.99    2.05 
15.55    7.23 
3.47    2.13
2.88    1.68
2.96     1.76
3.01    1.87 
3.28    2.02 
10.81    4.39
3.63    1.88
1.68    1.25
2.90     1.87
2.64    1.91
7.66    4.19
2.64    1.73
2.54    1.68
2.52    1.67





















































aObtained from the Confirmatory Factor Analysis
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Table 3   Descriptives, Chronbach’s alphas and factor loadings for the Portuguese  
version of the CIS-20 for the CF group (N=89)
46.57    6.90
6.49     1.00
5.52    1.77 
5.84     1.42
5.34     1.82
5.72    1.73
5.43    1.64
6.22    1.24
6.01    1.46 
25.53    6.92 
5.17    2.05
4.58    1.82
5.26     1.82
5.28    1.85 
5.24    1.94 
15.11    4.96
5.25    1.88
2.02    1.45
3.45     2.09
4.39    1.95
14.11    5.02
4.21    2.25
5.02    1.99
4.88    1.98





















































aObtained from the Confirmatory Factor Analysis
Subjective fatigue  29-56
CIS1    3-7 
CIS4    1-7 
CIS6    2-7 
CIS9    1-7 
CIS12    1-7 
CIS14    1-7 
CIS16    2-7 
CIS20    1-7 
Concentration   5-35 
CIS3    1-7 
CIS8    1-7 
CIS11    1-7 
CIS13    1-7 
CIS19    1-7 
Motivation   4-27 
CIS2    1-7 
CIS5    1-6 
CIS15    1-7 
CIS18    1-7 
Physical activity   3-21 
CIS7    1-7 
CIS10    1-7 
CIS17    1-7 
CIS-20P total   54-129
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Table 4   Descriptives and comparison (independent t-tests) of the CIS-20P total 
and scales for the healthy and CF sample
Table 5   Correlations (Pearson) between fatigue severity (total CIS20-P) and 
Vitality, Physical and Psychological HrQoL in the healthy and Chronic Fatigue 
sample 
Note. Values are the mean ± SD. *p<0.001
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Background: Few studies focus on cross-cultural differences in 
Chronic Fatigue Syndrome (CFS). 
Purpose: This study aimed to (1) compare fatigue severity and 
impairment, somatic complaints, psychological distress and quality 
of life (QoL) in a population of Portuguese and Dutch patients, (2) 
explore the differential contribution of behavioral and cognitive 
determinants of fatigue severity; and (3) investigate the relation 
between fatigue severity and somatic complaints on the one hand 
and QoL on the other in both populations.  
Methods: Eighty-five female patients from Portugal (Mean age= 
47.54) and 167 female CFS patients from the Netherlands (Mean 
age = 44.93) participated in the study. All participants were 
surveyed for demographic and clinical characteristics, fatigue 
severity, somatic symptoms, psychological distress, (physical and 
psychological) QoL, physical activity, behavior regulation patterns 
and illness representations. 
Results: Cross-cultural differences were found in relation to 
working status, duration of fatigue symptoms, psychological 
distress, somatic complaints and psychological QoL. Although 
behavioral characteristics and illness representations were 
significantly associated with fatigue severity in both Portuguese 
and Dutch patients, there were important differences in the 
determinants of CFS. Moreover, higher levels of fatigue and 
severity of other somatic complaints were related to poor QoL.
Conclusions: These findings show cross-cultural similarities 
and differences in clinical characteristics and psychological 
determinants of CFS that are important in view of diagnosis and 
treatment.






Somatic symptoms, such as fatigue, are an important reason for 
doctor visits [1, 2] and it is estimated that these symptoms remain 
medically unexplained in about one third of the cases [1]. Usually, 
fatigue is explained by life circumstances and is transitory, but 
for some, fatigue symptoms are indeed medically unexplained, 
can be severe and become chronic, resulting in functional and 
social impairment (e.g. inability to work), high use of health care 
resources and lower Quality of Life (QoL) [2-4]. According to 
the Centers for Disease Control and Prevention (CDC) fatigue is 
classified as Chronic Fatigue Syndrome (CFS) when it lasts for at 
least six months, is not alleviated by rest, is debilitating, results in 
a significant reduction of daily activities, cannot be explained by an 
organic disease and is accompanied by four or more of the following 
symptoms: unrefreshing sleep, lengthy malaise after exertion 
(lasting for over 24 hours), impaired memory or concentration, sore 
throat, tender cervical or axillary lymph nodes, muscle pain, multi-
joint pain without swelling or redness and headaches of a new type 
or severity [5]. 
Co-morbidity between CFS and psychological distress 
(depression and anxiety) was found in several studies, although 
the relationship remains unclear [6-8].  Some prospective studies 
found the occurrence of psychiatric disorders during adulthood to 
be associated with later CFS [9, 10]. Other studies suggest that the 
high rates of psychological distress in CFS patients may be due to 
a common negative affective reaction to a chronic health problem 
[6], to disability associated with fatigue [7], to difficulties in the 
diagnosis of CFS [8], or as a result of the lack of legitimization of the 
disease by medical doctors [8], among other explanations. Patients 
with CFS also experience a great number and higher severity of 
other somatic complaints [4, 11]. Several studies indicate that these 
patients are hypersensitive to somatic sensations, which can lead to 
a worsening and increase of the number of symptoms perceived  [6, 
12, 13].                   
A psychological perspective on CFS can provide a better 
understanding of the cognitive and behavioral factors associated 
with the onset and perpetuation of unexplained fatigue [2, 6]. More 
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specifically, patients’ illness representations and coping strategies 
can contribute to the worsening and perpetuating of fatigue [6, 13, 
14]. Patients with CFS tend to believe that their illness has severe 
consequences, will last for a long period of time (timeline) and 
expect many associated symptoms [6, 13, 15]. A prospective study 
revealed that perceived consequences, timeline, uncontrollability 
and emotional response predicted worsening and maintenance 
of chronic fatigue [16].  Patients who belief that they suffer from 
a severe illness, that their CFS is out of control or incurable and 
will lead to adverse consequences, usually develop passive ways of 
coping with their illness leading to high disability and psychological 
distress [2, 13, 17]. In relation to behavior regulation (coping) it 
has been suggested that CFS patients tend to adopt a “boom and 
bust pattern” (also called “All-or-nothing behavior”) or a limiting 
behavior pattern to deal with their illness [13, 16]. All-or-nothing 
behavior refers to the systematic alternation between periods 
of excessive activity (when feeling good), and, as a consequence 
of that, feeling extremely fatigued and having to rest for longer 
periods of time [13, 18]. Limiting behavior refers to the excessive 
resting and inactivity, which can be associated with patient 
complaints related to exercise intolerance and post-exertional 
malaise. Patients’ perceptions and expectations related to symptom 
exacerbation as a consequence of exercise can explain the reduced 
levels of physical activity found in these patients [6]. At the same 
time, lack of physical activity and excessive resting are factors 
that can result in physical deconditioning which, in turn, might 
perpetuate fatigue and physical disability [19].  The importance of 
identifying and understanding the specific cognitive and behavioral 
determinants of CFS is reinforced by the promising results of CBT 
and graded exercise approaches in CFS management [20, 21]. 
CFS is considered to be a heterogeneous clinical condition. 
Patients may present with different levels of (mental and physical) 
fatigue severity, psychological distress, additional somatic 
symptoms and different levels of impairment and disability [3, 6]. 
For this reason, fatigue severity and related somatic symptoms, 
psychological distress and QoL, may vary between countries and 
cultures [22, 23]. Most studies on the prevalence and clinical 
characteristics of CFS have been conducted in  North-West 
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Europe, North America and Oceania [23], while there are very 
few international studies that compare patient populations from 
different countries [3, 22, 23].  Hickie and colleagues [22] explored 
CFS worldwide, using existing data from different cultures. 
Results revealed a five-factor model of symptoms (musculoskeletal 
pain and prolonged fatigue, neurocognitive difficulties, sleep 
disturbance, inflammation and mood disturbance), confirming that 
CFS is indeed a universal disease. Another study on health related 
QoL conducted with US, UK and German CFS patients, showed that 
these patients reported a lower QoL in all countries [3]. In a study 
comparing the prevalence and recognition of CFS in primary health 
care services between Brazil and England [23], the prevalence 
of CFS appeared to be similar in both countries, but there were 
differences in the recognition of CFS as a discrete disorder leading 
to a lower number of diagnosed patients in Brazil. 
Likewise, cross-cultural research on the psychological 
determinants of CFS, such as behavioral (e.g. physical activity) and 
cognitive (e.g. illness representations) factors is lacking, although 
this type of research can contribute to the cultural adaptation of 
existing CFS models and the development of tailored treatment 
strategies. For this reason, we conducted a comparative study 
between two economically and culturally distinct countries: 
Portugal (a Southern European country) and the Netherlands (a 
North-Western European country), as we expected differences in 
clinical characteristics and determinants of CFS. Available data 
reveal differences in psychological distress and physical activity 
between the two populations [24, 25]. 
This is an exploratory study aiming at: (1) comparing fatigue 
impairment and severity, somatic complaints, psychological 
distress and (physical and psychological) QoL in Portuguese and 
Dutch CFS patients (2) exploring  differential effects of behavioral 
(physical activity and behavior regulation patterns) and cognitive 
factors (illness representations) on fatigue severity in the study 
populations and (3) examining the contribution of fatigue severity 
and somatic complaints to (physical and psychological) QoL in 
Portuguese and Dutch CFS patients.
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Method
Participants and Procedures 
This cross-sectional study included participants from two 
countries: Portugal and the Netherlands. In both cases, inclusion 
criteria were: meeting the CDC criteria for CFS [5]; being at 
least 18 years old; being fluent in Portuguese/Dutch; and having 
the capacity to provide an informed consent. Exclusion criteria 
were similar for both samples: presence of a concurrent somatic 
condition that could explain fatigue symptoms and/or presence 
of a severe psychiatric disorder (according to the CDC criteria for 
exclusionary medical and psychiatric conditions). Table 1 presents 
the demographic and clinical characteristics of the samples.
Participants from Portugal were recruited via various health care 
institutions and from the national Chronic Fatigue Syndrome and 
Fibromyalgia Patients Association. CFS patients from the health 
care institutions were referred by their medical doctor, based on 
the inclusion and exclusion criteria for the study.  Patients from 
the Patients Association had a clinical diagnosis of unexplained 
chronic fatigue. Patients were approached by the research team to 
complete the questionnaires. Participants from the Netherlands 
were recruited through the national Chronic Fatigue Syndrome 
Patients Association. All Dutch patients were medically diagnosed 
as having CFS. The members of this association were invited via 
email by the patient association to complete the questionnaire. For 
both samples, informed consent was obtained and confidentiality 
of the data was guaranteed by the research team. Furthermore, 
the inclusion and exclusion criteria were checked by the research 
team, using self-report measures (CDC checklist of CFS symptoms; 
presence and name of chronic disease; presence and name of 
psychiatric disorder). 
For this study patients from Portugal and the Netherlands were 
matched on age, gender (only female patients were included) and 





 Socio-demographic characteristics include age, gender, education 
and employment status (Table 1). Clinical information was gathered 
using 4 indicators: (1) presence of persistent fatigue, (2) duration 
of fatigue symptoms (months), (3) number of doctor visits in 
the previous 6 months, and (4) a CDC based symptom checklist 
for CFS. The checklist includes the 8 major symptoms of CFS 
defined by the CDC criteria [5]. Respondents are asked to rate 
using a dichotomous scale (Yes/No) whether they experienced the 
symptoms for the last 6 months. To be diagnosed with CFS patients 
need to have a complaint of persistent unexplained fatigue for at 
least 6 months and have at least 4 of the major CFS symptoms listed 
by the CDC [5].
Fatigue Severity 
The Checklist of Individual Strength (CIS-20R) was used to 
assess fatigue levels [26]. The CIS-20R is a 20 item self-report 
questionnaire that assesses four dimensions of fatigue: subjective 
experience of fatigue, lack of concentration, lack of motivation and 
activity reduction. Items are rated on a 7-point Likert scale ranging 
from “Yes, that is true” to “No, that is not true”. A total CIS-20R 
score (fatigue severity), ranging from 20 to 140, can be calculated 
by adding the scores from each dimension. Higher scores indicate 
higher levels of fatigue severity. For the purpose of this study only 
the total fatigue severity score and the subjective experience of 
fatigue dimension were used. A cut-off point of 35 for subjective 
experience of fatigue [27] is used to define clinical levels of fatigue. 
The CIS-20R is a well validated and reliable measure for CFS 
patients [26].  Data on the Portuguese version of the CIS-20R reveal 
good reliability of the dimensions subjective experience of fatigue 
and total fatigue severity (α = 0.89 and α = 0.90, respectively) [28]. 
Somatic Complaints
Severity of physical symptoms was measured by means of the 
Patient Health Questionnaire-15 (PHQ-15) [1]. The PHQ-15 
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assesses the presence and severity of 15 somatic symptoms (e.g. 
back pain). A higher score indicates a higher level of somatization. 
Moreover, scores of 5, 10, and 15 represent cut off points for low, 
medium, and high somatic symptoms severity, respectively [1].
Psychological Distress 
The depression and anxiety subscales from the validated 
Brief Symptom Inventory (BSI) were used to assess levels of 
psychological distress [29]. Individuals rank each symptom on 
a 5-point Likert scale (from “never” to “very frequently”). Final 
scores range from 0 to 4 and higher scores represent higher levels 
of depression and anxiety. Cut-off points of 1.80 and 1.33 are used to 
define clinical levels of depression and anxiety, respectively [30].
Quality of Life (QoL) 
The Short Form Health Survey-12 (SF-12V.2) [31] was used to 
assess physical and psychological functioning and overall health-
related QoL. The SF-12v2 is a well validated measure consisting of 
8 domains: general health perception, physical functioning, role 
limitations due to physical problems, bodily pain, vitality, role 
limitations due to emotional problems, social functioning and 
mental health. These 8 dimensions are combined into a physical 
functioning score (Physical QoL) and a psychological functioning 
score (Psychological QoL), ranging from 0 to 100, with lower scores 
representing worst health functioning and QoL.
Physical Activity 
Levels were assessed using the Short Questionnaire to Assess 
Health-Enhancing Physical Activity [32] sports section in which 
participants indicate the types of physical activities they presently 
do (e.g. swimming), the frequency per week (e.g. 3 days per week) 
and duration per day (e.g. 50 minutes). Bicycling and walking 
frequency were also included. For the purpose of this study, the 
intensity of each activity was not included. To score the physical 
activity measure, total minutes of activity is calculated for each 
activity by multiplying frequency (days/week) and duration 
(minutes/day). Total physical activity score for each participant was 
calculated by making the sum of each activity score. 
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Behavior Regulation Patterns 
Using the All-or-nothing and Limiting behavior scales from The 
Behavior Responses to Illness Questionnaire (BRIQ) [33]. The first 
dimension assesses the “boom and bust pattern” usually observed 
in CFS and the second dimension assesses the limitations in daily 
activities and the excessive rest that patients take due to their 
fatigue problems). Higher scores (ranging from 1 to 5) represent a 
more frequent use of a boom and bust pattern and more reduced 
daily activities, respectively. Portuguese and Dutch versions of the 
BRIQ have a very good internal consistency for the All-or-Nothing 
scale (α =0.84 and α =0.88 (respectively), but much lower although 
still acceptable alphas for the Limiting behavior scale (0.68 and 
0.72, respectively). 
Patients’ illness representations 
Using the Brief Illness Perception Questionnaire (Brief IPQ) 
[34]. The Brief IPQ consists of 8 items, rated on a 10-point scale, 
representing 8 illness perceptions: illness consequences, timeline 
(expected duration of illness), personal control, treatment control, 
identity (disease label), illness coherence (understanding), illness 
concern and emotional response. The Brief IPQ dimensions are 
scored separately. Higher scores on illness consequences, timeline, 
identity, illness concern and emotional response, indicate a higher 
perceived impact of CFS. Higher scores on personal control, 
treatment control and illness coherence, represent more positive 
illness representations or in other words control over the illness. 
Data Analyses 
Descriptive data and differences between the Portuguese and Dutch 
samples for demographics and clinical information related to CFS 
were explored using univariate chi-square tests (for dichotomous 
variables) and two-sided t-tests (for continuous variables). Pearson 
correlation coefficients were conducted to examine the univariate 
relations between the determinants and the dependent variables 
(fatigue severity, physical and psychological QoL). For statistical 
power reasons, only determinants that showed a significant relation 
with the dependent variables at a p<.01 level in either sample 
were entered in the subsequent hierarchical regression analyses 
60
(Tables 2 and 3). Therefore, the regression analyses examined the 
respective contribution of the behavioral characteristics (physical 
activity, all-or-nothing behavior and limiting behavior) (block 1) and 
the illness representations consequences, personal control, identity, 
illness concern and emotional response (block 2) to fatigue severity 
(Table 4). 
In addition, regression analyses were conducted to examine the 
association between fatigue severity and somatic complaints in 
on the one hand and Physical and Psychological QoL, on the other 
hand. There was no multicolinearity between the variables.
 For the regression analyses, we considered p values lower than or 
equal to 0.05 as significant. Data analyses were conducted using the 
statistical software SPSS v19. 
Results
Descriptive and univariate analyses
Table 1 presents descriptive data for both study populations 
and the results of comparative tests for the following variables:  
demographic characteristics, working status, use of health care 
resources, fatigue symptoms, fatigue severity, somatic complaints, 
psychological distress and QoL (physical and psychological 
functioning) in Portugal and the Netherlands. A significant 
difference was found for educational level (p< 0. 05). Dutch 
patients had a higher educational level than Portuguese patients. 
Furthermore, there was a significant difference in working status: 
68.7% of the Dutch respondents reported not to be working, while 
44.7 % of the Portuguese reported not to work. In addition, there 
was a longer duration of fatigue symptoms (p< 0.01) in the Dutch 
sample (13.8 ys) than in the Portuguese sample (10.7 ys).
No significant differences were found for fatigue severity and 
subjective experience of fatigue.  Both Portuguese and Dutch 
patients presented high levels of fatigue severity and subjective 
experience of fatigue. The large majority of the patients in both 
samples met clinical levels of fatigue. Portuguese patients reported 
a higher severity of (other) somatic symptoms than Dutch patients 
(p< 0.05).  In relation to psychological distress, the Portuguese 
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CFS patients reported significantly higher levels of depression (p< 
0.001) and anxiety (p< 0.001), while significantly more Portuguese 
participants also reached a clinical level of depression (51.8% 
vs 10.8%; p< 0.001) and anxiety (64.7% vs 24%; p< 0.001).  Both 
Portuguese and Dutch patients presented low levels of physical 
and psychological functioning, but the score for psychological 
functioning was significantly higher in the Dutch population (p< 
0.01). 
Hierarchical Regression Analyses 
Table 4 shows the results of the hierarchical regression models 
for fatigue severity. In the Portuguese sample, the regression 
model including the behavioral factors (block 1) was significantly 
different from the null model (F(3)=10.022, p<0.001) and explained 
27 % of the variance in fatigue severity. Higher levels of physical 
activity were significantly associated with lower fatigue severity 
(p<0.001). In addition, patients who importantly reduced their 
daily activities (limiting behavior) presented higher fatigue severity 
levels (p<0.05). Adding illness representations to the model led to 
an increase of 18% in explained variance (block 2). The belief that 
chronic fatigue is a very serious problem (identity) and a higher 
emotional response to CFS were significantly associated with 
higher fatigue severity levels (p<0.05 and p<0.01 respectively). 
The final model explained 45% of the variance in fatigue severity 
(F(2)=7.848, p<0.001). 
With respect to the fatigue severity in the Dutch sample, the 
regression model including the behavioral factors (block I) was also 
significantly different from the null model (F(2)=11.644, p<0.001) 
and explained 18% of the variance in fatigue severity. Patients 
who adopted an all-or-nothing behavior pattern presented higher 
fatigue severity levels (p<0.05). Illness representations (block 2) led 
to a significant increase in the explained variance (27%). A higher 
belief in personal control over CFS was significantly associated 
with lower levels of fatigue severity (p<0.001). Furthermore, 
patients who considered the illness as threatening (consequences) 
presented higher fatigue severity levels (p<0.01). The final model 
explained 46% of the variance in fatigue severity (F(8)=16.287, 
p<0.001).
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The regression model for Physical QoL including fatigue severity 
and somatic complaints was significantly different from the null 
model, in both the Portuguese (F(2)=12.262, p<0.001) and the 
Dutch (F(2)22.71, p<0.001) sample, explaining respectively 23% 
and 22% of the variance in this variable. Higher fatigue severity and 
higher somatic distress were significantly associated with lower 
levels of physical functioning in Portuguese (ß=-.39, p<0.001 and 
ß=-.23, p<0.05, respectively) and Dutch patients (ß =-.17, p<0.05 
and ß =-.19, p<0.05, respectively). Similar results were found 
for Psychological QoL. The regression models including fatigue 
severity and somatic complaints were significantly different from 
the null model in both the Portuguese (F(2)=25.207, p<0.001) and 
the Dutch sample (F(2)=12.727, p<0.001), explaining respectively 
46% and 14% of the variance in psychological Qol. Higher 
fatigue severity was significantly associated with lower levels of 
psychological functioning in both samples (ß =-.49, p<0.001 and ß 
=-.29, p<0.001, respectively).  In the Portuguese sample, a higher 
level of somatic distress was also significantly associated with lower 
psychological QoL (ß =-.34, p<0.001).
Discussion
In this cross-cultural study, we found a difference in educational 
level: the Dutch patients were higher educated. This difference is 
in line with available data on educational level in these countries 
[35]. An important finding was the high rate of patients not working 
at the time of study participation. Even though we do not know 
why patients were not working, this confirms the high levels of 
functional impairment in CFS patients [2, 4]. Our results show that 
this is even much more pronounced in Dutch patients. Apart from 
cultural differences between both countries, this difference can also 
be attributed to economical factors and differences in the health 
care and social security system. Another possible explanation is the 
significantly longer duration of chronic fatigue that was observed in 
the Dutch patients. 
As expected, in both countries, levels of fatigue severity were 
very high and the majority of the patients met a clinical level 
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of CFS.  In addition, physical and psychological QoL were poor 
in both samples, confirming earlier findings showing that high 
levels of disability are associated with CFS [2, 3]. Fatigue severity 
and somatic complaints were significantly associated with lower 
physical QoL in both samples. Psychological functioning was 
significantly lower and depression and anxiety significantly 
higher in the Portuguese sample. About half of the Portuguese 
patients even met clinical levels of anxiety and depression. These 
results are in line with the cultural differences in the experience 
and expression of distress between both countries [24]. These 
important differences in psychological distress can also be 
explained by the fact that CFS is, in contrast to the Netherlands, 
not recognized as a specific disorder by primary care health 
professionals in Portugal. As a result, Portuguese patients may 
present with higher levels of frustration, anxiety, feelings of 
loneliness, helplessness and hopelessness [8]. 
The second study question regards the contribution of behavioral 
and cognitive variables to fatigue severity in both samples. 
The regression models explained 45% (Portugal) and 46% 
(Netherlands) of the variance in fatigue severity. Interestingly, 
there are important differences in the determinants that were 
significantly associated with fatigue severity. In relation to the 
behavioral determinants, higher levels of physical activity were 
significantly associated with lower levels of fatigue severity in the 
Portuguese sample, which is in accordance with previous research 
[36, 37] and strengthens the current recommendation for CFS 
patients to engage in physical activity rather than refraining from 
it [38]. Additionally, limiting behavior (reducing daily activities 
and excessive resting) was also significantly associated with fatigue 
severity in the Portuguese patients. The fact that Dutch patients 
were more physically active and that physical activity was not a 
significant determinant of fatigue severity in this sample backs 
the importance of tailored physical activity for CFS patients 
(e.g. Graded Exercise Therapy). However, finding a good balance 
between activity and rest on a daily basis is equally important [18, 
33, 38]. This assumption is reinforced by the fact that a boom-and-
bust (all or none behavior) cycle was significantly associated with 
higher fatigue severity levels in the Dutch patients, which is in line 
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with previous research [13, 16]. 
With respect to illness representations, in the Portuguese 
sample, the belief that CFS is a very serious condition (identity) 
was significantly associated with higher fatigue severity levels. 
This result confirms earlier findings that patients who believe that 
their illness is very severe, adopt more passive ways of dealing 
with their health problem (such as limiting behavior) and as a 
result of that, present higher levels of disability and psychological 
distress [2, 13, 17]. In fact, emotional response was also 
significantly associated with fatigue severity in the Portuguese 
sample. Emotional response was a significant determinant only in 
the Portuguese sample, which is in line with existing differences in 
psychological distress between the two countries [24]. For Dutch 
patients, the perception of having personal control over the illness 
was significantly associated with lower fatigue levels. On the other 
hand, thinking that CFS has severe consequences was significantly 
associated with higher fatigue severity. Overall our findings are 
in line with previous research in which positive illness beliefs are 
associated with lower fatigue severity and negative beliefs with 
higher fatigue severity [13].
While these findings are valuable, several limitations of this study 
should be discussed. A major limitation is that it was carried out in 
health care centers and patients associations. As a consequence, 
the results cannot be generalized to the whole CFS population in 
both countries. In addition, there was a difference in recruitment 
strategy. Portuguese patients were partly recruited via medical 
doctors, while all Dutch patients were recruited via e-mail by the 
patient association only. This may have led to a selection bias. 
Moreover, due to the fact that the confirmation of the diagnosis 
of CFS was based on self-reports, it cannot be excluded that 
some patients do not fulfill all the CDC criteria for CFS. Ideally, 
this diagnosis should also rule out other somatic and psychiatric 
causes of the symptoms, by means of a full clinical assessment. 
Differences between the two samples in depression, anxiety and 
psychological QoL, can thus also be attributed to differences in 
diagnosis. Another limitation is the cross-sectional design of the 
study which limits the conclusions that can be drawn about the 
causality of the relationships. A longitudinal study would provide 
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more valid data on the psychological predictors of CFS and the 
relationship between fatigue severity and disability. Moreover, 
there were differences in the sample size and only female patients 
were included in the analyses. Finally, due to the fact that there are 
no normative data for the Portuguese CIS-20R and the BSI, the 
comparisons of the respective clinical levels should be interpreted 
with care.  
Despite these limitations, this study is innovative due to fact that 
cross-cultural research on psychological aspects of CFS is very 
limited. CFS is considered to be a multi-factorial disorder, with 
biological, social and psychological factors contributing to its onset 
and perpetuation. Our findings suggest that fatigue severity and 
related impairment are very similar in CFS patients from Portugal 
and The Netherlands, which is in line with the idea that the illness 
is not restricted to one type of culture [22, 23]. Nevertheless, there 
seem to be significant differences in psychological distress between 
the Portuguese and the Dutch patients. 
This study shows that a psychological approach can contribute 
to the understanding and treatment of CFS. The fact that 
illness representations and behavioral patterns were important 
determinants of fatigue severity in both countries, suggest that 
similar interventions, such as psychological interventions that 
address patients’ beliefs about their illness as well as interventions 
that focus on behavioral regulation or modification strategies 
should be offered internationally. However, due to the differences 
found in the specific determinants, interventions should also be 
tailored to patients’ needs and focus more on emotion regulation 
and the increase of physical activity levels in Portuguese patients, 
while encouraging personal control and establishing a good balance 
between daily activities and rest can be important intervention 
targets for Dutch patients.
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Table 1   Descriptives and differences in demographics and clinical 
characteristics, fatigue severity, somatic complaints, psychological distress and 
































165.71 ± 92.22 
4.28±4.67
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*p <0 .05. **p<0.01. Values are the mean ± SD unless otherwise indicated. 
Female patients, no. (%) 
Age, years
Educational level, no. (%) 
Primary and Lower education 
Secondary education
Tertiary education
Not working, no. (%) 
Illness duration, months 
Medical visits, no.
CDC CFS Diagnosis, no. (%) 
Fatigue severity
Subjective experience of fatigue




















Table 2   Correlations (Pearson) for age, illness duration, fatigue severity, somatic complaints, QoL, psychological 
distress, behavioral and cognitive factors in the Portuguese sample 
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Table 3   Correlations (Pearson) for age, illness duration, fatigue severity, somatic complaints, QoL, 
psychological distress, behavioral and cognitive factors in the Dutch sample
*p < .01
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Table 4   Hierarchical regression analyses for fatigue severity by country
Predictors
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An updated systematic review and meta-analysis was conducted 
to (1) evaluate the effects of behavioral and psychological 
interventions containing a graded physical activity component 
upon fatigue severity, physical functioning, physical activity and 
psychological distress, and to (2) examine potential moderator 
effects of trial characteristics (type of control, setting, provider, 
length of treatment, psychological component, flexibility in 
physical activity, and minimal face to face patient-provider 
contact). Pertinent content of selected studies was extracted and 
rated on a scale of methodological quality. Sixteen randomized 
controlled trials (N= 1843) were included in the meta-analyses. 
Significant small to medium effect sizes (Hedge’s g) were found 
for all outcomes at post-treatment and follow-up (g=0.22 to 
g=0.67), with the exception of physical activity at post-treatment 
(g=0.11). The largest effects were found for fatigue severity 
(g=0.62 to g=0.67). Subgroup analyses revealed that minimal 
contact interventions had additional beneficial effects upon 
fatigue and depression. Interventions provided by psychologists-
psychotherapists and interventions conducted in secondary-
tertiary settings also resulted in more beneficial effects on fatigue. 
We found some indication of publication bias. The small number of 
studies and variability between them are limitations of this study. 
Future research should explore additional moderating effects in 
order to improve the effectiveness of interventions.
Keywords: Meta-analysis, chronic fatigue, graded physical 
activity/exercise, moderators, psychological, interventions.
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Highlights
Interventions including physical activity have beneficial effects 
on chronic fatigue.
 
The number of trials is modest and there is heterogeneity 
between them. 
 
Type of setting and provider of treatment moderate fatigue 
severity effect sizes. 
 
Minimal direct contact interventions are promising.
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Introduction
Chronic Fatigue (or Idiopathic Chronic Fatigue-ICF) is a condition 
characterized by the presence of new onset unexplained persistent 
fatigue (lasting for at least 6 months) that is not alleviated by rest, 
is debilitating and leads to significant functional impairment. 
Commonly, these patients experience additional rheumatologic 
and neuropsychiatric symptoms (Lehman, Lehman, Hemphill, 
Mandel, & Cooper, 2002; Afari & Buchwald, 2003;). When at 
least four of these symptoms are present (i.e. unrefreshing sleep, 
lengthy malaise after exertion lasting for over 24 hours, impaired 
memory or concentration, sore throat, tender cervical or axillary 
lymph nodes, muscle pain, multi-joint pain without swelling or 
redness and headaches of a new type or severity) it is diagnosed as 
Chronic Fatigue Syndrome (CFS; or Myalgic Encephalomyelitis- 
ME) according to the widely used Centres for Disease Control 
and Prevention (CDC) criteria (Fukuda et al., 1994). Another 
set of diagnostic criteria commonly used is the Oxford Criteria 
(Sharpe, 1991), which differs from the CDC criteria in that the 
Oxford Criteria requires mental fatigue to be present, but do not 
require the presence of additional somatic symptoms. A panel 
of experts has recently proposed a new international consensus 
criterion (Carruthers et al., 2011), which does not require the 
presence of fatigue for at least 6 months, but requires the presence 
of post-exertional malaise as well as the presence of at least three 
symptoms related to neurological impairments (e.g. headaches), 
three immune, gastro-intestinal and/or genito-urinary symptoms 
(e.g. nausea), and one symptom related to energy production/
transport impairments (e.g. subnormal body temperature). 
The prevalence of CFS/ME is reported to be in between 0.007% 
and 2.6% in general population samples, varying according 
to several factors such as the criteria used to diagnose CFS/
ME (Ranjith, 2005). It is more common in younger adults 
and among women (Afari & Buchwald, 2003). In terms of 
prognosis, full recovery rates are low, but it is common for 
patients to experience an improvement in symptom severity 
(Cairns & Hotpof, 2005). CFS/ME is also associated with a 
high use of health care resources and represents an important 
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socioeconomic burden (Sabes-Figuera et al., 2010).
Physical activity and Chronic Fatigue
Several studies emphasize the fact that lack of physical activity 
and prolonged physical inactivity (rest) can result in physical 
deconditioning as well as in other physiological and psychosocial 
consequences that may perpetuate fatigue and physical disability 
(Fulcher & White, 2000; Clark, Clark, & White, 2005; Nijs, 
Wallman, & Paul, 2011b). It has therefore been recommended 
that CFS/ME patients engage in physical activity/exercise 
instead of refraining from it (NICE, 2007). Physical activity that 
is too vigorous can however perpetuate fatigue symptoms (Nijs, 
Paul, & Wallman, 2008; Nijs et al., 2011b). Patients’ perceptions 
and expectations with respect to symptom exacerbation as a 
consequence of physical exertion can lead to fear of physical activity 
(Clark et al., 2005; Prins, Van der Meer, & Bleijenberg, 2006; Nijs et 
al., 2008) and explain the reduced levels of physical activity found 
in patients with chronic fatigue (Van der Werf, Prins, Vercoulen, 
van der Meer, & Bleijenberg, 2000; Nijs, et al., 2011a). Not 
surprisingly, it is common to find a “boom-and-bust pattern” (or 
“all-or-nothing” behavior) in these patients, which is the systematic 
alternation between periods of over-activity (when feeling good) 
and, as a consequence of that, feeling extremely fatigued and 
having to rest for longer periods of time. For these reasons, physical 
activity should be balanced, gradually introduced and offered with 
caution to CFS/ME patients (Clark et al., 2005; NICE, 2007; Nijs et 
al., 2011b). 
Graded Exercise Therapy (GET) has been recommended as a 
treatment for CFS/ME patients (NICE, 2007). GET is based on the 
assumption that aerobic exercise (e.g. brisk walking) or physical 
activity (e.g. housework, gardening) must be initiated at a level 
(intensity and frequency) that doesn’t exacerbate symptoms 
and must be gradually increased until patients reach an optimal 
level of activity. GET follows the exercise prescription guidelines 
from the American College of Sports Medicine, tailored to each 
patient’s initial level of physical capacity. Most GET interventions 
follow a similar protocol (Fulcher & White, 1998). GET is usually 
delivered by an exercise physiologist or physical therapist, and 
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consists of supervised aerobic exercise sessions and/or home-
based aerobic exercise prescription (e.g. walking). GET focuses 
on avoiding overexertion by advising patients not to exceed the 
recommended levels of physical activity/exercise. At the same 
time, in most GET interventions patients are encouraged not to 
reduce or stop doing physical activity/exercise when symptoms get 
worse. Recent approaches to GET have advocated that flexibility in 
graded exercise programs according to individual tolerance levels 
can be beneficial for CFS/ME patients. This implies that exercise 
can be reduced or even stopped when symptoms get worse (Nijs et 
al., 2008; Wallman, Morton, Goodman, Grove, & Guilfoyle, 2004). 
A Cochrane review (Edmonds, McGuire, & Price, 2004) and a 
recent meta-analysis (Castell, Kazantsis & Moss-Morris, 2011) 
reported beneficial effects of GET on fatigue severity and functional 
impairment in patients with chronic fatigue.  
Because of the benefits of physical activity for patients suffering 
from CFS/ME, a large number of Cognitive Behavioural Therapy 
(CBT) trials have incorporated a graded physical activity/exercise 
component. The primary focus of CBT for these patients is on 
challenging cognitions and behaviors related to the perpetuation of 
fatigue (e.g. somatic illness attributions). Patients are encouraged 
to engage in a gradual increase of physical activity and to balance 
daily activities (e.g. activity and rest). In addition, sleep hygiene 
is usually addressed and patients are supported to set goals for 
functional recovery. The positive effects of CBT upon chronic 
fatigue management have been shown in a Cochrane review (Price, 
Mitchell, Tidy, & Hunot, 2008) and in two meta-analyses (Malouff, 
Thorsteinsson, Rooke, Bhullar, & Schutte, 2008;  Castell et al., 
2011). Some CBT approaches distinguish between relative-active 
patients (characterized by an alternation of over-activity and rest) 
and low-active patients and intervene accordingly (Bleijenberg, 
Prins, & Bazelmans, 2003).
Another recent approach to CFS is multidisciplinary 
rehabilitation, consisting of a combination of treatments such as 
CBT, a gradual increase in physical activity/exercise, balancing daily 
physical activities and rest according to the patients’ symptoms, 
increasing awareness of the body and its relation to psychological 
well-being, and social/functional reintegration, tailored to patients’ 
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needs and goals (Cox, 1999; Thomas, Sadlier, & Smith, 2008; Vos-
Vromans et al., 2012). As there is a lack of evaluation studies of 
this approach, it is difficult to draw conclusions with respect to its 
effects.  
Previous meta-analyses
Two meta-analyses tried to compare the efficacy of physical 
activity interventions to psychological interventions in patients 
with chronic fatigue. The first one, conducted by Malouff and 
colleagues in 2008 reviewed the effects of CBT, including 12 trials 
(1371 patients). Overall, there was a medium effect size (d=0.48) for 
fatigue. A comparison of interventions containing only a (graded) 
activity component to interventions containing, next to activity, a 
cognitive component, did not yield  significant differential effects 
(d=0.60 and d=0.43, respectively). Other moderator analyses 
(treatment format, type of comparison group, sample type, 
diagnostic criteria used, number of hours of treatment, number of 
sessions, and number of months of follow-up) also did not result in 
significant differential effects.
The meta-analysis by Castell and colleagues (2011) compared 
the effects of GET (n=5) vs. CBT (n=16) trials upon the following 
outcomes: fatigue severity, functional impairment, and 
psychological distress (anxiety and depression). Both types of 
intervention presented similar overall post-treatment effects 
(g=0.28 and g=0.33, respectively) for CFS patients. The overall 
effect sizes for anxiety and depression were however higher 
within the CBT subset. In addition, the authors also examined 
potential moderator effects of study characteristics that were 
previously analysed in the Malouff et al. (2008) meta-analysis 
(type of comparison group, treatment format, number of hours 
of treatment, and diagnostic criteria used) as well as treatment 
setting, and treatment duration. Number of treatment hours was a 
significant predictor of treatment effects, but accounted only for a 
small proportion of the variance of the effects (Castell et al., 2011). 
Both meta-analyses (Malouff et al., 2008; Castell et al., 2011) 
have however limitations worth mentioning. First, in the Malouff 
et al (2008) study the authors aimed to evaluate the effects of CBT 
interventions, but also considered trials with an emphasis on GET 
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as a type of CBT as they included them in the overall effect. Second, 
in the comparison between “activity treatments” and “activity plus 
cognitive treatments”, the authors included studies in the “activity 
treatments” category that had a cognitive component (e.g. Powell, 
Bentall, Nye, & Edwards, 2001). In the meta-analysis conducted 
by Castell and colleagues (2011), this same trial was included in 
the group of CBT trials. Third, in the Castell et al. meta-analysis 
(2011), potential moderators were analyzed only for the group of 
CBT trials, due to a low heterogeneity found in the GET group. 
In addition, several of the CBT trials included graded exercise 
components, limiting the conclusions that can be drawn from a 
comparison between CBT and GET interventions. Finally, Malouff 
and colleagues (2008) did not distinguish between post-treatment 
and follow-up results and only post-treatment effects were 
presented in the Castell et al study (2011).
Focus of the systematic review and meta-analysis
In this study, we intend to address some of these limitations and 
extend the scope of the meta-analysis in the following ways. First, 
no meta-analysis has yet assessed the effects of behavioural and 
psychological interventions on physical activity among CFS/
ME patients, which is a key behaviour targeted in interventions 
for chronic fatigue management. Second, there are a number of 
recently published trials assessing the effects of GET, CBT with a 
graded exercise component, and rehabilitation approaches that 
were not included in the previous reviews and meta-analyses. 
Third, several interventions targeting CFS/ME patients present 
specific treatment characteristics that have not yet been taken into 
account as moderators: (1) flexibility in physical activity/exercise 
levels and goals, in accordance with patients’ exercise tolerance 
(Nijs et al., 2011b); and (2) minimal contact interventions as 
compared to more intensive interventions. 
Based on recent systematic reviews on minimal contact and self-
help treatments (Cuijpers, Donker, van Straten, Li & Anderson, 
2010; Haug, Nordgreen, Ost, & Havik, 2012; Ahl, Mikocka-Walus 
, Gordon &Andrews, 2013; Pajak, Lackner, & Kamboj, 2013), we 
considered minimal-contact interventions as self-management 
interventions that consisted of a maximum of three initial face-to-
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face sessions followed by remote additional guidance and feedback 
during the treatment period (e.g. by email, telephone). Usually 
these interventions also provide patient manuals with information 
and assignments related to disease management. Most CBT and 
GET interventions are typically resource-intensive, as they usually 
require considerable direct provider-patient contact. Recent 
reviews have revealed that minimal contact interventions are 
promising for the treatment of various psychological (e.g. Haug et 
al, 2012) and physical symptoms (e.g. Pajak et al., 2013). In addition, 
recent controlled trials of minimal contact interventions in CFS/
ME showed promising results (e.g. Tummers, Knoop, van Dam, & 
Bleijenberg, 2012).
The aims of the current systematic review and meta-analysis 
are thus: 
 1- To determine the overall effect of behavioral interventions with 
a graded physical activity/exercise component on fatigue severity, 
physical functioning/functional impairment, physical activity 
and physical capacity, as well as psychological distress (anxiety 
and depression); both at post-treatment and at follow-up, among 
patients with ICF and CFS/ME.
2- To examine whether the effects on these outcomes are 
moderated by the type of care provided to the control condition, 
the treatment setting, the treatment provider, and the length of 
treatment.
3- To examine if treatment effects are influenced by the presence 
of a psychological component in the treatment, by flexibility in 
physical activity levels or goals, and by the amount of contact 
between provider and patient (intensive versus minimal contact). 
Methods
 
This systematic review and meta-analysis is reported in accordance 
with the Preferred Reporting Items for Systematic Review and 
Meta-Analysis (Liberati et al., 2009) statement and APA’s Meta-




Studies were included if they were conducted in adult patients 
presenting (Idiopathic) Chronic Fatigue or Chronic Fatigue 
Syndrome/Myalgic Encephalomyelitis (CFS/ME). 
Types of interventions
Studies had to include an arm of a behavioral and/or psychological 
intervention with a graded physical activity/exercise component, 
targeting chronic fatigue management.
Types of comparisons
Studies had to include a control condition, consisting of usual 
care, waiting list control, or another type of intervention (e.g. 
relaxation). 
Types of outcomes
Studies had to present statistical data allowing the calculation 
of effect sizes, on at least one of the following outcomes - fatigue 
severity, functional impairment/physical functioning, physical 
activity and/or physical capacity, and psychological distress 
(depression and/or anxiety), measured at baseline (pre-treatment), 
at post-treatment and/or at follow-up.  
Types of studies
Studies were included if they were randomized controlled trials 
(RCTs) published in peer review journals in English.
There were no restrictions with respect to the type of 
diagnostic criteria used, setting, format and source of delivery 
of the intervention, as well as with respect to the length of the 
intervention and follow-up measurement point(s).
Search strategy and study selection
Initially, electronic databases (MEDLINE, Cochrane Database 
of Clinical Trials, PsychINFO and Web of Science) were searched 
for relevant articles published between 1988 and 2013 to coincide 
with the first diagnosis criteria for CFS (Holmes et al., 1988). A 
comprehensive search strategy was used, with the combination of 
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the following keywords: chronic fatigue or unexplained chronic 
fatigue or idiopathic chronic fatigue or chronic fatigue syndrome 
or CFS or myalgic encephalomyelitis or ME, psychological or 
cognitive or behavior(u)r or CBT or graded exercise therapy or 
exercise or physical activity or aerobic or rehabilitation, and 
treatment or intervention or trial or RCT (complete search 
strategies can be obtained from the authors).  Next, content 
pages of key journals were browsed (e.g. Journal of Psychosomatic 
Research). Finally, reference lists from previous review articles 
and included studies were hand searched to find additional studies 
(Appendix A). 
One author (MM) and an independent researcher (AC) read the 
titles and abstracts retrieved. If the studies appeared to meet the 
inclusion criteria, full texts were obtained and reviewed by the first 
author (MM). A second author (SM) checked and approved the final 
selection of studies. 
Coding of study characteristics
Two researchers (MM and MJG) independently coded 
characteristics from selected studies using a pre-specified form 
developed by the authors (Complete coding form is available 
from the authors). The following information was extracted 
from each selected study: 1) bibliographic information (authors, 
year of publication, country and reference); 2) type of diagnostic 
criteria (CDC, Oxford, other); 3) sample characteristics (sample 
size, gender, age); 4) setting (primary care, secondary-tertiary, 
university setting); 5) provider (psychologist/psychotherapist, 
exercise physiologist, physical therapist, nurse, occupational 
therapist, other); 6) type of care provided to the intervention group 
(graded physical activity/exercise therapy, cognitive-behavioral 
treatment, rehabilitation treatment, other behavioral and 
psychological approaches); 7) type of care provided to the control 
group (passive control – waiting list control, treatment as usual, 
other; active control– relaxation/flexibility, counseling, other); 8) 
format of delivery (individual or group; face-to-face, telephone, 
email); 9) length of intervention and number of patient-provider 
sessions, 10) drop-out rate, 11) outcomes assessed (fatigue severity, 
physical functioning/impairment, physical activity, physical 
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capacity, depression, anxiety, other) ; 12) measures used to assess 
outcomes (type and name of measure); and 13) assessment periods 
(baseline, post-treatment and follow-up).
In addition, the following characteristics were coded: 1) presence 
vs. absence of a psychological component within the intervention 
(e.g. cognitive behavioral therapy); 2) presence vs. absence of 
flexibility in setting physical activity/exercise levels or goals; 
3) whether the intervention was a minimal or a more intensive 
intervention in terms of direct (face to face) contact hours. These 
characteristics were coded as 1 (yes) and 0 (no). (Complete coding 
form can be obtained from the authors). 
The average inter-rater agreement was very good (Cohen’s 
kappa= 0.84). Disagreements in coding were resolved by consensus 
between the two coders (MM and MJG). A third researcher (SM, 
VDG) resolved any remaining disagreements.
Quality and risk of bias assessment
The methodological quality of the included trials was assessed 
using a 29-item modified version of the Cochrane Collaboration 
Depression, Anxiety and Neurosis Review Group (CCDAN) 
quality rating scale (Lackner, Mesmer, Morley, Dowzer, & 
Hamilton, 2004; Moncrieff, Churchill, Drummond, & McGuire, 
2001), validated by Lackner and colleagues (Lackner et al., 
2004). The scale assesses characteristics of both internal and 
external validity of trials. Each item is scored 0 (not done and/
or not reported), 1 (done and/or reported to some extent) or 
2 (adequately done and/or adequately reported), with the 
exception of items 23 (Interests declared) and 29 (Consecutive 
subjects), which are scored 0 or 2. Total scores range from 0 
to 58; higher scores indicate higher methodological quality. 
Risk of bias (high/low/uncertain) was classified based on the 
following items from this scale: Selection bias - concealment of 
allocation (item 6); Detection bias - blinding of assessors (item 
13); Attrition bias (incomplete outcome data) - Information 
on attrition (item 16) and inclusion of drop-outs in analyses 
(item 19), following the guidelines contained in the Cochrane 
collaboration’s tool for assessing risk of bias (Higgins et al., 
2011).
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Discrepancies in quality rating were resolved by consensus 
between the two coders (MM and MJG). Inter-rater agreement 
was satisfactory (Cohen’s kappa= 0.68).
Data extraction
Effect sizes (ES) were the standardized mean difference [(mean 
a-mean b/ pooled change SD)] with Hedge’s g correction for small 
samples (Hedges, 1981). To calculate effect sizes for selected 
outcomes, we extracted sample sizes and baseline, post-treatment 
and/or follow-up means and standard deviations (SD) for the 
intervention and control groups. Authors of included studies were 
contacted when necessary to retrieve missing data in published 
reports. If this information remained unavailable, the following 
alternative information was extracted to calculate the effect sizes: 
1) post-treatment and/or follow-up means, SD and sample size 
for each group; 2) Mean difference, 95% confidence interval and 
samples size for independent group comparisons 3) sample size and 
p value for independent group comparison, and 4) raw difference 
in means and confidence limits for independent groups. When 
reported in the original trials, we used data from intention-to-
treat analyses. If there was more than one follow-up assessment 
point available, the longest period available without crossovers was 
chosen. This was the case for four trials (Deale, Chalder, Marks, & 
Wessely, 1997; Fulcher & White, 1997; Powell et al., 2001, Sharpe et 
al. 1996). In one study the pooled (post-treatment and follow-up) 
mean and SD was used for the effects of the intervention on physical 
activity at follow-up, as this was the only statistical information 
available (O’Dowd, Gladwell, Rogers, Hollinghurst, & Gregory, 
2006). When several measures were reported for the same outcome 
(e.g. physical functioning/ impairment), we chose the measure 
most commonly used across the studies included.
In the case of studies presenting more than one intervention 
group meeting eligibility criteria, the following choices were made 
regarding the selection of the intervention group for inclusion 
in the meta-analysis: 1) for the trial conducted by White and 
colleagues (2011) the Graded Exercise Therapy intervention arm 
was selected, since the other intervention arms (Adaptive Pacing 
and Cognitive-behavioral Therapy) were not exercise oriented 
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interventions; 2) in the case of the trial conducted by Jason et al. 
(2007) the Cognitive-Behavioral Therapy intervention arm with 
a graded aerobic physical activity component was selected; 3) for 
the study conducted by Powell and colleagues (2001), for which 
there were three intervention arms differing in treatment-dose 
(Minimum intervention, Telephone intervention and Maximum 
intervention),  the Minimum Intervention arm was chosen as there 
were no significant differences in the effect sizes between the three 
intervention arms. Regarding control comparisons, in the case 
of the trial conducted by Jason and colleagues (2007), the Active 
Relaxation condition was chosen as the control comparison due to 
its similarities with other control conditions included in this meta-
analysis. 
Data Analyses
Analyses were conducted using the Comprehensive Meta-Analysis 
Software version 2.2 (Borenstein, Hedges, Higgins, & Rothstein, 
2005). We conducted separate meta-analyses for each outcome 
(fatigue severity, functional impairment/physical functioning, 
physical activity and physical capacity, depression and anxiety) and 
for each measurement point (post-treatment and follow-up). 
Meta-analyses were conducted using the recommended random-
effects model, in which the summary effect is an estimate of the 
mean of a distribution of effect sizes (Borenstein, Hedges, Higgins, 
& Rothstein, 2009); the only exceptions were the analyses for the 
effects of the interventions upon physical activity and physical 
capacity at post-treatment and follow-up, in which the fixed-effect 
model was used, due to the limited number of studies (<5 studies) 
available for the analysis (Borenstein et al., 2009). Effect sizes (ES) 
were the standardized mean difference with Hedge’s g correction 
(Hedges, 1981), interpreted according to Cohen’s (Cohen, 1992) 
guidelines (values of 0.20, 0.50 and 0.80 correspond to small, 
medium and large effect sizes). Z-values and corresponding 
p-values were considered as indicator of the significance of the 
effect. We also inspected the standard residuals (i.e. how much each 
study differs from the overall effect) for outliers (>1.96). 
Meta-analyses were inspected for heterogeneity using: 1) 
Cochran’s Q statistic (Cochran, 1954), for which a significant 
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p-value (<.05) demonstrates that studies don’t share a common 
effect size (i.e. there is heterogeneity in the effect sizes between 
studies); and 2) I2 statistic (Julian, Simon, Jonathan, & Douglas, 
2003) that assesses the proportion of observed dispersion that is 
real (i.e. that is due to real differences in the true effect sizes). The I2 
ranges from 0 to 100%, with values of 25%, 50% and 75% reflecting 
low, moderate and high heterogeneity (Julian et al., 2003). 
Whenever heterogeneity of effect sizes was observed (Q p<.05 or 
I2 ≥50%), subgroup analyses were conducted to examine whether 
effect sizes varied according to the following potential moderators: 
type of control group (coded as passive or active); setting (coded 
as primary care, secondary-tertiary care, university setting); 
provider of the treatment (coded as psychologist, psychiatrist or 
psychotherapist, exercise physiologist or physical therapist, and 
nurse); psychological intervention component (coded as yes or 
no); flexibility in physical activity program (coded as yes or no); 
and minimal contact (coded as yes or no). Subgroup analyses 
were conducted using mixed-effect models (i.e. random-effects 
model is conducted within subgroups and a fixed-effect model was 
used across subgroups; Borenstein et al., 2009). Between-groups 
Q statistic and corresponding p-values was used to compare the 
mean effect across subgroups, when there were at least three 
studies in each subgroup. Due to statistical power effects on the 
significance of p-values, we also considered within-groups estimate 
points (Hedge’s g), confidence intervals (CI), and the I2 statistic 
(Borenstein et al., 2009). Further, meta-regression analyses using 
random-effect models were conducted to analyze the moderation 
effect of the continuous variable length of treatment (in weeks) 
on treatment effect. Meta-regressions were analyzed based on the 
Z-value and associated p-value of the slope and were only conducted 
for the outcomes presenting at least ten studies (Borenstein et al., 
2009).
For both types of moderator analyses (subgroups and meta-
regression), adjusted R2 was used to examine how much of the 
true variance was explained by the moderators. Adjusted R2 was 
calculated based on the two estimates for T2 (variance of the true 
effects) using the formula:                                                (Borenstein et al., 
2009). 
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Due to the limited number of studies, especially at the follow-up 
measurement, these analyses were conducted for the longest 
period of assessment available (post-treatment or follow-up). 
Sensitivity analyses 
Sensitivity analyses were carried out to explore whether treatment 
effects were affected by methodological quality and risk of bias. 
The effect of total methodological quality on the magnitude of 
the effect size was analyzed by means of meta-regression (using 
the aforementioned approach). Publication bias was examined 
using the following approaches: 1) visual inspection of funnel plot 
for asymmetry; 2) Egger’s test (Sterne & Egger, 2001) to confirm 
the visual impression; and 3) Duval and Tweedie’s ‘trim and fill’ 
method (Duval & Tweedie, 2000), which allows the estimation of 
an adjusted effect size taking into account possible missing studies.  
To confirm the validity of the results obtained, primary analyses 
were repeated excluding 1) studies presenting a high/uncertain risk 
of bias across categories, 2) studies presenting less strict diagnostic 
criteria (e.g. persistent fatigue for less than 6 months), and 3) 
studies in which the intervention and comparison conditions 
included additional pharmacological treatment for CFS.
Results
Description of included studies 
A total of 214 potentially relevant articles (after removing 
duplicates) were identified in the literature search and additional 
hand searches. After the screening of titles and abstracts 168 
studies were excluded. The remaining 46 eligible studies were 
reviewed, which resulted in the inclusion of 26 studies reporting 
on 16 trials in the present meta-analysis (see Figure 1; references 
of excluded studies and reasons for exclusion are presented in 
Appendix B). Tables 1 and 2 show the characteristics of the trials 
included in the meta-analysis. 
Study characteristics
Most studies were conducted in the United Kingdom (n=9) and 
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the Netherlands (n=3), in secondary-tertiary care settings (e.g. 
specialized CFS clinics) (n=11) or in primary care (n=3).
 
Participant characteristics
In total, 1843 participants were included in the meta-analysis, with 
a mean age of 39 years; approximately 75% were women. Most trials 
included CFS patients diagnosed according to the Oxford or/and 
the CDC criteria. The exceptions were (1) the study conducted by 
Ridsdale and colleagues (2012) targeting patients with a complaint 
of persistent unexplained fatigue of at least 3 months, and (2) 
the trial conducted by Prins, Van der Meer & Bleijenberg (2001), 
which included patients with ICF. In seven studies, severity of the 
disease, established on the basis of cut-off scores for fatigue severity 
and functional impairment/physical functioning scales, was an 
additional criterion for patient inclusion in the trial. Drop-out 
percentages in intervention conditions ranged from 0% (Wallman 
et al, 2004) to 35% in the trial conducted by Prins and colleagues 
(2001), which was one of the trials that lasted for a longer period 
of time (8 months) and consisted of a high number of sessions (16 
sessions).
Outcome measures
Ten RCTs (Deale et al., 1997; Fulcher & White, 1997; Wearden et 
al., 1998; Powell et al., 2001; Wallman et al., 2004; Moss-Morris, 
Sharon, Tobin, & Baldi, 2005; O’Dowd et al., 2006; Wearden et 
al., 2010; White et al., 2011; Ridsdale, Hurley, King, McCrone, & 
Donaldson, 2012) assessed fatigue severity using the Chalder 
Fatigue Scale (Chalder et al., 1993). In three other trials (Prins et 
al., 2001; Knoop, Van der Meer, & Bleijenberg, 2008; Tummers 
et al., 2012) fatigue severity was assessed with the Checklist of 
Individual Strength (Vercoulen, Alberets, & Bleijenberg, 1999). One 
study (Jason et al., 2007) used the Fatigue Severity Scale (Krupp, 
LaRocca, Muir-Nash, & Steinberg, 1989) and another trial (Sharpe 
et al., 1996) used a single-item to assess fatigue.
Of the thirteen studies assessing functional impairment/physical 
functioning, eleven studies (Deale et al., 1997; Fulcher & White, 
1997; Powell et al., 2001; Moss-Morris et al., 2005; O’Dowd et al., 
2006; Jason et al., 2007; Knoop et al., 2008; Wearden et al., 2010; 
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Núñez et al., 2011; White et al., 2011; Tummers et al., 2012) used the 
Short Form Health Survey-36 (Ware & Sherbourne, 1992), one trial 
(Ridsdale et al., 2012) used the Work and Social Adjustment Scale  
(Mundt, Marks, Shear, & Greist, 2002) and another study (Prins 
et al., 2001) used the Sickness Impact Profile (Bergner, Bobbitt, 
Carter, & Gilson, 1981). Physical activity was assessed in seven 
trials, by means of actigraphy (Prins et al., 2001 and Knoop et al, 
2008, reported in Wiborg, Knoop, Stulemeijer, Prins, & Bleijenberg, 
2010), the six-minute walking test (Sharpe et al., 1996; Jason et 
al., 2007; White et al., 2011), the incremental shuttle walking test 
(O’Dowd et al., 2006), and a timed step test (Wearden & Emsley, 
2013). Physical capacity was assessed in four trials (Fulcher 
& White, 1997; Moss-Morris et al., 2005; Wearden et al., 1998; 
Wallman et al., 2004;) by means of laboratory physical capacity 
measures (e.g. oxygen consumption). 
Eleven studies assessed psychological distress (depression and/or 
anxiety). Nine of these (Fulcher & White, 1997; Wearden et al., 1998; 
Powell et al., 2001; Sharpe, 1996; Wallman et al., 2004; O’Dowd et 
al., 2006; Wearden et al., 2010; White et al., 2011; Ridsdale et al., 
2012) used the Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983), two RCTs (Deale et al., 1997; Jason et al., 2007) used 
the Beck Depression Inventory  (Beck, Steer, & Brown, 1996), and 
the Beck Anxiety Inventory (Hewitt & Norton, 1993) was used in 
one trial (Jason et al., 2007).
Intervention characteristics
In six trials the intervention group received Graded Exercise 
Therapy (GET), which consisted of exercise prescription (aerobic 
activities) adapted to the patient’s physical capacity assessed 
at baseline (e.g. 40% of V02 max) taking into account a gradual 
increase in the duration and intensity of aerobic activities (e.g. 
walking). Patients were recommended not to exceed the levels 
of exercise agreed upon beforehand by the therapist and patient 
in order to avoid overexertion, and to maintain these levels if 
symptoms got worse. The exception was the graded exercise 
program conducted by Wallman and colleagues (2004) in which 
patients were advised to reduce their activity levels if symptoms 
got worse (i.e. flexibility in physical activity levels-pacing). GET 
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interventions consisted of supervised aerobic exercise sessions 
and/or home-based exercise prescription. The number of sessions 
ranged from 8 to 14 sessions, lasting for 12 to 24 weeks, with the 
exception of one trial which had only 1 face-to-face session and 6 
telephone contacts (Wallman et al., 2004). One GET trial presented 
a booster session after the end of the intervention (White et al, 
2011). GET interventions were conducted by exercise physiologists 
and/or physical therapists, except in one trial (Moss-Morris et al., 
2005) where the intervention was delivered by psychologists. In 
one of the trials both intervention and control groups included a 
placebo drug component (Wearden et al., 1998). 
Two trials (Powell et al., 2001; Wearden et al., 2010) consisted 
of Pragmatic Rehabilitation, an educational treatment providing 
patients with an explanatory model for their symptoms (i.e. a 
model integrating physical deconditioning, circadian dysrhythmia 
and disturbed sleep patterns). The program, collaboratively 
established by therapist and patient, included a home-based graded 
exercise program, normalization of sleep patterns, and practicing 
rest and relaxation. The treatment also included an educational 
support manual. The trial conducted by Powell and colleagues 
(2001) was delivered by psychologists and provided minimal 
contact to patients, consisting of 2 face-to-face sessions and 2 brief 
telephone contacts (plus access to a telephone helpline), lasting for 
12 weeks. The trial conducted by Wearden and colleagues (2010) 
was delivered by nurses, had 5 face-to-face home visits and five 
additional telephone contacts, lasting for 18 weeks. 
In seven other trials, the intervention condition consisted of 
Cognitive-Behavioral Therapy (CBT) with a graded physical 
activity/exercise component. In general, these interventions 
challenge cognitions and behaviors related to the perpetuation 
of fatigue and aim at increasing patients’ sense of control over 
symptoms. Patients are encouraged to engage in a gradual 
increase of exercise levels, sleep hygiene is addressed and patients 
are supported to set personal recovery goals (e.g. work). Two 
of these RCTs (Knoop et al., 2008; Tummers et al., 2012) were 
minimal contact CBT interventions, consisting of patient (self-
help) CBT-based manuals (with assignments) and regular email 
or telephone contacts to provide feedback. In addition, these 
97
two CBT interventions distinguished between relatively active 
(characterized by an alternation of over-activity and rest) and low 
active patients. The first group of patients was initially encouraged 
to balance their daily activities and rest, and both patient groups 
were supported to gradually increase their physical activity levels 
(Bleijenberg, Prins, & Bazelmans, 2003). With the exception of 
these two trials, the number of face-to-face CBT sessions ranged 
from 8 to 16 sessions, with a duration of 16 to 32 weeks. Four 
interventions were conducted by psychologists/psychotherapists 
(Sharpe, 1996; Deale et al., 1997; Prins et al., 2001; Knoop et al., 
2008). Two interventions were conducted by nurses (Wearden et 
al., 2010; Tummers et al., 2012). Another trial was delivered by 
a team consisting of psychologists/ psychotherapists, physical 
therapists and occupational therapists (O’Dowd et al., 2006). 
Only one intervention was delivered in a group format (O’Dowd 
et al., 2006).
Finally, one study (Núñez et al., 2011) consisted of a 
multidisciplinary treatment (called multiconvergent thrapy), 
combining CBT and GET group sessions and pharmacological 
treatment (painkillers and non-steroidal anti-inflammatory drugs). 
The CBT component of this trial also included progressive muscle 
relaxation, assertiveness training, and memory and attention 
training. The GET component included aerobic exercise (walking) 
carried out according to the protocols and also included relaxation 
and flexibility training. 
Control condition characteristics
The type of control conditions differed across trials. Ten RCTs 
compared the intervention arms against passive control groups, 
such as waiting list (Knoop et al., 2008; Tummers et al., 2012), or 
treatment as usual (Moss-Morris et al., 2005; O’Dowd et al., 2006; 
Powell et al., 2001; Prins et al., 2001; Ridsdale et al., 2012; Sharpe et 
al, 1996; Wearden et al., 2010; White et al., 2011). 
The remaining six trials had active control groups, presenting a 
structure/format similar to the intervention arms. In two of these 
trials, control groups received flexibility and relaxation training, 
conducted either at home (Wallman et al., 2004) or in the same 
setting and with the same provider as the intervention arm (Fulcher 
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& White, 1997). In both trials, control subjects were encouraged to 
avoid doing other physical activities. In two other RCTs patients 
in the control group received  relaxation training (Deale et al., 
1997; Jason et al., 2007), which consisted of progressive muscle 
relaxation, imagery and rapid relaxation skills (e.g. breathing 
focus). No advice was given on rest or physical activities. In the trial 
conducted by Wearden and colleagues (1998) participants in the 
control group received an exercise placebo (advice to do physical 
activity when capable and to rest when needed) and a drug placebo 
(similar to the intervention arm). In another trial patients received 
advice (called exercise counseling) on doing aerobic activities and 
stretching exercises at home (Núñez et al., 2011). 
Quality of the studies and risk of bias 
Table 2 shows the quality of the trials and risk of bias (for the 
detailed classification of each item see Appendix C). The quality 
of the trials varied, with scores ranging from 29 to 51. The trial 
conducted by Núñez (2011) showed the lowest quality score, and 
presented a high or uncertain risk of bias on all criteria. In relation 
to attrition bias, most studies presented adequate drop-out 
information and inclusion. Thirteen trials reported an adequate 
method of concealment and ten studies did not report details on 
blinding of assessors.
Synthesis of results
Table 3 shows the overall results of the meta-analysis for all 
outcomes at post-treatment and follow-up (the forest plots are 
presented in Appendix D). Table 4 presents the results of the 
subgroup analysis for all outcomes for the longest period of 
assessment available.
Effects on Fatigue severity
Fatigue severity data was available for 14 trials at post-treatment 
(varying from 3 to 8 months after baseline) and for 9 trials at 
follow-up (varying from 12 to 17 months after baseline). Significant 
medium effect sizes were found for fatigue severity at post-
treatment (g=0.62; 95% CI 0.45-0.79) and follow-up (g=0.67; 95% 
CI 0.37-0.96). At both assessment points, the effects varied widely 
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from study to study. The trial conducted by Powell et al. (2001) 
showed the largest effect sizes (g=1.79 and g=2.08, respectively). 
The standard residuals showed these values were outliers (3.22 and 
3.03, respectively). The results of the overall effect sizes if this study 
was removed would vary within 0.09 and 0.18 from the initial point 
estimate, respectively, which means this study had a large impact 
on the overall effect at both time points. The smallest effects were 
found in the trial conducted by Deale and colleagues (1997) at post-
treatment (g=0.28) and the trial by Ridsdale (2012) at follow-up 
(g=0.10). 
There was evidence of moderate to high heterogeneity between 
trials at both assessment points (Q= 34.84, p<0.001; I2=63%, and Q= 
43.52, p<0.001; I2=82%, respectively), indicating that the variance 
could not be explained by sampling error alone (Table 3). For 
this reason, we examined the potential moderators of variance 
in effect sizes for the combined post-treatment and follow-up 
data (k=15, g=0.66, Z=6.814, p<0.001; 95% CI 0.47-0.85; Q= 48.43, 
p<0.001; I2=71%; Table 4). Interventions conducted in secondary-
tertiary settings, interventions delivered by psychologists or 
psychotherapists, and interventions providing minimal contact 
(versus more intensive contact), showed higher effects upon fatigue 
severity (p=0.01, p<0.05, p<0.05, respectively) and explained 38%, 
33% and 20% of the variance in fatigue severity, respectively. 
In addition, the overall effect sizes for interventions containing 
a psychological component and allowing flexibility in physical 
activity levels/goals were larger, but also presented high levels of 
heterogeneity (Table 4). 
Effects on Functional impairment/physical functioning
Eleven trials at post-treatment (3-8 months) and eight trials 
at follow-up (12-17 months) presented data for the effects of 
interventions on functional impairment/physical functioning 
(Table 3). Combined effect sizes were g=0.30 (95% CI 0.14-0.46) at 
post-treatment and g=0.39 (95% CI 0.13-0.66) at follow-up. At both 
assessment points, the effects varied widely from study to study. 
The trial conducted by Deale et al. (1997) showed the largest effect 
sizes at both assessment points (g= 0.92 and g=1.35, respectively). 
At follow-up, the standard residual of this trial revealed it was 
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an outlier (2.32). If removed the overall effect size would drop 
to g=0.29. The trial conducted by O’Dowd et al. (2006) showed 
negative effects (g= -0.20) at post-treatment and the trial conducted 
by Núñez and colleagues (2011) showed a negative effect (g= -0.10) 
at follow-up. 
The results for functional impairment/physical functioning 
showed evidence of moderate to high heterogeneity between 
trials (Q= 22.67, p<0.05; I2=56% and Q= 30.45, p<0.001; I2=77%, 
respectively). Subsequent subgroup and meta-regression analyses 
were conducted for the longest period of assessment available 
(k=13, g=0.36, Z=4.28, p<0.001; 95% CI 0.19-0.52; Q= 30.04, p<0.05; 
I2=60%). There were no significant associations between study 
characteristics and the effect sizes of the interventions (Table 4), 
indicating that none of the variance in the treatments effects on 
functional impairment/physical functioning was explained by the 
moderators analyzed (adjusted R2=0%). 
Effects on Physical activity and Physical capacity 
The overall effect size for physical activity at post-treatment 
was not significant (k=4, 5-8 months; g=0.11; 95% CI -0.07-0.28). 
The trial by Sharpe et al. (1996) showed the largest and the only 
significant effect size (g=0.63) on physical activity, with a standard 
residual of 2.13. If removed, overall effect size would drop to g=0.04. 
At follow-up, we found a significant small effect size (k=5, 12-17 
months; g=0.41; 95% CI 0.25-0.57; Table 3). At follow-up, the trial 
of Sharpe et al. (1996) showed the largest effect size (g= 0.73) and 
the trial by Wearden et al (2010) the lowest effect (g=0.11). There 
was considerable heterogeneity between trials at post-treatment 
(Q=4.64, p=0.20; I2=35%) and no evidence of heterogeneity at 
follow-up (Q=4.52, p=0.34; I2=11%). The overall effect size for 
physical capacity at post-treatment was small but significant (k=4, 
3-6 months; g=0.27; 95% CI 0.00-0.54). There was evidence of 
heterogeneity between trials (Q= 10.90, p<0.01; I2=73%). The trial 
conducted by Moss-Morris et al. (2005) showed a negative effect 
(g= -0.97), that is considered an outlier effect (standard residual: 
-3.27). If this trial was removed, the overall effect would increase 
to g=0.43.
In order to conduct moderator analyses, data for both physical 
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activity and physical capacity at the longest available period of 
assessment were combined. Combining physical activity and 
physical capacity assessments resulted in a small but significant 
effect size with moderate heterogeneity between trials (k=11, 
g=0.27, Z=2.64, p<0.01; 95% CI 0.07-0.48; Q= 27.19, p<0.01; I2=63%).  
Due to the limited number of trials, subgroup comparisons were 
conducted only for the following characteristics: 1) type of control 
group, 2) presence of a psychological component and 3) flexibility 
in physical activity/exercise program. There were no significant 
associations between these characteristics and the effect size of the 
interventions upon physical activity/physical capacity, indicating 
that none of the variance in this combined outcome variable was 
explained by these characteristics (adjusted R2=0%). 
Effects on Depression
Data was available for ten trials at post-treatment (3-6 months) 
and seven trials at follow-up (12-17 months). Overall, interventions 
yielded significant effect sizes on depression levels at post-
treatment (g=0.41; 95% CI 0.22-0.59) and follow-up (g=0.36; 95% 
CI 0.14-0.58). At both assessment points, the trial conducted by 
Powell et al. (2001) showed the largest effect sizes (g=0.93 and 
g=1.12, respectively). At follow-up, the standard residual of this trial 
was 2.41. The overall effect, if this study was removed, decreased to 
g=0.25. At post-treatment the smallest effect sizes were found in 
the trial conducted by Fulcher and colleagues (1997) (g=0.03), in 
which patients were excluded at baseline if presenting a psychiatric 
disorder. If removed the overall effect would increase to g=0.44. At 
follow-up, the smallest effect was found for the trial conducted by 
Jason et al (2007) (g=0.08). 
For depression there was evidence of considerable heterogeneity 
between studies (Q=16.56, p=0.06; I2=46%, and Q=13.17, p=0.04; 
I2=54%, respectively) (Table 3). Subsequent subgroup analyses 
and meta-regression analyses were conducted for the longest 
available period of assessment (k=12, g=0.35, Z=3.84, p<0.001; 95% 
CI 0.17- 0.54; Q= 27.19, p<0.001; I2=68%). There were no significant 
moderator effects for type of control condition, type of setting 
and presence of a psychological component. Interventions with 
minimal direct patient-provider contact had significantly higher 
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effects upon depression (p=<0.001), explaining 52% of the variance 
in depression. In addition, meta-regression showed a marginal 
association between depression and length of the intervention 
(slope: -0.03, Z=-1.67, p=0.10). Furthermore, there was a marginal 
moderator effect for flexibility in physical activity levels (p<0.10; 
adjusted R2=9%). 
Effects on Anxiety
Small but significant effects were found for anxiety at post-
treatment (k=7, 3-6 months; g=0.28; 95% CI 0.13-0.43) and follow-
up (k=6, 12-17 months; g=0.22; 95% CI 0.08-0.37) (see Table 3). 
At post-treatment, the trial conducted by Wallman et al. (2004) 
showed the largest effect size (g=0.57) and the trial by Wearden and 
colleagues (1998) showed the smallest (g=0.12). At follow-up, the 
trial conducted by Powell and colleagues (2001) showed the largest 
effect size (g=0.52) and the smallest effect was found in the trial 
conducted by Sharpe et al (1996) (g=0.07).  There was no evidence 
of heterogeneity between the trials on both assessment points (Q= 
2.70, p=0.85; I2=0% and Q= 2.29, p=0.81; I2=0%, respectively). For 
that reason, no further moderator analyses were conducted.
Sensitivity analyses
Meta-regressions with respect to methodological quality did not 
reveal any significant slope for any of the outcomes assessed (Table 
4). Visual inspection of the funnel plots revealed asymmetry for 
fatigue severity. Egger’s test did not show a significant asymmetric 
funnel plot at post-treatment (intercept: 2.54, 95% CI -0.41-5.48, 
p=0.09). After adjustment with the trim-and-fill procedure the 
magnitude of the effect sizes decreased from g=0.62 to g=0.47 at 
post-treatment (95% CI 0.28-0.66; number of trimmed studies=4).  
At follow-up, inspection of the funnel plot for fatigue severity 
showed the presence of asymmetry, although Egger’s test did not 
indicate a significant asymmetric plot (intercept: 3.81, 95% CI 
-1.56-9.15, p=0.17). After adjustment the point estimate dropped 
from g=0.67 to g=0.46 (95% CI -0.12-0.80; number of trimmed 
studies= 2). Furthermore, inspection of the funnel plot of the 
effects for physical impairment/functioning at post-treatment 
revealed the presence of asymmetry. Egger’s test showed a marginal 
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significant asymmetric funnel plot (intercept: 1.01, 95% CI -2.80-
4.84, p=0.56). After adjustment with the trim-and-fill procedures, 
the magnitude of the effect dropped from g=0.30 to g=0.24 (95% CI 
0.07-0.41, number of trimmed studies=2). We also found presence 
of asymmetry for physical capacity at post-treatment. Egger’s test 
indicated an asymmetric funnel plot (intercept: -8.79, 95% CI -17.31 
– 0.28, p=0.05). After adjustment the point estimate dropped from 
g=0.27 to g=0.18 (95% CI -0.06-0.42, number of trimmed studies=1). 
There was no indication of asymmetry for other outcomes.
Primary analyses were repeated with the exclusion of the 
trial by Nuñez (2011), which presented a high risk of bias, 
poor methodological quality (table 2) and included additional 
pharmacological treatment in the intervention arm. Excluding 
this study led to an increase in the magnitude of treatment effects 
for functional impairment/physical functioning at follow-up from 
g=0.39 to g=0.47. Analyses were also repeated with the exclusion 
of the trial by Jason (2007) due to high/uncertain risk of bias in 
all categories. Excluding this trial led only to very small increases 
in the overall point estimates between 0.02 (physical activity) to 
0.03 (depression). The exclusion of the trial conducted by Ridsdale 
(2012) because of less restrictive diagnostic criteria (complaint of 
fatigue for more than 3 months), led to an increase in the overall 
point estimate for fatigue severity at follow-up (from g= 0.67 
to g=0.74), and to increases of approximately 0.03 for the other 
outcomes. 
Discussion
This meta-analysis examined the effectiveness of behavioral 
and psychological treatments focusing on graded aerobic 
physical activity/exercise in chronic fatigue patients. 
Treatments included Graded Exercise Therapy (GET), 
Cognitive behavioral Therapy (CBT), pragmatic rehabilitation 
and multicomponent approaches. Sixteen trials assessing 
fatigue severity, physical functioning /functional impairment, 
physical activity/physical capacity, and/or psychological 
distress (depression and anxiety) at post-treatment and/
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or follow-up, were included. In addition, this meta-analysis 
analyzed the potential moderating effects of the following 
trial characteristics: care provided to the control condition, 
treatment setting, provider of the treatment, length of 
treatment, whether the intervention included a psychological 
component (or not), flexibility in setting physical activity 
levels or goals in accordance with the patients’ exercise 
tolerance, and whether or not the intervention was a minimal 
(direct face to face) contact intervention. 
Our results indicate that interventions focusing on graded 
physical activity/exercise have beneficial effects on chronic fatigue 
management, which is in accordance with the results from previous 
reviews (Edmonds et al., 2004; Malouff et al., 2008; Price et al., 
2008; Castell et al., 2011). Interventions had a moderate impact 
on fatigue severity at post-treatment (g=0.62) and at follow-up 
(g=0.67). The post-treatment result obtained was somewhat similar 
to the results found in the Malouff study (2008) [Physical fatigue: 
d=0.81; mixed (physical and mental) fatigue: d= 0.52], and higher 
than the effect sizes reported by Castell et al (2011; GET: g= 0.41; 
CBT: g=0.36) Treatment effects varied widely between studies 
and subsequent subgroup comparisons revealed that several trial 
characteristics were significant moderators of the effect of the 
interventions on fatigue severity. Interventions conducted in 
secondary-tertiary settings had a higher effect on fatigue severity 
reduction than interventions conducted at primary care. Castell 
(2011) also found the lowest intervention effect in primary care 
trials. It is however important to point out that of the studies 
included in our meta-analysis, only three studies were conducted 
in primary care settings, each of them with clearly distinct features. 
One trial, the Pragmatic Rehabilitation trial, was conducted by 
nurses who did home visits (Wearden et al., 2010), another was a 
GET trial conducted by physical therapists (Ridsdale et al., 2012), 
and the last one was a CBT trial with a graded exercise component 
delivered by several health care specialists to groups of patients 
(O’Dowd et al., 2006). Interventions delivered by psychologists or 
psychotherapists were more effective in reducing fatigue severity, 
although heterogeneity within this subgroup was high. Previous 
meta-analyses did not examine this moderator effect. Finally, 
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minimal contact self-management interventions, consisting of a 
maximum of 3 face-to-face sessions, providing additional remote 
guidance and in many cases including patient (self-help) manuals, 
were associated with larger effects on fatigue severity. This result 
is in line with recent research that pointed at the beneficial effects 
of minimal contact interventions on psychological (Haug et al., 
2012) and physical symptoms (Pajak et al., 2013). Furthermore, 
in a recent trial directly comparing CBT delivered face-to-face to 
CBT delivered by telephone (with an initial face-to- face session), 
similar beneficial effects were found on fatigue, social adjustment 
and physical functioning in CFS/ME patients (Burgess, Andiappan, 
& Chalder, 2012). 
Regarding physical functioning/functional impairment, there 
were small treatment effects at both assessment points (g=0.30 
and g=0.39), which is in line with the results from a previous meta-
analysis (e.g. Castell et al., 2011). Again, we found that intervention 
effects varied widely between studies and that some interventions 
had no significant effects on physical functioning/functional 
impairment. None of the moderators explained the observed 
variance in treatment effect. 
This is the first meta-analysis assessing the impact of 
interventions with a graded activity/exercise component on 
physical activity and physical capacity. We found few studies 
reporting on the effects of interventions on physical activity/
capacity. At post-treatment, interventions had a trivial effect on 
physical activity (g=0.11) and a small effect on physical capacity 
at post-treatment and (g= 0.27). At follow-up, overall effect on 
physical activity was of small magnitude (g=0.41). None of the 
moderators explained the observed variance in treatments effect. 
However, due to the limited number of studies, these analyses 
were only conducted for some of the potential moderators. One 
of the possible reasons for the small effects found may be the 
heterogeneous measurement of physical activity/physical capacity. 
Some studies made use of actigraphy, while others relied on walking 
tests or on physiological measures. 
The small effect of existing (psychological and behavioural) 
interventions targeting physical activity and physical capacity may 
point at the fact that alternative ways of promoting physical activity, 
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e.g. making use of motivational counseling and self-regulation 
approaches (e.g. Janssen, De Gucht, van Exel, & Maes, 2013) may be 
more succesful in changing this health behaviour. The discrepancy 
that was found in this meta-analysis between the effects found 
for fatigue severity and for physical activity could indicate that 
the mere increase of physical activity does not necessary lead to 
improved outcomes in terms of chronic fatigue management. 
Flexibility in physical activity levels or goals combined with pacing 
(balance between activities and rest) may be equally important 
for chronic fatigue management (Nijs et al., 2008). It could also 
be hypothesized that the effect of the interventions on fatigue 
cannot be explained by changes in physical activity and/or physical 
capacity. This hypothesis is in accordance with a study conducted 
by Wiborg (Wiborg et al., 2010) that examined whether (changes 
in) physical activity mediated the effect of CBT on fatigue in three 
separate trials. CBT interventions reduced fatigue, but did not have 
an effect on physical activity. As a consequence, no mediation effect 
of physical activity was found.
For depression, small effect sizes were found at both assessment 
points (g=0.41 and g=0.32), slightly higher than the effect sizes 
found in previous reviews (Edmonds, 2004; Castell et al, 2011). 
Interventions with minimal face to face contact were associated 
with larger effect sizes, and a marginal significant effect was found 
for the length of the intervention. Interventions that allowed 
for flexibility in physical activity levels presented higher effects 
on depresion. Finally, small effect sizes were found for anxiety 
at both assessment points (g=0.28 and g=0.22). The magnitude 
of the effects is higher than what was found in a previous meta-
analysis (Castell et al., 2011; GET: g= 0.01; CBT: g=0.15). Our 
results should however be interpreted with care as only a small 
number of studies were included in the analyses for anxiety at 
both assessment points. It may be the case that patients with more 
severe psychological distress or co-existing mood disorders will 
benefit more from additional emotional regulation approaches (e.g. 
CBT for mood disorders). In fact, two recent trials have found that 
depressive symptoms were a significant moderator of treatment 
effects (Tummers, Knoop, van Dam & Bleijenberg, 2013; Wearden, 
Dunn, Dowrick, & Morriss, 2012). Future reviews could address 
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the potential moderator effect of psycholological distress in a wide 
range of trials. 
 For all outcomes, heterogeneity in effect sizes was not associated 
with type of care provided to the control condition (passive vs. 
active) as was found in previous meta-analyses (Malouff et al, 2008; 
Castell et al, 2011). Similarly, a flexible approach to physical activity 
levels or goals was not significantly associated with higher effect 
sizes, except for the marginal effect found for depression. We did 
not find a significant difference in effects between interventions 
focusing only on physical activity or also containing a psychological 
component, but results point to a greater effect of this last type of 
treatment on both fatigue and depression. Finally, heterogeneity in 
treatment effects was not associated with the length of treatment 
for any of the outcomes. 
Limitations and suggestions for future research 
The present meta-analysis has a number of limitations. First, 
although interventions have shown beneficial effects for most 
outcomes, we found a high level of heterogeneity between studies 
that could not be (fully) accounted for by the moderators that we 
examined. The limited number of trials included in this review 
limits the conclusions that can be drawn from the moderator 
analyses, because non-significant effects may be due to low 
statistical power (Borenstein et al., 2009). Future studies should 
continue to explore other potential moderators that can account 
for differences between trial results. Among these are patient and 
disease-related characteristics (e.g. illness duration, severity of 
disease, mood disorders, avoidance or all-or-nothing behaviors), 
treatment features (e.g. physical activity, flexible graded activity 
+ pacing) or design-related moderators such as single-centre vs. 
multi-centre trials. 
Second, sensitivity analysis revealed some indication of 
publication bias for the outcomes fatigue severity, physical 
functioning and physical capacity. The existence of unpublished 
trials with negative results could have reduced the effect sizes 
for some of the outcomes analyzed. Adjusted effect sizes and 
re-analysis excluding trials with low methodological quality, 
did not alter the significance of the effect sizes, with the 
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exception of physical capacity. In addition, the sample size of many 
trials included in this meta-analysis was small, which constitutes a 
methodological limitation (Borenstein et al., 2009). 
Third, promising recent trials adopting a multidisciplinary 
rehabilitation treatment approach, could not be included because 
they were non-randomized and/or did not provide enough statistical 
information. The only study on multidisciplinary rehabilitation that was 
included (Núñez et al., 2011) was characterized by poor methodological 
quality.
Fourth, most of the coding of intervention characteristics was based on 
the intervention description provided in the articles. In many cases these 
descriptions were limited, and e.g. did not present enough information 
regarding the behavior change techniques used. For this reason, we were 
not able to explore the moderating effect of behavior change techniques 
(e.g. use of self-regulation strategies such as goal setting).  The same 
accounts for the description of the content of manuals that were used in 
different interventions. Future studies should give a sufficiently detailed 
account of the content of the intervention/self-help manual offered to 
patients. 
Fifth, although we compared our results to the results of previous meta-
analyses, this comparison is hampered by a number of differences related 
to the focus of the meta-analysis as well as the statistical procedures that 
were followed. More in particular, this meta-analysis (1) included recently 
published studies that were not included in previous meta-analyses, (2) 
did not include studies targeting children/youth with chronic fatigue, (3) 
was conducted separately for each outcome at post-treatment and follow-
up, (4) compared activity based interventions  to interventions with an 
additional psychological component, which was not limited to CBT, and 
(5) as Castell previously stated (2011) different procedures for calculating 
effect sizes may have been adopted based on the information provided in 
the original trials included in this meta-analysis. 
Sixth, although most outcomes were assessed using validated self-
report scales, the way scores were calculated was not always clear. Future 
randomized controlled trials should pay more attention to the way 
statistical data are presented, making an effort to present effect sizes and 
raw data (means and standard deviations) for all outcomes, trial arms and 
assessment periods.
Seventh, the number of studies included in this meta-analysis that 
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presented follow-up data (without crossovers) was limited and 
only available for a maximum period of 17 months. Hence, although 
these interventions seem to lead to sustainable beneficial effects on 
chronic fatigue management (Malouff et al, 2008), more research 
is needed to understand long-term effects as well as the potential 
mechanisms contributing to the maintenance of self-management 
behaviors.
Finally, future studies should also examine the effect of 
interventions on additional outcomes (e.g. recovery rate), and 
compare different treatment formats (telephone, web-based, face 
to face). 
Conclusion 
This meta-analysis of behavioral and psychological interventions 
targeting graded activity suggests that these interventions have 
sustained beneficial effects on chronic fatigue management, in 
particular on fatigue severity reduction for which a medium effect 
was found. The finding that minimal contact interventions have 
similar and in some cases higher effects on fatigue severity and 
depression compared to more intensive interventions is important 
as these interventions can be more easily implemented in standard 
health care, can be useful for patients presenting difficulties in 
regularly attending health care facilities (Burgess et al., 2012), 
and can be suitable for patients who do not need more intensive 
forms of treatment (Tummers et al., 2012). All trials included in 
this meta-analysis had an initial face to face contact with patients, 
which may have led to increased motivation of patients to engage 
in a behavior change process (Burgess et al., 2012). Most of these 
minimal interventions also included patient (self-help) manuals 
and allowed flexible physical activity/exercise levels that take into 
consideration the patients’ own resources, which can add to chronic 
fatigue management. Notwithstanding the beneficial effects of the 
behavioral and psychological interventions included in this meta-
analysis and the valuable indications about targets and format of 
future interventions, more research is needed to identify optimal 
features of interventions for chronic fatigue management. 
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610 records identified through 
database searching
7 additional records identified 
through other sources
214 records after 
duplicates removed
168 records excluded214 records screened
20 full-text articles excluded
· No RCT/No control group 
(n=9)
· Did not include a graded activity 
component (n=5)
· Not ICF/CFS patients (n=3)
Data unsuitable and no additional 
information available (n=3)
46 full-text articles 
assessed for eligibility
26 studies included 
























































































































































12 face to face 
sessions /12 weeks
8 face to face 
sessions / 26 weeks
1 face to face
+ 6 telephone calls/ 
12 weeks
12 face to face 
sessions/12 weeks
14 face to face 
sessions
23  weeks
8 face to face
sessions+ 2 tel. 
calls/24 weeks




5 home visits+ 5 


















FAT, PF, PA, 
DEP
FAT, PA, DEP, 
ANX
FAT, PA, DEP, 
ANX
FAT, PF, PA
FAT, PF, PA, 
DEP, ANX
FAT, PF, DEP, 
ANX
FAT, PF, DEP, 
ANX
FAT, PF, PA, 
DEP, ANX
Table 1 Details of included studies
aAU= Australia; NL= The Netherlands; NZ= New Zealand; UK= United Kingdom; US= United States of America. bCF= Chronic Fatigue; CFS= Chronic Fatigue Syndrome; ICF= Idiopathic Chronic 
Fatigue. cSample characteristics at baseline. dPercentage of withdrawal in intervention condition. eGET=Graded Exercise Therapy; CBT= Cognitive-behavioral therapy. fMeasurement periods 
included in the meta-analyses (months from baseline): PT= Post-treatment; FU= Follow-up.gFAT= Fatigue severity; PA= Physical activity; PF= Physical functioning; DEP= Depression; ANX= 
Anxiety. * Passive control group; **Active control group
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aAU= Australia; NL= The Netherlands; NZ= New Zealand; UK= United Kingdom; US= United States of America. bCF= Chronic Fatigue; CFS= Chronic Fatigue Syndrome; ICF= Idiopathic Chronic 
Fatigue. cSample characteristics at baseline. dPercentage of withdrawal in intervention condition. eGET=Graded Exercise Therapy; CBT= Cognitive-behavioral therapy. fMeasurement periods 
included in the meta-analyses (months from baseline): PT= Post-treatment; FU= Follow-up.gFAT= Fatigue severity; PA= Physical activity; PF= Physical functioning; DEP= Depression; ANX= 
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16 face to face 
sessions/ 16 weeks
13 face to face 
sessions /16-24 
weeks
16 face to face 
sessions /32 weeks
8 face to face group 
sessions/16 weeks
13 face to face 
sessions/26 weeks
1 face to face session 
+ email or telephone 
calls every 2 
weeks/≥16 weeks
1 face to face 
session+ email every 
2 weeks /≥20 weeks
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Table 1 Details of included studies (continued)
aAU= Australia; NL= The Netherlands; NZ= New Zealand; UK= United Kingdom; US= United States of America. bCF= Chronic Fatigue; CFS= Chronic Fatigue Syndrome; ICF= Idiopathic Chronic 
Fatigue. cSample characteristics at baseline. dPercentage of withdrawal in intervention condition. eGET=Graded Exercise Therapy; CBT= Cognitive-behavioral therapy.. fMeasurement periods 
included in the meta-analyses (months from baseline): PT= Post-treatment; FU= Follow-up.gFAT= Fatigue severity; PA= Physical activity; PF= Physical functioning; DEP= Depression; ANX= 
Anxiety. * Passive control group; ** Active control group. n/a= information not available. n/a= information not available
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Table 2   Classification on Methodological quality, risk of bias and moderators of included interventions 
Study ID


















Fulcher 38 Low Low Low Low No No No
Wearden 
(1998)
42 Low Low Low Low No No No
Wallman 32 Unclear Unclear Low Low No Yes * Yes
Moss-
Morris
33 Low Unclear Low Low No No No
White 51 Low High Low Low No No No
Ridsdale 41 Low Unclear Low Low No No No
Powell 41 Low Unclear Low Low Yes Yes Yes
Wearden 
(2010)
49 Low Low Low Low Yes No ** Yes
Sharpe 42 Low Unclear Low Low Yes No No
Deale 42 Low Unclear Low Low Yes No No
Prins 44 Low Unclear Low Low Yes No Yes
O’Dowd 46 Low Low Low Low Yes No Yes
Jason 30 Unclear Unclear Unclear High Yes No  No
Knoop 35 Low Unclear Low Low Yes Yes Yes
Tummers 40 Low High Low Low Yes Yes Yes
Nunez 29 Unclear Unclear High Unclear Yes No No













1640 0.62 (0.45-0.79) 7.12** 34.84** 63% 14





1451 0.30 (0.14-0.46) 3.59** 22.67* 56% 11





513 0.11 (-0.07-0.28) 1.21 4.64 35% 4





214 0.27 (0.00-0.54) 1.96* 10.90** 73% 4
Depression Post-
treatment
921 0.41 (0.22-0.59) 4.38** 16.56† 46% 10
Follow-up 838 0.36 (0.14-0.58) 3.24** 13.17* 54% 7
Anxiety Post-
treatment
686 0.28 (0.13-0.43) 3.67** 2.70 0% 7
Follow-up 778 0.22 (0.08-0.37) 3.13** 2.29 0% 6
Table 3   Effects of interventions for each outcome at post-treatment and follow-up
†p<0.10, *p<0.05; ** p<0.01; aData available only at post-treatment. 
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Table 4   Subgroup analysis assessing the effect of study characteristics upon effect 
size at the longest assessment period available, separated by outcome
 †p<0.10; * p<0.05; ** p<0.01; 1p-values correspond to subgroup differences in effects. a Wallman  et al. (2004) trial was 
not included as it was the only study conducted in an university laboratory department; Jason et al (2007) study was not 
included as no information regarding the exact location setting was provided. bThe study conducted by O’Dowd (2006) was 
not included because the intervention was provided by specialists from multiple fields. n/a=not enough interventions in the 
subgroup to allow for a comparison
Moderator
Fatigue Physical functioning Physical activity           Depression
k g
(95% CI)
Z p1 I2 k g
(95% CI)
Z p1 I 2 k g
(95% CI
























3.40** 0 4 0.42
(0.10-0.81)
3.27** 84 4 0.37
(0.12-0.62)
























7.65** 69 9 0.44
(0.25-0.64)
4.42** 63 7 0.22
(-0.06-0.50)


























2.90** 16 3 0.40
(0.07-0.73)
2.35* 63 4 0.44
(0.16-0.73)







6.95** 72 5 0.69
(0.41-0.98)
4.74** 67 4 0.06
(-0.23-0.35)






















Yes 9 0.77 
(0.53-1.01)
6.31** 75 9 0.36
(0.19-0.66)
3.41** 66 6 0.27
(-0.01-0.55)
1.90† 57 7 0.46
(0.16-0.76)
3.03** 71





















4.99** 81 6 0.36
(0.17-0.70)
3.90** 52 5 0.24
(-0.06-0.54)




















5.48** 84 3 0.47
(0.13-0.82)
2.69** 50 2 0.20
(-0.27-0.69)
0.84 56 3 0.85
(0.59-1.10)
6.52** 34
Meta-Regressions             k Slope Z p k slope Z p k slope Z P k Slope Z P
Length of treatment 15 -0.03 -1.58 0.11 13 -0.02 1.29 0.24 11 -0.00 -0.28 0.79 12 -0.03 -1.67 010
Methodological quality 15 -0.02 -0.91 0.36 13 0.01 0.93 0.35 11 0.02 1.31 0.19 12 -0.01 -0.58 0.57
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Moderator
Fatigue Physical functioning Physical activity           Depression
k g
(95% CI)
Z p1 I2 k g
(95% CI)
Z p1 I 2 k g
(95% CI
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(0.53-1.01)
6.31** 75 9 0.36
(0.19-0.66)
3.41** 66 6 0.27
(-0.01-0.55)
1.90† 57 7 0.46
(0.16-0.76)
3.03** 71





















4.99** 81 6 0.36
(0.17-0.70)
3.90** 52 5 0.24
(-0.06-0.54)




















5.48** 84 3 0.47
(0.13-0.82)
2.69** 50 2 0.20
(-0.27-0.69)
0.84 56 3 0.85
(0.59-1.10)
6.52** 34
Meta-Regressions             k Slope Z p k slope Z p k slope Z P k Slope Z P
Length of treatment 15 -0.03 -1.58 0.11 13 -0.02 1.29 0.24 11 -0.00 -0.28 0.79 12 -0.03 -1.67 010
Methodological quality 15 -0.02 -0.91 0.36 13 0.01 0.93 0.35 11 0.02 1.31 0.19 12 -0.01 -0.58 0.57
Table 4   Subgroup analysis assessing the effect of study characteristics upon 
effect size at the longest assessment period available, separated by outcome 
(cont.)
 †p<0.10; * p<0.05; ** p<0.01; 1p-values correspond to subgroup differences in effects. a Wallman  et al. (2004) trial was 
not included as it was the only study conducted in an university laboratory department; Jason et al (2007) study was not 
included as no information regarding the exact location setting was provided. bThe study conducted by O’Dowd (2006) 
was not included because the intervention was provided by specialists from multiple fields. n/a=not enough interventions 
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Table B.1   Full-Text Studies Excluded and Reasons for Exclusion 
Study author(s), year of publication & 
publication title
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1-Clear objectives 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
2-Sample size 1 1 1 1 2 2 1 2 2 1 2 2 1 2 2 1
3-Trial duration 2 2 1 1 2 2 2 2 2 2 2 2 2 1 1 2
4-Power calculation 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 1
5-Allocation method 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1
6-Allocation concealment 2 2 1 2 2 2 2 2 2 2 1 2 0 2 2 0
7-Treatment clearly described 2 2 2 2 2 2 2 2 1 2 2 2 2 1 2 2
8-Manualized treatment 0 0 0 0 2 1 0 2 2 1 1 2 1 1 1 1
9-Representative sample 2 2 1 1 2 2 2 2 2 2 2 2 1 1 2 1
10-Inclusion criteria 1 1 1 1 2 1 2 2 2 1 2 1 1 2 2 1
11-Exclusion criteria 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
12-Described demographics 0 1 0 1 2 2 2 2 2 2 2 2 2 1 1 1
13-Assessor blinded 1 1 0 0 0 0 0 2 0 1 0 1 0 0 0 0
14-Treatment compliance 1 2 1 1 2 1 1 1 1 0 1 1 1 1 1 0
15-Treatment side effects 1 0 0 0 2 0 0 1 1 0 0 1 0 0 0 0
16-Dropout information 2 2 2 2 1 1 1 2 1 2 1 2 0 1 2 1
17-Outcome measures 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
18-Between-group 
comparisons 2 2 1 1 2 2 1 2 1 2 2 2 1 2 2 1
19-Dropout inclusion 1 2 2 1 2 2 1 1 1 1 2 2 0 2 2 0
20-Well-presented results 2 1 2 2 2 2 2 2 1 2 2 1 1 1 2 1
21-Appropriate analysis 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 1
22-Justified conclusions 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
23-Insterests declared 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
24-Allegance to therapy 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
25-Follow-up duration 1 0 0 0 1 1 2 2 1 1 1 1 1 0 0 1
26-Cointervention avoided 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1
27-Drug use assessed 1 2 0 0 2 0 1 2 1 1 0 2 0 0 0 1
28-Tratment credibility 0 0 0 0 2 1 0 1 0 0 1 1 1 0 1 0
29-Consecutive subjects 0 2 0 0 2 0 2 0 2 2 2 0 0 0 0 1
Total Quality 38 42 32 33 51 41 41 49 42 42 44 46 30 35 40 29
Appendix C
Table C.1   Consensus Ratings of Methodological Quality
0 = Not done and/or not reported; 1= Done and/or reported to some extent; 2 = Adequately done and/or adequately reported
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Protocol for the “four steps 
to control your fatigue 
(4-STEPS)” randomised 
controlled trial: A self-
regulation based physical 
activity intervention for 
patients with unexplained 
chronic fatigue
Manuscript published
M. Marques, V. De Gucht, S. Maes & I. Leal (2012). 
Protocol for the “four steps to control your fatigue 
(4-steps)” randomised controlled trial: a self-
regulation based physical activity intervention for 





Background: Unexplained Chronic Fatigue is a medical 
condition characterized by the presence of persistent, severe 
and debilitating medically unexplained fatigue, leading to 
impaired functioning and lower quality of life. Research 
suggests that physical activity can contribute to the reduction 
of fatigue and other somatic symptoms and can thus 
significantly improve physical functioning and quality of life 
in these patients. Based on the self-regulation (SR) theory 
of behaviour change, we developed a brief physical activity 
program for patients suffering from unexplained chronic 
fatigue which focuses on the training of self-regulation skills, 
the “4-STEPS to control your fatigue” program. 
Methods/Design: This is a multi-centre, randomised 
controlled trial (RCT) that will be carried out in local primary 
care centres and at the Portuguese Fibromyalgia and Chronic 
Fatigue Syndrome Patients Association. Patients aged between 
18 and 65 and fulfilling operationalized criteria for Idiopathic 
Chronic Fatigue (ICF) and Chronic Fatigue Syndrome (CFS) 
will be recruited and randomly allocated to standard care (SC) 
or standard care plus a self-regulation based physical activity 
program (4-STEPS). Patients will be assessed at baseline, 
after the intervention (3 months) and at 12 months follow-up. 
The primary outcome is fatigue severity.
Discussion: The results of the RCT will provide information 
about the effectiveness of a brief self-regulation intervention 
for promoting physical activity in patients with unexplained 
chronic fatigue. If the program proves to be effective, it may 
be considered as an adjunctive treatment for these patients.
Trial Registration: ISRCTN70763996
Keywords: Unexplained Chronic Fatigue, Physical activity, 




Fatigue is a common symptom in adults worldwide, being reported 
by around 20% of patients seeking medical care [1]. A recent 
epidemiological review concluded that physical activity can reduce 
fatigue and improve energy [1]. Recent literature emphasizes 
that fatigue should be considered as a multidimensional concept, 
incorporating both physical and mental fatigue [2]. Due to its 
subjective nature, fatigue is difficult to define and measure. It is a 
personal experience that cannot be objectively measured [3]. 
In most cases, fatigue is transient, but for some, fatigue symptoms 
become chronic, resulting in disability [4]. When fatigue lasts for at 
least six months, is not alleviated by rest, is debilitating, results in 
a significant reduction of daily activities and cannot be explained 
by an organic disease (unexplained chronic fatigue), it is classified 
as Idiopathic Chronic Fatigue (ICF) [4,5]. If ICF is accompanied 
by four or more of the following symptoms - unrefreshing sleep, 
lengthy malaise after exertion (lasting for over 24 hours), impaired 
memory or concentration, sore throat, tender cervical or axillary 
lymph nodes, muscle pain, multi-joint pain without swelling or 
redness and headaches of a new type or severity - it is diagnosed 
as Chronic Fatigue Syndrome (CFS) according to the Center for 
Disease Control (CDC) criteria [6]. 
CFS prevalence has been reported to be in between 0.2% and 2% 
in general population samples [7].  Prevalence rates vary according 
to several factors such as the criteria used to diagnose CFS [4]. In 
terms of prognosis, a systematic review conducted by Cairns and 
Hotpof [8] found that full recovery from untreated CFS is rare. 
It is more common for patients to experience an improvement 
in symptom severity. CFS etiology remains unknown [4] and 
it is considered to be associated with a combination of several 
predisposing (e.g. genes), precipitating (e.g. life events) and 
perpetuating (e.g. physical inactivity) factors [9].
Patients with unexplained chronic fatigue often report 
complaints related to exercise intolerance and post-exertional 
malaise [4]. Prins, van der Meer and Bleijenberg [9] considered 
patients’ perceptions and expectations related to symptom 
exacerbation as a consequence of exercise, to be the main cause 
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of the reduced levels of physical activity found in patients 
with unexplained chronic fatigue, rather than physical fitness 
limitations per se. Other studies pointed out that lack of physical 
activity and excessive resting are factors that result in physical 
deconditioning which, in turn, perpetuates fatigue and physical 
disability [10]. It has therefore been recommended that ICF/CFS 
patients engage in physical activity instead of refraining from it to 
manage their symptoms [10,11,12]. 
To promote physical activity in ICF/CFS, Graded Exercise 
Therapy (GET) has been recommended. GET is based on the 
assumption that in patients with unexplained chronic fatigue, 
physical activity must be initiated at a level that doesn’t exacerbate 
symptoms and must be gradually increased until patients reach 
an optimal level of activity. Graded exercise programs follow the 
exercise prescription guidelines from the American College of 
Sports Medicine [13], tailored to each patient’s level of physical 
activity. GET is usually delivered by an exercise physiologist or 
physical therapist, and consists of supervised exercise sessions and/
or home-based exercise prescription (e.g. walking). Research has 
demonstrated that GET has a positive effect on physical activity and 
leads to decreased levels of fatigue [14,15,16,17]. 
Cognitive-behavioral therapy (CBT) has also demonstrated 
to be an effective treatment approach to CF. CBT interventions 
developed for ICF/CFS patients focus primarily on changing 
illness cognitions and expectations, as well as increasing control 
over symptoms. The CBT model makes a distinction between 
precipitating factors - factors that contribute to the initiation of a 
health problem - and perpetuating factors - factors that contribute 
to the maintenance of the health problem [18]. Since physical 
inactivity is considered to be a perpetuating factor of unexplained 
chronic fatigue, most CBT interventions also focus on physical 
activity promotion.  A recent review conducted by Price and 
colleagues [19] concluded that CBT interventions have a positive 
effect on fatigue, depression and anxiety in ICF/CFS patients. 
In patients with unexplained chronic fatigue a “boom and bust 
pattern” is frequently found, that is, a  systematic alternation 
between periods of excessive activity (when feeling good), and, as 
a consequence of that, feeling extremely fatigued and having to 
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rest for longer periods of time [20, 21]. Pacing, which is having an 
appropriate balance between activity and rest, is considered to be 
an important technique for reducing fatigue symptoms. Pacing 
implies that patients are encouraged to set realistic goals on a daily 
basis in terms of activity and rest periods; it is often combined with 
graded exercise [22, 23]. 
CBT uses several self-regulation (SR) techniques. 
SR can be defined as a sequence of actions and/or steering 
processes intended to attain a personal goal [26]. According to 
SR theory, individuals set personally important goals that guide 
their behavior [27]. In this goal-guidance process, self-regulation 
cognitions (e.g. self-efficacy expectations and autonomous/
controlled motivation), emotions (positive and negative affect) and 
skills (e.g. self-monitoring and feedback), are considered to play 
an important role, both in goal setting, active goal pursuit and goal 
maintenance/attainment [27].  As a consequence, SR models not 
only contribute to our understanding of the influence of life goals 
on medically unexplained physical symptoms (MUPS)  in general, 
and fatigue in particular [24], but interventions based upon these 
models may also encourage patients to change their personal 
goals from symptom avoidance to more active and positive goals  
[25].  In their review, Maes & Karoly [27] distinguished a number 
of self-regulation strategies associated with behavior change and 
derived a set of guidelines for interventions. These self-regulation 
core processes are: realistic outcome expectations; illness 
representations; goal setting (personal goals, ownership); planning; 
progress evaluation and feedback; efficacy support;  attention and 
emotion control; control over competing goals; self-monitoring; 
self-reinforcement; facilitate social support; goal reformulation; 
relapse prevention; anticipatory coping [27].
One of the main intervention techniques based on self-regulation 
theory is Motivational Interviewing (MI), developed by Miller 
& Rollnick [28]. MI is a directive, client-centered technique for 
eliciting behavior change, by helping clients to explore and resolve 
perceived conflicts (ambivalence) with respect to behavior change 
and analyze the discrepancies between their current behavior 
and their life goals and values. It aims at increasing autonomous 
regulation and self-efficacy (i.e. confidence in one’s ability to 
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perform a certain behavior) and promotes the transition from 
planning (motivational phase) to action (goal pursuit).  MI has been 
successful in promoting physical activity in healthy populations 
[29], but there is limited research on MI interventions in patients 
with ICF/CFS and other MUPS.  Powell and colleagues [30] 
evaluated an intervention based upon MI techniques to encourage 
graded physical exercise in CFS patients. The intervention led to 
increased physical functioning and decreased fatigue. In addition, 
the minimum intervention condition, consisting of only two face-
to-face sessions, proved to be as successful as more extended 
versions of the program. A study conducted with fibromyalgia 
patients also showed a significant increase in physical exercise 
frequency, as well as reduced pain and physical impairment after an 
MI intervention [31].
Based on the empirical literature we developed a brief self-
regulation based physical activity program for patients suffering 
from unexplained chronic fatigue, the “4-Steps to control your 
fatigue” (4-STEPS) program. In this intervention program, the 
combination of graded exercise and pacing is incorporated [22]. 
The development and evaluation of brief interventions is important 
because of the time, money and energy consuming efforts 
associated with longer interventions.  
The main objective of the study is to evaluate the efficacy of the 
4-STEPS program in promoting physical activity and in reducing 
fatigue. 
Methods/Design
Design of the study 
This is a two-arm multi-centre randomised controlled trial in 
patients who meet operationalised criteria for either ICF or CFS. It 
consists of a 3-month intervention and a 12-month follow-up phase 
(Figure 1). There are 3 measurement points: baseline, post-test (3 
months) and follow-up at 12 months.
Approval for the trial was obtained from the Ethics Committee 
of the North Regional Health Administration (Ref: 27.09), from the 
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directors of each participating health care institution and from the 
Portuguese Fibromyalgia and Chronic Fatigue Syndrome Patient 
Association.
Setting 
The trial, including measurements and intervention sessions is 
conducted in five Portuguese primary care centres, in a private 
practice clinic and at the Portuguese Fibromyalgia and Chronic 
Fatigue Syndrome Patient Association.
Participants
Patients attending their physician with a main complaint of 
unexplained fatigue of at least six months duration are recruited 
for the study. Inclusion criteria are: meeting the operationalised 
criteria for ICF or CFS (CDC criteria) [6]; aged between 18 and 65; 
fluent in spoken Portuguese; capacity to provide informed consent. 
Exclusion criteria are: presence of a concurrent somatic condition 
which can explain the fatigue symptoms; patients with severe 
psychiatric disorders.
Power calculation
The sample size was calculated based on the primary outcome 
(fatigue severity). A power calculation [32], using an independent 
samples t-test (5% level of significance) indicated that a sample 
size of 34 will have 80% power to detect a mean difference of 7 
points [33, 34] between the intervention and the control group, 
on the subjective experience of fatigue subscale of the Checklist of 
Individual Strength (CIS-R) [35].
Anticipating a drop-out rate of 20% [33], we aim at recruiting 41 
subjects per group at baseline. 
Randomization method 
Participants are recruited from consecutive referrals and 
allocated to one of the two trial arms by the research team leader. 
Randomisation sequence is stratified by centre with a 1:1 allocation 
to the two treatment arms. Standard care is given to all participants 




Different procedures are followed for recruiting patients from 
the primary health care institutions on the one hand and from the 
patient association on the other.
Health care institutions
First, patients that meet the inclusion/exclusion criteria are 
approached for participation by their primary care physician. 
Secondly, the physician provides a brief explanation of the study to 
the patient and asks for the patient’s authorization to be contacted 
by a member of the research team.  Third, patients receive 
information from the principal investigator about the trial and what 
their participation involves. Finally, patients are assigned to either 
the intervention or the control condition by randomized sampling. 
All patients willing to participate sign a written informed consent 
before being enrolled in the study. 
National Fibromyalgia and Chronic Fatigue Patient Association
 Initially, a letter containing information about the trial, what 
participation involves and the written informed consent form 
is sent to all members of the association from the Lisbon and 
Porto region that meet the inclusion/exclusion criteria and have 
previously indicated they were available for participation in 
research studies. Patients who wish to participate in the study 
return the written informed consent and are subsequently 
randomly assigned to either the intervention or the control group.
Interventions
Control Group
 In addition to standard medical care, patients that are assigned 
to this group receive a flyer with information about the general 
health benefits of physical activity and the current physical activity 
guidelines for adults [13]. 
Intervention Group
In addition to standard care, patients in the intervention group 
receive the 4-STEPS program that consists of:
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sessions aimed at exploring important health and life goals, 
increasing participants’ motivation and confidence to be physically 
active and setting a specific personal physical activity goal. The first 
MI session takes place 1 week after the baseline assessment and 
the second MI session takes place 2 weeks after the first. The MI 
session is delivered by a psychologist with MI training (member of 
the research team). The duration of the sessions is approximately 
1 hour.  Details on the topics addressed in the MI sessions are 
presented in Table 1.
about 20 minutes and are provided 2 weeks and 6 weeks after 
the last MI session. Details on the topics addressed during the 
telephone sessions are presented in Table 1.
designed to help patients change their level of physical activity 
(Informational booklet and Workbook). The Informational booklet 
is provided at the end of the baseline assessment, the  “Step 1” part 
of the Workbook is provided at the first MI session and the parts 
“Step 2”, “Step 3” and “Step 4” are given during the second MI 
session. Details on the topics that are addressed in the SR booklets 
are presented in Table 2.
taken) during the 3 month intervention period. Instructions on 
how to use the pedometer are given in the baseline assessment 
session (Table 2). 
activity records (physical activities, mental activities and rest). 
The first daily activity record is given to the patient at the end 
of the first MI session; patients are asked to fill out the activity 
record in the time period between the first and second MI session. 
This homework assignment aims at evaluating the patients’ daily 
activities management and possibly recognizing an erratic pattern 
of rest and activity (boom and bust cycle). At the end of the second 
MI session, patients receive daily activities records that can be used 
to monitor changes in daily activity patterns during the subsequent 
nine weeks.
148
patients receive a leaflet for their partner or significant other in 
order to increase social support.
Assessments
Measures will be collected at baseline, 3 months later and 12 
months after baseline. All measures are self-report. Data will 
be collected in both the health care institutions and the patient 
association, at all times (Table 3). Primary and secondary 
outcomes, predictors and process evaluation measures are 
described below. A description of measures and time points can be 
found in Table 3. 
Primary Outcome
The primary outcome is the reduction of perceived fatigue severity, 
which is assessed by means of the Checklist of Individual Strength 
(CIS-20R) [35]. A difference of 7 points between the intervention 
and the control group on the main dimension (= the subjective 
feeling of fatigue subscale) of the CIS-20 R is considered to be a 
clinically significant difference [33, 34].
Secondary Outcomes
criteria and using the CDC-CFS Symptom Inventory [36].
pain interference subscale of the Brief Pain Inventory (BPI) [37].
Need for Recovery Scale (NFR) [38]. 
questions: (1) number of visits to the primary care physician and 
medical specialists, (3) use of medication.
working, number of hours working, working part-time due to 
fatigue, dropped out of work due to fatigue, number of days absent 
from work.
Behaviour Responses to Illness Questionnaire (BRIQ) [39] are used 
to assed behavioural symptom management. 
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Inventory (BSI) [40, 41]. 
DSM-IV criteria for sleep disorders [42] and six questions from the 
Pittsburgh Sleep Quality Index (PSQI) [43]. 
of the Patient Health Questionnaire-15 (PHQ-15) [44].
Form Health Survey-12 (SF-12V.2) [45].
physical activity level. The first is the pedometer (YAMAX SW-
200), a portable device that counts the number of steps taken, by 
detecting hip motions. Participants are asked to use the pedometer 
on a daily basis for seven consecutive days and register their daily 
number of steps on a form that is provided to the patient. The 
second measure is the  Sports subscale of the SQUASH  [46]; in this 
subscale  participants indicate the type of physical activity they 
do (e.g. swimming) including  the frequency per week (e.g. 3 days 
per week) and duration per day (e.g. 50 minutes) for each of these 
activities. The intensity of each of these activities is calculated 
based on the Ainsworth’s Compendium of Physical activities [47].
Predictors
Scale from 0cm- no impact at all to 10cm-exterme impact) of a 
serious life event experienced prior to the onset of fatigue. 
Questionnaire (Brief IPQ-R) [48].
Questionnaire - Short Version (CERQ-short) [49] were used to 
assess adaptive cognitive coping strategies, and a version of the 
Pain Catastrophizing Scale (PCS) adapted for fatigue [50] was used 
to measure catastrophic cognitions related to CF symptoms.
are measured with the Self-regulation Skills Battery (SRSB) [51]. 
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with the Barriers Efficacy Scale [52].
assessed using the respective scale from the Treatment Self-
regulation Questionnaire (TSRQ) [53].
planning are assessed using the measures from Sniehotta and 
colleagues [54].
Process evaluation
Participant satisfaction with the self-regulation based 4-steps 
program will be assessed. 
Analysis plan
We will use the SPSS and AMOS software packages for 
data analysis. Descriptive analysis will be performed for 
demographics, clinical information and process evaluation, 
stratified by treatment condition. Differences between the 
control and intervention group for the primary and secondary 
outcome measures will be assessed using MAN(C)OVA 
and AN(C)OVA. We also intend to use regression analysis 
and structural equation modelling to analyse longitudinal 
relationships between predictors, possible mediators and 
outcomes (path analysis).
Discussion
Physical activity seems to be very important for patients 
suffering from unexplained chronic fatigue, while SR 
interventions seem to be effective in promoting long-term 
health behaviour change. The 4-STEPS program will be the 
first brief SR based physical activity intervention for ICF/CFS 
patients. We are not aware of any RCT to promote physical 
activity in these patients conducted in Portugal. This RCT 
will provide information on the efficacy of the intervention as 
well as on the predictors of physical activity, fatigue and other 
somatic symptoms. The fact that it is a brief intervention, 
that requires minimal personal contact with the health care 
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professional and that patients receive self-help materials to 
support them can also be seen as an advantage from a cost-
effectiveness point of view if the trial has a significant effect.  
If proven effective, this program can be considered as an 
adjunctive treatment for ICF/CFS.
152
Status of the trial
The 4-STEPS recruitment started in January 2011 and it is ongoing. 
List of abbreviations
CFS Chronic Fatigue Syndrome
CBT Cognitive Behavioural Therapy
GET Graded Exercise Therapy
ICF Idiopathic Chronic Fatigue
ISRCTN International Standard Randomised Controlled Trial
MUPS (Medically Unexplained Physical Symptoms)
RCT Randomised Controlled Trial
SR Self-regulation
4-STEPS: “4 Steps to control your fatigue” program
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MM, VDG and SM contributed to the design of the study and the 
creation of the Support materials. VDG, SM and IL participate 
in the study coordination. MM wrote the draft version of 
the manuscript. All authors reviewed and approved the final 
manuscript.
Acknowledgements
This study was carried out as part of a grant from the Portuguese 
Foundation for Science and Technology to the first author (SFRH/
BD/47579/2008). 
 The authors would like to thank Maria João Gouveia for her 
contribution to the support materials.
153
References
 1. Puetz TW: Physical activity and feelings of energy and fatigue: 
epidemiological evidence. Sports Medicine 2006, 36(9):767-780.
2. Torres-Harding S, Jason LA: What is fatigue? History and 
epidemiology. In Fatigue as a window to the brain. Edited by DeLuca J. 
Cambridge: MIT Press; 2005:3-17.  
3. Wessely S: Foreword. In Fatigue as a window to the brain. Edited by 
DeLuca J. Cambridge: MIT Press; 2005: x-xvii.  
4. Afari N, Buchwald D: Chronic Fatigue Syndrome: A review. American 
Journal of Psychiatry 2003, 160:221-236.
5. Huibers MJH, Berskans AJHM, Van Schayck CP, Bazelmans JFM, 
Knothneurs JA, Bleijenberg G: Efficacy of cognitive behavioral therapy 
by general practitioners for unexplained fatigue among employees: 
randomized controlled trial. British Journal of Psychiatry 2004, 
184:240-246.
6. Fukuda K, Strauss SE, Hickie I, Sharpe MC, Dobbins, JG, Komaroff 
A: The chronic fatigue syndrome: a comprehensive approach to its 
definition and study. Annals of Internal Medicine 1994, 121:953-959. 
7. Campling F, Sharpe M:  Chronic Fatigue Syndrome (CFS/ME). 2nd 
edition. Oxford: Oxford University Press; 2008. 
8. Cairns R, Hotpof M: Prognosis of chronic fatigue syndrome: a 
systematic review. Occupational Medicine 2005, 55:20-31.
9. Prins JB, Vand der Meer JWM, Bleijenberg G: Chronic fatigue 
syndrome. The Lancet 2006, 367:346-355.
10. Fulcher KY, White PD: Strength and physiological response 
to exercise in patients with chronic fatigue syndrome. Journal of 
Neurology and Neurosurgery Psychiatry 2000, 69:302-307.
11. Berne K: Chronic Fatigue Syndrome, Fibromyalgia and Other Invisible 
Illnesses: The Comprehensive Guide. Alameda, CA: Hunter House 
Publishers; 2002.
12. National Institute for Health and Clinical Excellence: Guideline 
53: chronic fatigue syndrome/myalgic encephalomyelitis (or 
encephalopathy). London, 2007.  
13. American College of Sports Medicine: ACSM’s guidelines for exercise 
testing and prescription. 8th revised edition. Baltimore; 2019. 
14. Fulcher KY, White PD: Randomised controlled trial of graded 
exercise in patients with the chronic fatigue syndrome. BMJ 1997, 
154
314(7095):1647-52.
15. Wallman KE, Morton AR, Goodman C, Grove R, Guilfoyle AM: 
Randomised controlled trial of graded exercise in chronic fatigue 
syndrome. Medical Journal of Australia 2004, 180(9):444-448.
16. McGuire L, Edmonds L, Price JR: Exercise Therapy for Chronic 
Fatigue Syndrome. Cochrane Database Syst Rev 2004, 3:CD003200.
17. Moss-Morris R, Sharon C, Tobin R, Baldi JC: A randomized 
controlled graded exercise trail for chronic fatigue syndrome: outcomes 
and mechanisms of change. Journal of Health Psychology 2005, 
10(2):245-259. 
18. Ridsdale L, Darbshire L, Seed PT: Is graded exercise better than 
cognitive behavior therapy for fatigue? A UK randomized trial in 
primary care. Psychological Medicine 2004, 34:37-49. 
19. Price JR, Mitchell E, Tidy E, Hunot V: Cognitive behaviour therapy 
for chronic fatigue syndrome in adults. Cochrane Database Syst 
Rev 2008, 3:CD001027. 
20. Burgess M, Chalder T: Overcoming Chronic Fatigue. London: 
Constable  & Robinson; 2005.
21. NHS Foundation Trust and St. Bartholomew’s Hospital: Graded 
Exercise Therapy: A self-help guide for those with chronic fatigue 
syndrome/myalgic encephalomyelitis. London; 2009. 
22. Nijs J, Paul L, Wallman K: Chronic fatigue syndrome: an 
approach combining self-management with graded exercise to avoid 
exacerbations. Journal of Rehabilitation Medicine 2008, 40:241-247. 
23. White PD, Sharpe MC, Chalder T, DeCesare JC, Walyin R: Protocol 
for the PACE trial: a randomised controlled trial of adaptative pacing, 
cognitive behaviour therapy and graded exercise as supplements to 
standardised specialist medical care versus standardised specialist 
medical care alone for patients with the chronic fatigue syndrome/
myalgic encephalomyelitis or encephalopathy. BMC Neurology 2007, 
7:6. 
24. De Gucht V, Maes S: Explaining medically unexplained symptoms: 
toward a multidimensional theory-based approach to somatisation. 
Journal of Psychosomatic Research 2006, 60:349-35.
25. Deary V: A precarious balance: using a self-regulation model to 
conceptualize and treat chronic fatigue syndrome. British Journal of 
Health Psychology 2008, 13: 231-236. 
26. Maes S, Gebhardt W: The health behavior goal model. In Handbook 
155
of Self-regulation. Edited by Boekaerts M, Pintrich PR, Zeidner M.  San 
Diego, CA: Academic Press; 2000:343-368. 
27. Maes S, Karoly P: Self-regulation assessment and intervention 
in physical health and illness: a Review. Applied Psychology: An 
International Review 2005, 54(29):267-299. 
28. Miller WR, Rollnick S: Motivational Interviewing: Preparing People 
for Change. New York: Guilford Press; 2000.
29. Resnicow K, DiIorio C, Soet JE, Borrelli B, Hecht J: Motivational 
interviewing in health promotion: it sounds like something is changing. 
Health Psychology 2002, 21(5):444-451.
30. Powell P, Bentall RP, Nye FJ, Edwards RHT: Randomised controlled 
trial of patient education to encourage graded exercise in chronic 
fatigue syndrome. BMJ 2001, 322:387. 
31. Ang D. Kesavalu R, Lydon JR, Lane KA, Bigatti S: Exercise-based 
motivational interviewing for female patients with fibromyalgia: a case 
series. Clinical Rheumatology 2007, 26(11):1843-9. 
32. Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible 
statistical power analysis program for the social, behavioural and 
biomedical sciences. Behavior Research Methods 2007, 39:175-191.   
33. Knoop H, Van der Meer JW, Bleijenberg G: Guided self-instructions 
for people with chronic fatigue syndrome: a randomised controlled trial. 
British journal of Psychiatry 2008, 190:340-341.
34. Stulemeijer M, de Jong LW, Fiselier TJ, Hoogveld SW, Bleijenberg 
G: Cognitive behaviour therapy for adolescents with chronic fatigue 
syndrome: randomised controlled trial. BMJ 2005, 330(7495):820.
35. Vercoulen JHMM, Alberets M, Bleijenberg G: De Checklist 
Individual Strenght (CIS). Gedragstherapie 1999, 32:31-36. 
36. Wagner D, Nisenbaum R, Heim C, Jones JF, Unger ER, Reeves WC: 
Psychometric properties of the CDC symptom inventory for assessment 
of chronic fatigue syndrome. Population Health Metrics 2005, 3:8.
37. Cleeland CS, Ryan KM: Pain assessment: global use of the brief pain 
inventory. Ann Acad Med Singapore 1994, 23:129-138. 
38. Van Veldhoven M, Broersen S: Measurement quality and validity 
of the “need for recovery scale”. Occupational Environmental Medicine 
2003, 60(Suppl 1):3-9.
39. Spence M, Moss-Morris R, Chalder T: The behaviour responses to 
illness questionnaire (BRIQ): a new predictive measure of medically 
unexplained symptoms following acute infection. Psychological 
156
Medicine 2005, 35:583-593. 
40. Degoratis, L.(1993). Brief Symptom Inventory: Administration, 
Scoring and Procedures Manual. 4th edition. Minneapolis: National 
Computer System.
41. Canavarro MC: Inventário de sintomas psicopatológicos – BSI. In 
Testes e provas psicológicas em Portugal. Volume 2. Edited by Simões M, 
Gonçalves M, Almeida L. Braga: SHO/APPORT; 1999:87-109.
42. American Psychological Association: Diagnostic and statistical 
manual of mental disorders (DSMIV-TR). 4th edition. Washington DC; 
2000.
43. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The 
pittsburgh sleep quality index (PSQI): a new instrument for psychiatric 
research and practice. Psychiatry Research 1989, 28(2):193-213.
44. Kroenke K, Spitzer R, Williamsm JBW: The PHQ-15: validity 
of a new measure for evaluating the severity of somatic symptoms. 
Psychosomatic Medicine 2002, 64:258-266.
45. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B: How to score 
version 2 of the SF-12® Health Survey. Lincoln, RI: Quality Metric 
Incorporated; 2002.
46. Wendel-Vos GCW, Schuit AJ, Saris WHM, Kromhout D: 
Reproducibility and relative validity of the short questionnaire to assess 
health-enhancing physical activity. Journal of Clinical Epidemiology 
2003, 56, 1163 – 1169.
47. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath 
SJ, O’Brien WL, Bassett DR, Schmitz KH, Emplaincourt PO, Jacobs DR, 
Leon AS: Compendium of physical activities: an update of activity codes 
and MET intensities. Medicine and Science of Sports & Exercise 2000, 
32(Suppl 9):498-504.
48. Broadbent E, Petrie KJ, Main J, Weinman J: The brief illness 
perception questionnaire. Journal of Psychosomatic Research 2006, 
60:631-637.
49. Garnefski N, Kraaij V: Cognitive emotion regulation questionnaire: 
development of a short 18-item version (CERQ-short). Personality and 
Individual Differences 2006, 41:1045-1053. 
50. Sullivan MJL, Bishop SR, Pivik J: The pain catastrophizing scale: 
development and validation. Psychological Assessment 1995, 7:524-532.
51. Maes S, Karoly P, De Gucht V, Ruehlman LS, Heiser W:  The self-
regulation skills battery (SRSB). Leiden(NL)/Phoenix (AZ): Leiden 
157
University  &   Arizona State University; 2006.
52. Marques M, Gouveia MJ: Portuguese version of the physical activity 
barriers efficacy questionnaire. In Proceedings of the Sixth National 
Conference on Health Psychology: 2 - 4 February 2006; Faro. Edited by
Leal I. Ribeiro JPL, Jesus SN. Edições ISPA; 1996: 497-501. 
53. Williams GC, Freedman ZR & Deci EL: Supporting autonomy to 
motivate glucose control in patients with diabetes. Diabetes Care 
1998, 21:1644-165.
54. Sniehotta FF, Scholz U, Lippke S, Ziegelmann J: Scale for assessment 
of implementation planning and coping planning. 2002.  [http://
userpage.fuberlin.de/~falko/scales/heartdocu.html]
158










Post-intervention assessment (at 3 months)











ü	 Listen to patient complaints, with emphasis on fatigue.
ü	 Illness perceptions.
ü	 Exploration of patients’ present physical activity behavior.
ü	 Current health behaviors and other activities are explored (physical activity, sleep, 
pain, etc.).
ü	 Discussion of the information on the booklet given previously (specially the relation 
between CF major symptoms and physical activity behavior and boom-bust pattern). 
ü	 Motivation and Confidence Scales: Exploration of the willingness to engage in 
physical activity (or adjust current physical activity behavior) and the confidence in one’s 
own capability to achieve this behavior with success.
ü	 Discussion of the pros and cons (not-) to change physical activity behavior 
(Decisional Balance).
ü	 Social support network is addressed. 
Motivational Interviewing
Session 2
ü	 Discussion of possible competing goals with physical activity (e.g. housework 
chores). 
ü	 Strategies to overcome obstacles to physical activity and competing goals are 
addressed. 
ü	 Based on the register of daily activities and steps taken (pedometer register) and 
GET scheme for physical activity, the patient establishes a personal physical activity goal 
for the following two months.
ü	 Discuss the possible reasons for perpetuation of symptoms and difficulty to change 
health behaviors in CF patients, namely perfectionism, fear of movement, presence of 
stressful situations and boom-bust pattern. (some are already mentioned at the first 
motivational interview and are now emphasized). 




ü	 Revision of the physical activity goal planning (adequacy to the patients’ present 
situation).
ü	 Relapse prevention (strategies to overcome new or persisting difficulties to physical 
activity and emotion control strategies).
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ü	 Overview of Chronic Fatigue: CDC diagnosis criteria, epidemiology information, etiology, 
possible factors that contribute to a better or words prognosis (e.g. physical inactivity/activity).
ü	 Physical activity: current physical activity guidelines for adults in general population, 
physical and psychological benefits of physical activity, benefits of physical activity for CF. 
Information about different types of physical activities (that are appropriated for CF) such as 
walking as well the importance and illustration of relaxation training.
ü	 Link between CF symptoms and physical (in-) activity (deconditioning cycle) and boom-
bust pattern (erratic pattern of rest and activity).
Self-regulation 
Workbook 
STEP 1 – “Am I ready to start?”
ü	 Motivation and Confidence Scales: Patients’ willingness and confidence to do adjusted 
levels of physical activity is assessed on a scale for ranging from 0% (not at all) to 100% (very 
much). 
ü	 Decisional Balance: list of the pros and cons (not-) to change in relation to physical activity.
ü	 Competing goals with exercise: information on the importance o analyzing possible 
competing goals (or conflicting activities) with exercise that may be refraining patients from 
physical activity. List of two main activities (e.g. other leisure activities).
ü	 Activity/Rest Diary and Pedometer log – instructions to use for two weeks (interval 
between MI sessions) and the importance of the pedometer as a motivational strategy. 
STEP 2 – “My physical activity goal”:
ü	 GET Scheme and daily activity management: information on the importance of increase 
physical activity level gradually, consider the way patients feel in different days (different levels 
if patients is feeling good or bad), importance of rest during physical activity, importance of 
adjusting physical activity levels to the amount of effort spent in that day (balance between 
activities and rest).
ü	 Goal setting activity: explanation of how to set a goal (SMART – specific, measurable, 
achievable, realistic and timely), formulation of a personal physical activity goal to achieve 
in 2 months time (e.g. to do brisk walking four days per week for 30 minutes (plus 10 minutes 
break), implementation intentions (type of activity, frequency and intensity, period of the day, 
with whom, where) and a goal ladder (patients formulate goals for every 2 weeks until reaching 
the two months time and main goal. 
ü	 Information on self-rewarding for each step goal achieved.
ü	 Tips for managing daily activities and incorporate physical activity on the daily routine
STEP3 – “Overcoming obstacles”:
Problem solving activity: List two main physical activity barriers and a strategy to overcome it.
STEP 4 – “I am physically active…and I want to keep that way”:
ü	Relapse prevention information and strategies.
ü	Resources and support for CF and physical activity.




ü	 Record containing the days of the week and hours each day. Patients fill the activities they 
do in each hour of day. The options are: physical activities, other activities (activities requiring 
mental effort) and rest. Each option is explained in detail. 
Leaflet for family ü	 Facts about CF.
ü	 Brief information on the relation between physical activity and CF. 
ü	 Tips for partners or other relatives to support patients with CF. 
161






Duration Symptoms and diagnosis X
CFS symptom checklist X X X
Presence of FM symptoms X X X
CIS-20R X X X
Impact of fatigue X X X
NFR X X X
Work related questions X X X
Brief IPQ-R X X X
Brief IPQ-R causes subscale X
CERQ positive subscales X X X
PCS X X X
BRIQ X X X
Social support X X X
BSI X X X
Sleep X X X
PHQ-15 X X X
SF-12 X X X
Physical Activity history X X X
Steps taken (pedometer) X X X
Physical activity intention X
Action planning X
Coping planning X
SRSB Physical activity goal elicitation X
SRSB Physical activity goal progress X X X
SRSB goal efficacy scale X
SRSB all scales X X
Barriers Efficacy X X X
TSRQ X X X
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Purpose: This study aimed at assessing the effects of a self-
regulation based brief physical activity program for patients 
suffering from unexplained chronic fatigue, the “4-STEPS to 
control your fatigue program”.  
Methods: A 12-week randomized controlled trial was conducted. 
Adult patients meeting the CDC criteria for idiopathic chronic 
fatigue were randomized to either the control condition (standard 
care) or the intervention condition (4-STEPS). The 4-STEPS was 
based on self-regulation principles and consisted of motivational 
interviewing and self-regulation skills training. All patients were 
assessed at baseline and post-treatment (12 weeks) for fatigue 
severity (primary outcome) and impact, physical activity (leisure-
time physical activity, number of daily steps, and personal activity 
goal progress), health-related quality of life, somatic distress and 
psychological distress (depression and anxiety). 
Results: Ninety-one patients (45 intervention and control 
patients) received the allocated intervention. At post-treatment, 
statistical analysis revealed a significant difference for subjective 
experience of fatigue (4.73 points; g=0.51) in favor of the 
intervention group. Mixed design ANCOVAs showed a significant 
effect of the 4-STEPS on fatigue severity, leisure-time physical 
activity, personal activity goal progress and health-related quality 
of life. No significant effects were found for number of daily steps 
and somatic and psychological distress. 
Conclusions: The 4-STEPS program has significant beneficial 
effects at post-treatment. This brief self-regulation based 
intervention looks promising for the management of unexplained 
chronic fatigue. 
Trial Registration: ISRCTN70763996





Unexplained or Idiopathic Chronic fatigue (ICF) is a condition 
characterized by the presence of severe and persistent fatigue 
(lasting for at least 6 months) that cannot be explained by an 
organic disease. According to the Centres for Disease Control 
and Prevention (CDC), persistent fatigue is diagnosed as 
Chronic Fatigue Syndrome (CFS) on condition that a minimum 
number of additional somatic symptoms are present [1]. CFS is 
a serious medical condition in which the patient’s functioning 
is significantly impaired leading to disability and lower 
health-related quality of life (HRQoL) [2]. One of the major 
symptoms is the presence of post-exertional malaise, which is 
characterized by severe exhaustion following physical activity. 
Patients’ perceptions and expectations related to symptom 
exacerbation as a consequence of exercise can lead to fear of 
physical exercise and can, therefore, explain the reduced levels 
of physical activity found in these patients [3, 4]. In addition, 
several studies emphasize the fact that the lack of physical 
activity and excessive resting found in these patients can result 
in physical deconditioning and, as a consequence, perpetuate 
fatigue severity and physical disability [4-6]. Therefore, 
(balanced) physical activity has been considered to be an 
important behaviour in managing chronic fatigue [7]. 
Graded Exercise Therapy (GET), a behavioural intervention 
targeting a gradual increase in aerobic exercise (in order to 
avoid overexertion), has been shown to have beneficial effects 
on fatigue severity in CFS patients [8]. Cognitive behavioural 
therapy (CBT), which usually incorporates changes in physical 
activity (and rest) behaviour, has also demonstrated to be 
effective in reducing fatigue symptoms in CFS patients [9]. A 
recent meta-analysis compared the effectiveness of GET and 
CBT [10]. Both were moderately effective in reducing fatigue 
and functional impairment. Still, results were heterogeneous.
Both CBT and GET interventions are usually resource-
intensive requiring a considerable number of contact hours and 
sessions (in general between 8 and 16 sessions) with patients 
[10, 11]. Recently, two randomised controlled trials that tried 
168
to overcome this limitation by conducting minimal contact CBT 
interventions based on self-guided instruction manuals and 
regular email contacts, showed promising results [12, 13]. Another 
intervention study (pragmatic rehabilitation) targeting physical 
activity for chronic fatigue patients, comparing treatment 
conditions that differ in intensity, found that the minimum 
intervention conditions (2 face-to-face sessions with or without 
7 brief telephone contacts) were as successful as a more extensive 
version of the program (9 face-to-face sessions) [14]. 
Adopting a health behaviour change framework, such as Self-
regulation (SR) theory [e.g. 15] can be useful for promoting 
physical activity in chronic fatigue patients [16, 17]. SR based 
interventions have demonstrated to be effective in promoting 
health behaviour change in chronic disease populations [17-
20]. According to SR theory behavior is a goal guidance process 
[16]. This process consists of a goal selection/ goal setting or 
motivational phase, an active goal pursuit or action phase and 
a goal attainment or maintenance phase. Several SR cognitions 
and skills are guiding this process, such as autonomous 
regulation of behavior (and goal ownership), self-efficacy, goal-
setting, planning, self-monitoring, feedback, emotional and 
attention regulation and relapse prevention strategies [16]. 
An important form of intervention that incorporates SR 
principles is Motivational interviewing (MI), which is a 
“collaborative conversation style for strengthening a person’s 
own motivation and commitment to change” ([21] p. 12). In 
MI, the patient’s own motivation for change is evoked and 
self-efficacy is strengthened. MI was found to be effective in 
promoting health behavior change, especially in helping patients 
move from ambivalence towards behavior change during a 
motivational phase [21, 22]. While MI mainly focuses on SR 
cognitions, SR skills are equally important, especially during the 
active goal pursuit and maintenance phase [16]. 
From this perspective, we developed a brief SR based 
intervention, combining MI and SR- skills training, to target 
physical activity among patients with unexplained chronic 
fatigue (the “4-STEPS to control your fatigue” program). This 
study aimed at evaluating the effects of the 4-STEPS program 
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upon fatigue severity and impact, physical activity, health-
related quality of life, somatic distress and psychological 
distress. 
Method
The rationale and details of the trial design were given in detail 
elsewhere [23] and will thus only be briefly summarized here.   
Trial design 
This was a 12-week parallel-group, multicentre randomized 
controlled trial, with equal randomisation (1:1) to either the 
intervention condition (4-STEPS program) or the control 
condition. Randomisation sequence was stratified by sample 
(Health Care centres and Patient Association), and within the 
first sample also by centre. Randomisation was conducted using 
computer-generated allocation numbers, under the supervision 
of a member of the research team, who did not take part in the 
subsequent phases of the trial. Group allocation was known to 
subjects, therapist and assessors. Patients were recruited from 
consecutive referrals. Patients were assessed at baseline (T1) and 
12-weeks later (post-treatment – T2). The primary outcome was 
subjective experience of fatigue and secondary outcomes were 
fatigue severity, fatigue impact, physical activity, health-related 
quality of life (HRQoL- physical and psychological functioning), 
somatic distress and psychological distress (depression and 
anxiety). Approval was obtained from the Portuguese Medical-
Ethics Committee of the North Regional Health Administration 
and from the medical board of each participating health care centre. 
The trial was conducted between January 2011 and December 2012.
Participants and procedure
Adult patients meeting the CDC criteria for idiopathic chronic 
fatigue (i.e. presenting a main complaint of unexplained fatigue 
of at least six months duration) were eligible to participate in the 
study [1]. Additional inclusion criteria were to fully understand and 
speak Portuguese and to have the capacity to provide an informed 
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consent. Patients presenting a concurrent somatic condition 
and/or a severe psychiatric disorder that could explain fatigue 
symptoms (according to the CDC criteria for exclusionary medical 
and psychiatric conditions [1]) were excluded.
The study was conducted in several Portuguese health care 
institutions (four public primary care centres and one private 
practice) and in the Portuguese Fibromyalgia and Chronic 
Fatigue Syndrome Patient Association. Based on the inclusion 
and exclusion criteria, patients from the health care centres were 
referred by their medical doctor. All patients were informed of 
the trial content and invited for an individual interview in the 
health care centre (baseline assessment). Patients from the 
patient association who met the criteria (i.e. clinical diagnosis 
of unexplained chronic fatigue) and previously indicated their 
willingness to participate in research received an institutional 
letter containing the details of the trial. Patients who wished 
to participate returned the written informed consent form and 
were invited for the baseline assessment. For both samples, the 
inclusion and exclusion criteria were checked by the research 
team, using self-report measures based on the CDC criteria. In 
addition to standard medical care, patients assigned to the control 
condition received a flyer with information about the general 
health benefits of physical activity and current physical activity 
guidelines for adults [24], and set a personal physical activity goal 
for the upcoming months. Participants assigned to the intervention 
condition additionally received the 4-STEPS program.
4-STEPS to control your fatigue
The 4-STEPS program consisted of a brief SR based intervention 
to promote physical activity in chronic fatigue patients. The 
intervention was delivered by one trained health psychologist (with 
motivational interviewing training) to individual patients. The 
intervention was structured around the SR phases of goal pursuit 
(goal selection and setting, active goal pursuit and goal attainment, 
maintenance and disengagement) [17]. 
Firstly, participants received two 1-hour face-to-face individual 
motivational interviewing sessions (weeks 1 and 3) aimed at: (a) 
exploring important health and life goals, to which a physical 
171
activity goal could be related, (b) increasing participants’ 
motivation and confidence to be physically active and (c) setting a 
specific personal physical activity goal. This personal and flexible 
physical activity goal, which took into consideration the need to 
avoid overexertion, was set by each patient during the second MI 
session. Patients also formed action plans regarding their goal (i.e. 
which physical activities would be done, and when, where, for how 
long and with whom each would take place).
 Secondly, participants received an informational booklet 
(available from the first author) containing information regarding: 
(a) the diagnosis of CF(S), (b) factors contributing to a better or 
worse prognosis, and (c) the link between CF(S) symptoms and 
physical (in-)activity and the boom-bust pattern (i.e. erratic pattern 
of rest and activity) commonly found in these patients. 
Thirdly, a SR based workbook (available from the first author) 
was given to patients. The SR workbook was divided in four steps, 
each one focusing on specific SR cognitions and skills: Step 1-“Am I 
ready to start?” (focusing on self-efficacy, motivation, and control 
over competing goals), Step 2- “My physical activity goal” (focusing 
on goal-setting, action planning and self-monitoring), Step 3 
“Overcoming obstacles” (focusing on coping efficacy and planning, 
feedback, and attention and emotion regulation i.e. control of 
distracting stimuli and negative emotions to maintain a focus on 
goal pursuit), and Step 4 “I am physically active...and I want to 
keep it this way” (focusing on relapse prevention, including coping 
efficacy and planning and goal reformulation). 
Fourthly, patients received two brief SR-based telephone-
counselling sessions (weeks 5 and 9). This telephone support aimed 
at reviewing the participants’ physical activity goal and providing 
relapse prevention strategies. 
Fifthly, patients received a pedometer to register steps taken 
on a daily basis during the 12-week intervention period. Finally, 
patients received a leaflet for their partner or significant other with 
relevant information on chronic fatigue, the objective of which was 
to increase social support. 
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Outcomes 
Patient characteristics Socio-demographic characteristics 
included age, gender, education and employment status. Clinical 
information was gathered using the following indicators: (1) 
presence of persistent fatigue, (2) duration of fatigue symptoms, 
(3) impact of fatigue on daily activities (4) whether fatigue was 
alleviated by rest, (5) number of medical consultations, and (6) a 
CDC based symptom checklist for CFS [25]. The checklist presents 
19 major and minor symptoms of CFS as defined by the CDC 
criteria [1]. Respondents are asked to rate if they experienced each 
of the symptoms for the last 6 months. For the purpose of this 
study a dichotomous scale (Yes/No) was used. A major symptom 
score is calculated by adding up the number of major symptoms 
presented (ranging from 1 to 8). To be diagnosed with CFS patients 
need to have a complaint of persistent unexplained fatigue (at 
least 6 months) that leads to a significant disability and to have at 
least 4 of the major CFS symptoms listed by the CDC. Patients not 
fulfilling the full criteria were classified as ICF patients. The self-
reported measures also included a question regarding the presence 
of chronic disease and/or psychiatric disease, as well as name and 
duration, if any.
Fatigue Severity was assessed at T1 and T2 by means of the 
Portuguese adaptation of the Checklist of Individual Strength 
(CIS20-P) [26], which is a well-validated and reliable measure 
for assessing fatigue severity in chronic fatigue patients [27]
{Vercoulen, 1999, De Checklist Individual Strenght (CIS);Marques 
M, , Psychometric properties of the Portuguese version of the 
Checklist of Individual Strength (CIS20-P)}. The CIS20 is a 20 
item self-report measure that assesses four dimensions of fatigue: 
subjective experience of fatigue, concentration, motivation and 
activities. Items are rated on a 7-point scale. A total score (total 
fatigue severity) can be calculated by adding up the scores for 
each dimension. For the purpose of this study only the subjective 
experience of fatigue dimension (primary outcome; range 8-56) 
and the total fatigue severity score (range 20-140) were used. 
Higher scores indicate more fatigue. A cut-off point of 35 on the 
subjective experience of fatigue dimension of the CIS20 is usually 
used to define a clinical level of fatigue [28].
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Fatigue impact (T1 and T2) was measured by means of a modified 
version of the pain interference dimension of the well validated 
Brief Pain Inventory (BPI) consisting of 7 items [29]. Participants 
were asked to rate on a 10-point scale how their fatigue interfered 
with several aspects of their life. The total score was used as an 
outcome. Higher scores indicate a higher fatigue impact (ranging 
from 0 to 10). 
Physical activity (T1 and T2) was assessed by means of:
a) A self-report measure of leisure-time physical activity based 
on the Short Questionnaire to Assess Health-enhancing Physical 
Activity (SQUASH) [30]. Participants indicate the number of 
days per week and minutes per day in which they engage in 
physical activities (bicycling, walking and other activities such as 
swimming). For each activity of at least moderate intensity (≥3 
METs based on the categories of the Ainsworth’s compendium 
of physical activities [31,32]), total minutes of physical activity 
per week is calculated by multiplying frequency (days/week) and 
duration (minutes/day). Total number of minutes of leisure-time 
physical activity (moderate to vigorous physical activity - MVPA) 
per week is calculated by taking the sum of each activity score. 
b) Physical activity was also measured by means of a pedometer 
(T1 and T2). Daily steps were assessed using Yamax Digiwalker SW-
200 pedometers, which have been demonstrated to be accurate and 
reliable [33, 34]. Participants were asked to wear the pedometer for 
seven consecutive days and register the daily number of steps at the 
end of each day. The mean of the daily steps over these seven days 
was used as an outcome measure.
c) Personal physical activity goal progress. Using a standardized 
goal-elicitation procedure, respondents specify a personal physical 
activity goal which they wish to pursue over the next months. At 
post-treatment, respondents were reminded of their personal goal 
and asked to indicate their progress on a 10 cm visual analogue scale 
(VAS), ranging from “I haven’t started yet” (0) to “I have achieved 
my goal” (10) [35]. Participants of the control group set a personal 
physical activity goal during the baseline assessment session and 
participants of the intervention group set their physical activity 
goal during the second Motivational Interviewing session.
Health-Related Quality of Life (HRQoL) (T1 and T2) was 
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measured using the Short Form Health Survey-12 (SF-12V.2) [36]. 
The SF-12v2 is a well validated measure that allows to calculate a 
physical functioning score (Physical HRQoL) and a psychological 
functioning score (Psychological HRQoL), ranging from 0 to 100, 
with lower scores representing worse HRQoL.
Somatic distress (T1 and T2) was measured by means of the 
Patient Health Questionnaire-15 (PHQ-15). The PHQ-15 assesses 
the presence and severity of 15 somatic symptoms (e.g. back 
pain). Patients are asked to indicate to what extent they have been 
bothered in the past 4 weeks by each symptom, with higher scores 
indicating higher somatic symptom severity (range 0 - 30) [37].
Psychological distress was assessed at T1 and T2 using the 
Depression and Anxiety subscales from the well-validated and 
widely used Brief Symptom Inventory (BSI) [38]. Individuals rank 
each symptom on a 5-point Likert scale (from “never” to “very 
frequently”) with higher scores representing more psychological 
distress. Scores were calculated by taking the mean of the items of 
each subscale (range 0-4). 
Sample size
An a priori analysis [39] showed that a sample of 34 participants 
in each group would be sufficient to detect a mean difference of 7 
points  [12, 40] between the intervention and the control group, on 
the subjective experience of fatigue dimension of the CIS20-P, with 
80% power at a 5% significance level. Considering a possible drop-
out of 20% we aimed at recruiting 41 subjects per group.
Statistical Analyses
Descriptive analyses were performed for gender, age, education, 
employment, clinical information and use of health care resources. 
Differences between groups at baseline were analyzed using t-tests 
(for continuous variables) and univariate chi-square tests (for 
dichotomous variables). The difference in subjective experience of 
fatigue (primary outcome) between the intervention and control 
groups at post-treatment was analyzed with an independent 
samples t-test. 
Effects of the intervention on primary and secondary outcomes 
were examined using 2 (baseline – T1 vs. post-treatment-T2) 
175
x 2 (intervention vs. control) mixed-model repeated measures 
analysis of covariance (ANCOVA), controlling for setting (Health 
care centres vs. Patient association) and disease duration. Effect 
sizes (ES) were the standardized mean difference [(mean a-mean 
b/ pooled SD)] with Hedge’s g correction for small samples 
[41]. Prior to analysis, data was inspected for normality and 
homogeneity of variance. Leisure-time physical activity was not 
normally distributed at both time points, and so it was logarithmic-
transformed (Lg + 1) for further analyses. Descriptive statistics 
for this variable are presented in a non-transformed format. 
Mixed design ANCOVAs were conducted with intention-to-treat 
analyses (ITT) using the last-observation-carried-forward method 
(LOCF), which included all participants for whom complete 
baseline data was available. We undertook sensitivity analyses to 
test the robustness of the results of the mixed design ANCOVAs 
using a) Complete Case analysis and b) Multiple Imputation 
analysis. Five imputation datasets were generated, based on the 
results from the complete case dataset, using outcome variables as 
predictors. Linear regression models were adopted for the Multiple 
Imputation, with the exception of leisure-time physical activity in 
which we used a Predictive Mean Matching (PMM) approach due to 
the non-normal distribution of this variable. Assumption that data 
was missing at random (MAR) was first verified. Each dataset was 
analyzed individually using mixed design ANCOVAs. Sensitivity 
analyses revealed similar results for three approaches, with the 
exception of Psychological HrQoL Therefore main results report 
the ITT analyses. Missing values at baseline due to incomplete 
assessment (number of steps per day and goal progress) were also 
imputed using Multiple Imputation. 
Finally, at T2, additional chi-square analyses were conducted for 
the complete dataset to compare the proportion of patients in each 
group a) who did not meet non-clinical levels for fatigue severity 
(<35) assessed by the subjective experience of fatigue sub-scale of 
the CIS20-P and b) who were physically active. Effect sizes (ES) 
were Risk Ratio (RR). We considered p values lower than or equal 
to 0.05 as significant. Data analyses were conducted using the 
statistical software SPSS v22.
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Results
Participant flow and patient characteristics 
Among the 165 individuals who were identified as eligible to 
participate and who were informed about the study, 99 patients 
were randomised to either the 4-STEPS program or the control 
condition, and 91 recruited into the trial with adequate baseline 
measures completed (intervention condition: n= 45; Control 
condition: n=46).  The flow of patients through the trial and reasons 
for exclusions and withdrawals are displayed in Figure 1. 
Demographics and clinical characteristics are presented in Table 
1. No significant differences were found for any of the demographics 
and clinical variables.
Intervention effects
A significant difference of 4.73 points in the subjective experience 
of fatigue was found between the intervention and the control 
group (t= -2.46, p=.016, 95% CI – 8.54 to -0.91, g=0.51). Patients 
in the intervention group presented with lower levels of fatigue 
severity than those in the control group. At T2, there was no 
significant difference in the proportion of patients presenting 
non-clinical levels of fatigue in the intervention (10/35 - 28.6%) 
and control groups (5/33 - 15.2%; X2=1.779, p=0.18; RR=1.89 95% CI 
0.72 to 4.94). This corresponds to an increase from baseline in the 
percentage of patients presenting non-clinical levels of fatigue of 
25.7% and 6.1%, respectively.
The results of the mixed design ANCOVAs for the ITT (LOCF) 
approach are presented in Table 2 (for a comparison of results 
between the three approaches see Table 3). There was a significant 
effect of the intervention on levels of subjective experience 
of fatigue and total fatigue severity, after controlling for the 
effect of the covariates (p=.028 and p=.019; respectively). In the 
intervention group there was a significant decrease from T1 to T2 
in the subjective experience of fatigue (mean change=-3.38, 95% CI 
-5.81 to -0.94; control group mean change= +0.35, 95% CI -1.89 to 
2.58) and total fatigue severity (mean change=-4.67, 95% CI –9.61 
to 0.28; control group mean change=+3.22, 95% CI -0.87 to 7.31). 
Likewise there was a significant time by group interaction in 3 out 
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of 5 imputed datasets for subjective experience of fatigue (p=.007 to 
p=.026) and in 4 out of 5 imputed datasets for total fatigue severity 
(p=.000 to p=.017). No significant effects were found for fatigue 
impact (p=.550; imputed data sets non-significant).
As for physical activity related variables, patients in the 
intervention group presented significantly higher levels of leisure 
time physical activity (p= .000) and progress toward a personal 
physical activity goal (p=.000), also significant in all 5 imputed 
data sets (p=000 to p=0.21 and p=<.001, respectively). There was 
a significant increase in the intervention group from T1 to T2 
for level of leisure-time physical activity (mean change=+79.11, 
95% CI 39.71 to 118.52; control group mean change=-0.98, 95% CI 
-29.03 to 27.07), and personal physical activity goal progress (mean 
change=+2. 66, 95% CI 1.79 to 3.53; control group mean change= 
+0.20, 95% CI -0.66to 1.05). The interaction effect for the number of 
steps/day was of small magnitude and not significant (p=0.56; mean 
change=+448, 95% CI 33 to 861; control group mean change=-387, 
95% CI -1096 to 322), significant in only one (out of five) imputed 
dataset (p=.027). There was a significantly higher proportion of 
physically active participants in the intervention group (26/35 - 
74.3%) in comparison to the control group (11/33 - 33.3%; X2=13.22, 
p= 0.00; RR=2.23 95% CI 1.32 to 3.75). Patients in either group 
reported no negative effects of exercise or participation in the 
study.
Repeated-measures ANCOVAs also showed a significant time 
by group interaction for physical and psychological HrQoL after 
controlling for the effect of the covariates (p=.002 and p=.047, 
respectively). Mean change in the intervention group from T1 to 
T2 was +5.11 (95% CI 1.05 to 9.17 and +5.28 (95% CI -0.39 to 10.17), 
respectively (control group mean change= -3.15, 95% CI -7.30 
to 0.88 and -0.81, 95% CI -381 to 2.20). There was a significant 
interaction effect in 3 out of 5 datasets imputed for physical HrQoL 
(p=.000 to p=.006) and only in 2 out of 5 datasets for psychological 
HrQoL (p=.003 to p=.048). No significant effects were found for 
somatic symptoms (p=.456) and psychological distress (depression 




This study examined the effect of a 12-weeks brief self-regulation 
(SR) based program for unexplained chronic fatigue (4-STEPS) 
targeting physical activity. Attrition to the trial was higher than 
initially anticipated (≥20%), but this study included a larger sample 
than what was established in the study protocol [23].  
At post-treatment, there was a significant beneficial effect of the 
4-STEPS program on the subjective experience of fatigue (primary 
outcome). Although the difference between the intervention and 
control conditions did not reach the 7 point target, the significant 
decrease in the subjective experience of fatigue in the intervention 
group (3.38) can be considered to be clinically significant as the 
difference exceeds 0.5 SD, a criterion used in other GET and CBT 
trials [42, 43]. Mixed-design analysis comparing the intervention 
and control conditions at T1 and T2 revealed a moderate beneficial 
effect of the 4-STEPS program on subjective experience of fatigue 
and total fatigue severity (g=0.44, g=0.39). These results are in line 
with the average effect size for fatigue severity found in a previous 
meta-analysis of graded exercise and psychological interventions 
for chronic fatigue management (g=0.41 and g=0.36) [10]. These 
effects are however lower than those found in other psychological-
based minimal interventions [12, 15]. No significant differences 
were found between the proportion of patients in each condition 
who reached non-clinical levels of fatigue (<35) at T2; however the 
number of patients presenting non-clinical levels of fatigue in the 
intervention condition is comparable to what is reported in other 
trials [12, 13]. Furthermore, we found an increase in the number of 
patients in the intervention group presenting non-clinical levels of 
fatigue compared to baseline. 
Beneficial effects were also found for leisure-time physical 
activity (g=0.77), resulting in a significantly higher number of 
active patients in the intervention group at T2. We observed a small 
increase in the daily number of steps in the intervention group 
( 450 steps) as compared to a reduction in the daily steps in the 
control group, but time by group interaction was not statistically 
significant. Current guidelines of physical activity for individuals 
with chronic disease recommend a minimum of 6500-8500 steps 
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a day, which was achieved by the intervention group at post-
treatment. Still, the average increase in the number of steps in 
pedometer-based interventions is about 2.215 steps/day (or effect 
size of 0.67), which is considerably higher than those obtained in 
our trial [44]. Earlier trials have found small to medium effects of 
exercise interventions on the levels of physical activity/capacity 
in chronic fatigue patients [42, 45]. Other studies did not find 
these beneficial effects [12, 46]. However, these studies measured 
physical activity in a different way, mainly in a laboratory setting 
making use of functional capacity measures [e.g. 46], walking tests 
[e.g. 42] or actigraphy [e.g. 12]. In addition, a large effect (g= 0.83) 
of the 4-STEPS program was found on patients’ progress in the 
attainment of their personal physical activity goal. This result 
points at the important role of self-regulation cognitions and skills 
in self-set health behavior goal pursuit. 
In addition, patients who received the 4-STEPS program showed 
a significant improvement in physical health-related quality of life 
(HrQoL; g=0.41). This effect is in line with the average effect size for 
functional impairment found in a previous meta-analysis (g=0.38) 
[10]. Furthermore, we found a significant effect of small magnitude 
for psychological HrQoL (p=0.47, g=0.33). These results point at 
the psychological deterioration and increasing disability resulting 
from the burden of a prolonged chronic condition. Likewise, no 
significant beneficial effects were found for psychological distress 
(depression and anxiety). This last result is in line with previous 
studies including CBT trials [10]. 
Because of contradictory findings of physical exercise programs in 
CF(S) it has been suggested recently that physical activity programs 
should incorporate flexible goals that take into consideration 
symptom fluctuation and rest [47]. In the present study, goals 
related to physical activities were personal and planned according 
to these principles. In addition, the findings of the present study 
support minimal contact interventions using manuals. As such, this 
theory-based brief intervention, using motivational interviewing 
principles and self-regulation skills training, encouraged patients 
to set self-chosen active and positive goals and provided them with 
the skills to put them into practice [16, 48]. 
In spite of its strengths, the present study also has some 
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limitations. First, the small sample size limits the generalizability 
of the findings. Likewise, the lack of significance found for some of 
the secondary outcomes may be due to low statistical power, as our 
study was not powered to detect changes in secondary outcomes. 
Second, this trial was carried out in health care centres and in 
patient associations. To deal with potential bias the randomisation 
procedure was stratified by sample, and repeated measure analyses 
were conducted controlling for the setting (Health care centres 
vs. Patient association). Differences in the recruitment strategy 
within these settings may have led to selection bias. Furthermore, 
the findings may also be biased by self-selection, due to the high 
rate of patients not interested in participating in the trial. It may be 
that patients willing to participate were more motivated to change 
than non-participants. Third, confirmation of CF(S) inclusion and 
exclusion criteria was based on self-reports according to the CDC 
criteria and it can therefore not be excluded that some patients did 
not fulfill all the criteria. Ideally, this diagnosis should also rule out 
other somatic and psychiatric causes of the symptoms, by means of 
a full clinical assessment and standardised psychiatric interview. 
Fourth, allocation of participants to the conditions was conducted 
prior to baseline assessments as the goal elicitation procedure 
took place at different moments for each condition (baseline 
assessment for the control group and at the second face-to-face 
session for the intervention group). This constitutes an additional 
potential source of bias. Fifth, the intervention was delivered by 
only one psychologist, which did not allow controlling for therapist 
effects in our analysis. Furthermore, due to resources constraints 
we could not assess treatment integrity, which is an important 
procedure to enhance validity of interventions. Sixth, men were 
largely underrepresented in the sample and as a consequence more 
studies are needed to determine the effectiveness of this program 
in men suffering from CF(S). Seventh, due to the fact that there 
are no normative data for the Portuguese CIS20, comparisons 
made regarding (non-)clinical levels of fatigue severity should 
be interpreted with care. Finally, this intervention combined 
motivational interviewing, several self-regulation techniques 
and motivational tools (e.g. pedometer) and the effect of these 
components cannot be separated. Future studies could address this 
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issue by using a full-factorial design.
In summary, this study shows that a brief SR intervention 
targeting (balanced) physical activity has significant post-treatment 
beneficial effects upon fatigue severity, physical activity, personal 
goal progress related to physical activity and health-related quality 
of life in chronic fatigue patients. This low-resource intervention 
looks promising for the management of chronic fatigue. A follow-up 
assessment (12-months) will provide the necessary information to 
evaluate the medium-term effects of the 4-STEPS program.
Other information
The trial is registered at http://www.controlled-trials.com, number 
ISRCTN70763996 and we have previously published the protocol of 
our trial [23]. This report followed the revised CONSORT guidelines 
for reporting randomized trials [49].
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Figure 1   Flow diagram of participants through the intervention.







·Not meeting inclusion criteria (n= 19) 
·Not interested (n=47)
·Allocated to control condition (n=50)
·Did not complete baseline assessment 
(n=4)
Not feeling well enough (n=3)
Lack of time (n=1)
·Received allocated intervention (n=46)
Allocated to intervention condition (n=49)
·Did not complete baseline assessment 
(n=4)
Not feeling well enough (n=2)
Lack of time (n=2)
·Received allocated intervention (n=45)
·Discontinued intervention (n=5) 
Lack of time (n=5)
·Lost to follow-up (n=5) 
Couldn’t contact (n=2)
Failing to provide a reason (n=2) 
Not feeling well enough (n=1)
Analyzed in intention to-treat analysis 
(n=45) 
Per-protocol analysis (n=35)
· Excluded from analysis (n=0)
·Discontinued intervention (n=0) 
·Lost to follow-up (n=13)
Couldn’t contact (n=4)
Failing to provide a reason (n=3)
 Lack of interest (n=3)
Lack of time (n=3)
Analyzed in intention to-treat 
analysis(n=46) 
Per-protocol analysis (n=33)
·Excluded from analysis (n=0)
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Age 46.96±10.39 49.20±11.49 0.33
Gender (women) 44 (97.8) 45 (97.8) 1.00
Education
Primary 12 (26.7) 16 (34.8)
0.65Secondary 17 (37.8) 17 (37.0)
Higher 16 (35.6) 13 (28.3)
Employed 24 (54.3) 25 (54.3) 1.00
Not working due to fatigue 1 10 (45.5) 11 (47.8) 1.00
Abseentism (n. days) 2 6.20 ± 10.44 14.36 ± 22.61 0.14
Physically active3 15 (33.3) 17 (37) 0.82
Disease duration (years) 9.81 ± 8.02 10.96 ± 9.06 0.53
Number of medical consultations 4.03± 2.88 5.10 ± 4.43 0.20
Number of major CDC CFS symptoms  6.42 ± 1.29 6.70 ± 1.38 0.33
Diagnostic criteria
ICF 5 (11.1) 3 (6.5) 0.49
CFS 40 (88.9) 43 (93.5)
Clinical Levels of Fatigue4,5
Yes 42 (93.3) 43 (93.5) 1.00
No 3 (6.7) 3 (6.5)
Setting
1.00
Health Care Centres 24 (53.3) 25 (54.3)
Patient Association 21 (46.7) 21 (45.7)
Note. Values are presented as Mean ± Standard Deviation or Frequencies (%). 1 n=21 in each condition. 2 n=20 (Intervention 
condition); n=22 (Control condition). 3Results for completers [Physically active: Intervention group = 14/35 (40%); Control 
condition= 15/33 (45.5%); p= 0.65]. 4Cut-off score of 35 on the Subjective Fatigue sub-scale of the CIS20. 5Results for completers 
[clinical levels= 34/35 (97.1%) and 30/33 (90.9%); p=0.35]. CDC = Centres for Disease Control and Prevention; ICF = Idiopathic 






Group x Time 
interactionª
Outcome T1 T2 T1 T2 F p gb
Subjective 
fatigue 
46.00±6.30 42.62±9.93 47.00±7.66 47.35±8.31 F=4.965 .028 0.44
Fatigue 
severity1
98.40±16.43 93.73±22.37 103.54± 19.07 106.76 ± 20.32 F=5.721 .019 0.39
Fatigue 
impact
6.25±1.89 5.89±2.38 6.88±1.90 6.33±2.21 F=0.360 .550 0.09
Leisure-
time PA2 
41.56±70.59 120.67±146.19 58.37 ±106.28 57.39± 152.00 F=20.38 .000 0.77
PA 
(steps/day) 
6629±2716 7077±2746 6773±2820 6385±2830 F=3.748 .056 0.30
Goal 
progress 
1.50±2.39 4.16±3.30 2.32±3.04 2.51±2.84 F=16.37 .000 0.83
Physical 
HRQoL 
38.22±17.78 43.33±21.87 31.30±18.90 28.15±21.43 F=9.880 .002 0.41
Mental 
HRQoL 
41.57± 16.12 46.85±19.71 37.59 ±17.62 36.79±19.15 F=4.075 .047 0.33
Somatic 
distress 
14.02±4.04 13.05±4.72 16.20 ±4.47 15.76±4.48 F=0.562 .456 0.12
Depression 1.49±0.88 1.55±0.95 1.55±0.95 1.91±0.93 F=0.182 .671 0.05
Anxiety 1.63±0.77 1.44±0.79 1.66±0.79 1.64±0.81 F=1.203 .276 0.29
Table 2   Changes in outcomes between baseline (T1) and post-treatment (T2)
Note. Values are presented as mean ± standard deviation. ª Mixed design repeated measures using intention to treat analysis, 
adjusted for disease duration and setting (Health care centres vs. Patient association). bg = Hedge’s g (interpreted according to 
Cohen’s d (0.20- small; 0.50- medium; 0.80- large). 1CIS20 total score. 2 Descriptives are presented in raw form. PA= physical 
activity. HRQoL= Health-related quality of life.
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Table 3   Comparison between methods of data analysis (Complete Dataset, 
Last-Observation Carried Forward, Multiple Imputation)
Outcome Fa p gb Model
Subjective Fatigue 4.97 .028 0.44 LOCF
4.49 .038 0.55 Complete Case
7.75 .007 0.58 Smallest MI effect (3/5 sig)
Fatigue severity1 5.72 .019 0.39 LOCF
5.43 .023 0.51 Complete Case
13.51 .000 0.69 Smallest MI effect (4/5 sig)
Fatigue Impact 0.36 .550 0.09 LOCF
0.56 .457 0.15 Complete Case
1.20 .331 0.12 Smallest MI effect (0/5 sig)
Leisure-time PA 20.38 .000 0.77 LOCF
11.19 .001 0.71 Complete Case
13.44 .000 0.70 Smallest MI effect (5/5 sig)
PA (Steps/day) 3.75 .056 0.30 LOCF
3.82 .055 0.40 Complete Case
5.04 .027 0.43 Smallest MI effect (1/5 sig)
PA Goal Progress 16.37 .000 0.83 LOCF
16.83 .000 1.04 Complete Case
22.84 .000 1.18 Smallest MI effect (5/5 sig)
Physical HRQoL 9.88 .002 0.41 LOCF
9.89 .003 0.52 Complete Case
14.46 .000 0.57 Smallest MI effect (3/5 sig)
Mental HRQoL 4.08 .047 0.33 LOCF
3.91 .052 0.43 Complete Case
9.07 .003 0.57 Smallest MI effect (2/5 sig)
Somatic Distress 0.56 .456 0.12 LOCF
0.42 .521 0.15 Complete Case
1.79 .152 0.26 Smallest MI effect (0/5 sig)
Depression 0.18 .671 0.05 LOCF
0.21 .646 -0.07 Complete Case
0.83 .210 0.02 Smallest MI effect (0/5 sig)
Anxiety 1.20 .276 0.29 LOCF
1.02 .317 0.28 Complete Case
5.06 .027 0.51 Smallest MI effect (1/5 sig)
ª Mixed design repeated measures, adjusted for disease duration and setting (Health care centres vs. Patient 
association). bg = Hedge’s g 1CIS20 total score. PA= physical activity. HRQoL= Health-related quality of life. LOCF 
= Last-observation-carried-forward. MI= Multiple Imputation.
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of a self-regulation based 
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Background: Physical activity is considered to be beneficial for 
patients suffering from unexplained chronic fatigue. 
Purpose: Examine the medium-term effects of a brief physical 
activity (PA) self-regulation (SR) based intervention (4-STEPS 
program), and explore the mediating effects of PA and SR skills. 
Methods:  A two-arm randomized controlled study (Usual Care 
vs 4-STEPS) was carried out. The 4-STEPS program consisted of 
Motivational Interviewing and SR-skills training. Fatigue severity 
(primary outcome) and impact, PA, health-related quality of life 
(HrQoL), somatic and psychological distress were assessed at 
baseline, post-treatment (12 weeks) and 12 months follow-up. 
Results: Ninety-one patients (45 intervention and 46 controls) 
were included. At follow-up, there were significant treatment 
effects on fatigue severity (g=0.72) and fatigue impact, leisure-time 
PA, and physical and psychological HrQoL. Fatigue severity at 
follow-up was partially mediated by post-treatment progress on a 
personal PA goal and SR skills (effect ratio= 26% and 32%).
Conclusions: Results suggest that a brief intervention, focusing on 
the formulation and pursuit of personal PA goals and the use of SR 
skills, produces sustained benefits for fatigue severity.
Trial Registration: ISRCTN70763996
Keywords: chronic fatigue, randomized controlled trial, physical 




Fatigue is a common symptom, usually transitory and explained by 
life circumstances, but for some, fatigue is medically unexplained 
and severe, resulting in disability and lower health-related quality 
of life [1, 2]. Unexplained fatigue is considered to be chronic if it 
lasts for at least 6 months (i.e. idiopathic chronic fatigue-ICF). 
If additional somatic symptoms as defined by the Centres for 
Disease Control and Prevention (CDC) are present, it is classified as 
Chronic Fatigue Syndrome (CFS) [3].
Prolonged physical inactivity (rest) and decreased physical 
capacity are considered to be perpetuating factors in CF(S) [4-
6]. At the same time, high levels of physical activity can cause 
overexertion and perpetuate fatigue symptoms [7, 8]. Not 
surprisingly, it is common to find a “boom-and-bust pattern” in 
these patients, which is the systematic alternation between periods 
of over-activity (when feeling good) and, as a consequence of that, 
feeling extremely fatigued and having to rest for longer periods 
of time [9, 10]. It is therefore recommended that CF(S) patients 
engage in physical activity based on Graded Exercise Therapy 
(GET) [1, 11].
GET consists of exercise prescription (aerobic activities) adapted 
to the patient’s physical capacity. GET aims to gradually increase 
exercise at a level that does not exacerbate symptoms. Patients are 
advised not to exceed the recommended levels of physical activity 
(in order to avoid overexertion) and are encouraged to maintain 
these levels even if symptoms get worse. GET has been shown to 
have beneficial effects on chronic fatigue management [12-14]. 
Because of the benefits of physical activity in patients suffering 
from CF(S), many Cognitive Behavioural Therapy (CBT) trials 
have also incorporated a graded exercise component. CBT also 
has beneficial effects on chronic fatigue [12, 13, 15]. Despite the 
beneficial effect of both GET and CBT on CF(S) patients, effects of 
trials are of small magnitude and heterogeneous [12,13]. Some trials 
found limited effects of these interventions [e.g. 16, 17], while others 
proved to be very effective [e.g. 18, 19]. One explanation for the 
differences in effectiveness may be that some interventions result 
in creating cognitive or behavioural changes that may mediate the 
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effect of the intervention on fatigue, while others do not result 
in such changes. In the present article we will therefore not only 
report on the medium-term effects of a self-regulation physical 
activity based program for CF(S) patients, but we will also explore 
possible mediators of these effects, more specifically physical 
activity and self-regulation skills.  
Recent studies have shown that self-regulation (SR) based 
interventions are effective in promoting long-lasting health 
behaviour change in various patients suffering from chronic 
diseases [20-22]. SR is one of the most prominent perspectives 
on health behaviour change, and considers that behaviour is a 
goal driven process [23, 24]. This dynamic-goal process consists 
of a goal selection and goal setting phase, an active goal pursuit or 
action phase and a goal attainment or maintenance phase, in which 
motivational and volitional aspects interact. Several SR cognitions 
and skills are guiding this process, such as self-efficacy, personal 
goal-setting, planning, self-monitoring, feedback, emotional and 
attention regulation and relapse prevention [23]. Personal goal 
setting, a central aspect in SR theory, is a first step and implies 
that formulating self-chosen and personally important goals guide 
behavior change and increase the likelihood of goal achievement 
and maintenance [23-25]. 
Motivational interviewing (MI), a “collaborative conversation 
style for strengthening a person’s own motivation and commitment 
to change” ([26] p. 12) is frequently used to evoke and strengthen 
patients’ own motivation and confidence to change, and to support 
patients in setting personal health-related goals by increasing the 
personal relevance of health goals. MI is considered especially 
helpful in helping patients move from ambivalence towards 
behavior change [26].  While MI mainly focuses on SR cognitions, 
SR skills play an important part not only in the formulation 
of health-related goals (e.g. physical activity) but also during 
active goal pursuit and during the maintenance phase of the 
behavioral change process [23]. Recent meta-analyses showed that 
interventions employing a combination of SR-skills (including self-
monitoring) were more effective than interventions not using these 
techniques in increasing PA in the general population [27] and in 
improving chronic disease related outcomes [28]. 
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Based on the self-regulation cognitions and skills described above 
we developed a brief SR-intervention targeting physical activity 
for patients with CF(S) (the “4-STEPS to control your fatigue” 
program). The 4-STEPS program consists of a combination of 
MI sessions, telephone self-regulation counseling, and SR skills 
based patient manuals. In this program participants set their own 
physical activity goals and are advised to gradually increase their 
physical activity levels according to a specific personal scheme 
[29], allowing flexibility in the intensity and duration of exercise 
according to symptom fluctuation, without exceeding one’s own 
capacity. This also implies that physical activity can be reduced 
or even stopped when symptoms get worse [29-31]. Furthermore, 
balance between activity and rest is also taken into account.
The 4-STEPS program was tested in a randomized controlled 
trial [32], in which patients were either assigned to the control 
group (usual care) or to a 12-week self-regulation intervention 
(4-STEPS program). Post-treatment beneficial effects of the 
4-STEPS program were found for fatigue severity, health-related 
quality of life, leisure-time physical activity and perceived physical 
activity goal progress. No effects were found for fatigue impact on 
daily life, daily steps, somatic distress, and psychological distress 
(depression and anxiety) [33]. 
The first objective of the present study is to report the 12-months 
follow-up results of the 4-STEPS intervention on fatigue severity 
(subjective experience and fatigue severity) and impact on daily 
life, physical activity (leisure-time physical activity and daily 
steps), health-related quality of life (physical and psychological 
component), somatic distress and psychological distress (anxiety 
and depression). The second objective is to examine the mediators 
of intervention effects on the subjective experience of fatigue. It 
is hypothesized that the intervention increases the intermediate 
targets of our intervention – physical activity and the use of self-
regulation skills -, and that this increase mediates the medium-




This study concerns the follow-up results of a randomized 
controlled trial that has been previously described in full detail 
[32]. It was a two-arm 12-week multicentre randomized controlled 
trial. Randomisation was stratified by sample (Health care centre 
and Patient Association), and within the first sample also by 
centre, with equal randomisation (1:1) to either the intervention 
condition (4-STEPS program) or the control condition. Allocation 
sequence was based on computer-generated allocation numbers 
carried out by a member of the research team, who did not take 
part in the subsequent phases of the trial. Group allocation was 
known to participants, therapist and outcome assessors. Patients 
were assessed at baseline (T1), and 3 (post-treatment-T2) and 12 
months (follow-up- T3) thereafter. Approval was obtained from 
the Portuguese Medical-Ethics Committee of the North Regional 
Health Administration and from the board of each participating 
health care center. The trial was conducted between January 2011 
and December 2012.
Participants and procedure
Adult patients meeting the CDC criteria for idiopathic chronic 
fatigue (i.e. presenting a main complaint of unexplained fatigue 
of at least six months duration) were eligible to participate in the 
study [3]. Additional inclusion criteria were to fully understand 
and speak Portuguese and to have the capacity to provide informed 
consent. Patients presenting a concurrent somatic condition 
and/or a severe psychiatric disorder that could explain fatigue 
symptoms (according to the CDC criteria for exclusionary medical 
and psychiatric conditions [3]) were excluded.
The trial was conducted in (a) several Portuguese Health Care 
Centres (public primary care centres and one private practice) 
and (b) via the Portuguese Fibromyalgia and Chronic Fatigue 
Syndrome Patient Association. In the first case, physicians referred 
patients based on the inclusion/ exclusion criteria. Patients from 
the patient association who met the criteria (i.e. clinical diagnosis 
of unexplained chronic fatigue) and indicated their willingness 
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to participate in the study received a letter from the association 
containing a description of the trial. All participants were informed 
of the content and structure of the trial and invited for the baseline 
assessment in the health care centre or at the office of the patient 
association. Patients willing to participate signed a written 
informed consent before enrolment. Baseline assessment consisted 
of a structured interview with each patient in which self-reported 
questionnaires were completed. The research team checked 
inclusion and exclusion criteria, using self-report measures 
based on the CDC criteria. A similar procedure was used for the 
assessments at T2 and T3.
Intervention
Participants continued to receive their usual care. Patients assigned 
to the control condition received a flyer with information about 
the general health benefits of physical activity and current physical 
activity guidelines for adults [34]. In addition, they set a personal 
physical activity goal for the upcoming months. Participants 
assigned to the intervention condition additionally received the 
“4-STEPS to control your fatigue” program.
One health psychologist (with expertise in motivational 
interviewing) delivered the “4-STEPS” program to individual 
patients. The intervention was based on the self-regulation phases 
of goal pursuit (goal selection and setting, active goal pursuit 
and goal attainment, maintenance and disengagement) [23]. 
First, participants received two 1-hour face-to-face individual 
motivational interviewing sessions (weeks 1 and 3) aimed at: (a) 
exploring important health and life goals, to which a physical 
activity goal could be related, (b) reducing ambivalence towards 
change (c) increasing participants’ motivation and confidence 
to be physically active and (c) setting a specific personal physical 
activity goal. This personal physical activity goal, which took into 
consideration the graded activity principles of flexibility and 
balance, developed by Nijs and colleagues [29] was set by each 
patient during the second MI session. Patients also formed action 
plans regarding their goal (i.e. which physical activities would be 
done, and when, where, for how long and with whom each would 
take place). 
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Second, participants received a booklet containing information 
regarding: (a) the diagnosis of CF(S), (b) the factors contributing 
to a better or worse prognosis, and (c) the link between CF(S) 
symptoms and physical (in-)activity and the boom-bust pattern (i.e. 
erratic pattern of rest and activity). 
Third, a self-regulation based workbook was given to the patients. 
The self-regulation workbook was divided in four steps, each one 
focusing on specific self-regulation cognitions and skills: Step 
1-“Am I ready to start?” (focusing on self-efficacy, motivation, and 
control over competing goals), Step 2- “My physical activity goal” 
(focusing on goal-setting, action planning and self-monitoring), 
Step 3 “Overcoming obstacles” (focusing on coping efficacy and 
planning, feedback, attention and emotion regulation (i.e. control 
of distracting stimuli and negative emotions to maintain a focus 
on goal pursuit) and Step 4 “I am physically active...and I want to 
keep it this way” (focusing on relapse prevention, including coping 
efficacy and planning and goal reformulation).
 Fourth, patients received two brief self-regulation based 
telephone-counseling sessions (weeks 5 and 9). This telephone 
support aimed at reviewing the participants’ physical activity goal 
and providing relapse prevention strategies. 
Fifth, patients received a pedometer to register their physical 
activity levels on a daily basis (steps taken) during the intervention 
period. In addition, at the end of the first MI session, patients 
received a weekly daily activities record to fill in, between sessions, 
with the amount of time each day spent in physical activities, 
mental activities and rest. This provides information on activity 
fluctuation throughout the week (possible erratic rest and activity 
pattern) and how to best include PA in the daily schedule. The first 
record was used to facilitate goal setting at the second MI session. 
After that, patients received several records that they could use to 
self-monitor daily activity patterns, if they would like to do so. 
Finally, patients received a leaflet for their partner or significant 
other with relevant information on chronic fatigue, the objective of 
which was to increase social support. 
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Outcomes 
Patient characteristics Socio-demographic characteristics included 
age, gender, education and employment status (Table 1). Clinical 
information was gathered using the following indicators: (1) 
presence of persistent fatigue, (2) duration of fatigue symptoms, 
(3) impact of fatigue on daily activities (4) whether fatigue was 
alleviated by rest, (5) number of medical consultations, and (6) a 
CDC based symptom checklist for CFS [35]. The checklist presents 
19 major and minor symptoms of CFS as defined by the CDC 
criteria [3]. Respondents were asked to indicate if they experienced 
each of the symptoms during the last 6 months. For the purpose of 
this study a dichotomous scale (Yes/No) was used. A total symptom 
score was calculated by adding up the number of major symptoms 
presented (ranging from 1 to 8). To be diagnosed with CFS, patients 
need to have a complaint of persistent unexplained fatigue (at 
least 6 months) that leads to a significant disability and to have at 
least 4 of the major CFS symptoms listed by the CDC. Patients not 
fulfilling the full criteria were classified as ICF patients. The self-
reported measures also included a question regarding the presence 
of chronic disease and/or psychiatric disease, as well as name and 
duration, if any.
Fatigue was assessed using the Checklist of Individual Strength 
(CIS20-P) [36], a well-validated and reliable measure for assessing 
fatigue severity in chronic fatigue patients [37]{Vercoulen, 1999, 
De Checklist Individual Strenght (CIS);Marques M, , Psychometric 
properties of the Portuguese version of the Checklist of Individual 
Strength (CIS20-P)}. The CIS20-P is a 20 item self-report measure 
that assesses four dimensions of fatigue: subjective experience of 
fatigue, concentration, motivation and daily activities. Items are 
rated on a 7-point scale. Total score of fatigue severity is calculated 
by adding up the scores from each dimension. For the purpose 
of this study only the subjective experience of fatigue dimension 
(primary outcome) and the total fatigue severity score were 
used. A cut-off point of 35 on the subjective experience of fatigue 
dimension of CIS20-P (range: 8-56) is usually used to define a 
clinical level of fatigue [38].
Fatigue impact was measured by means of a modified version of 
the pain interference dimension of the well validated Brief Pain 
202
Inventory (BPI) consisting of 7 items [39]. Participants were asked 
to rate on a 10-point scale how their fatigue interfered with several 
aspects of their life. Total score was used as the outcome, ranging 
from 0 to 10. Higher scores indicate a higher impact of fatigue. 
Physical activity was assessed by means of:
(a) A self-report measure of leisure-time physical activity based 
on the Short Questionnaire to Assess Health-enhancing Physical 
Activity (SQUASH) [40]. Participants indicate the number of 
days per week and minutes per day in which they engage in 
physical activities (bicycling, walking and other activities such as 
swimming). For each activity of at least moderate intensity (≥3 
METs based on the categories of the Ainsworth’s compendium of 
physical activities [41, 42], total minutes of physical activity per 
week are calculated by multiplying frequency (days/week) and 
duration (minutes/day). Total minutes of leisure-time physical 
activity (moderate to vigorous physical activity - MVPA) per week 
are calculated by taking the sum of each activity score. 
(b) Physical activity was also measured by means of a pedometer. 
Daily steps were assessed using Yamax Digiwalker SW-200 
pedometers, which proved to be accurate and reliable [43, 
44]. Participants were asked to wear the pedometer for seven 
consecutive days and register the daily number of steps at the end 
of each day. The mean of the daily steps over these seven days was 
used as an outcome measure.
(c) Physical activity goal progress and achievement was assessed 
at T1 and T2. Using a standardized goal-elicitation procedure, 
respondents specified at baseline a personal physical activity 
goal that they wished to pursue over the next months. At post-
treatment, respondents were reminded of their personal goal and 
asked to indicate their progress on a 10 cm visual analogue scale 
(VAS), ranging from “I haven’t started yet” (0) to “I have achieved 
my goal” (10) [45]. 
Health-Related Quality of Life (HRQoL) was measured using the 
Short Form Health Survey-12 (SF-12V.2) [46]. The SF-12v2 is a well-
validated measure that allows to calculate a physical functioning 
score (Physical HRQoL) and a psychological functioning score 
(Psychological HRQoL), ranging from 0 to 100, with lower scores 
representing worse HRQoL.
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Somatic distress was assessed with the Patient Health 
Questionnaire-15 (PHQ-15), which measures the presence and 
severity of 15 somatic symptoms (e.g. back pain), scored on a 0-3 
scale. Higher scores indicate higher somatic symptom severity 
(range: 0-30) [47].
Psychological distress was assessed using the Depression and 
Anxiety subscales from the well-validated and widely used Brief 
Symptom Inventory (BSI) [48]. Individuals rank each symptom on 
a 5-point scale, with higher scores representing more psychological 
distress. Scores were calculated by taking the mean of the items of 
each subscale (range: 0-4). 
Self-regulation skills were measured at T2 using the Self-
Regulation Skills Battery (SRSB) [45], which assesses the extent 
to which participants use self-regulation skills in pursuing a 
previously stated personal physical activity goal. We assessed six 
self-regulation skills (18 items): planning, self-monitoring, seeking 
feedback, focus attention on goal pursuit, emotional regulation, 
coping with problems and goal persistence. A composite score was 
calculated by taking the average of the mean scores of each subscale 
(range 1-5).  The internal consistency of the total scale was very high 
(Cronbach’s alpha=0.95). 
Outcomes were assessed at baseline (T1), post-treatment (T2) and 
follow-up (T3). The T2 measures of perceived physical activity goal 
progress and self-regulation skills were used as mediators. 
Sample size
An a priori analysis [49] using an independent sample t-test (5% 
significance level) showed that a sample of 34 participants in each 
group would have 80% power to detect a mean difference of 7 
points  [50, 51] on the subjective experience of fatigue dimension 
of the CIS20-P between the intervention and the control group. 
Anticipating a possible dropout of 20% we aimed at recruiting 41 
subjects per group.
Statistical Analyses
Descriptive analyses were performed for gender, age, education, 
employment, clinical information and use of health care resources. 
Differences between groups at T1 were analyzed using t-tests 
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(for continuous variables) and univariate chi-square tests (for 
dichotomous variables). At T3, an independent samples t-test 
was conducted to assess the difference in subjective experience 
of fatigue between the intervention group and the control group 
(primary outcome). The effects of the intervention on the proposed 
outcomes were examined using a 3 (timeline: T1, T2 and T3) x 
2 (condition: control and intervention) mixed-model repeated 
measures analysis of covariance (ANCOVA), controlling for setting 
(Health care centres vs. Patient association) and disease duration. 
Whenever there was a significant time x group interaction, 
contrasts were tested for significance. We calculated effect sizes 
for contrasts, which were the standardized mean differences with 
Hedge’s g correction for small samples [52], interpreted according 
to Cohen’s guidelines (values of 0.20, 0.50 and 0.80 correspond 
to small, medium and large effect sizes). Prior to the analyses, 
data was inspected for normality and homogeneity of variance. 
Leisure-time physical activity was not normally distributed at any 
of the time points and a logarithmic transformation was carried 
out for further analyses. Assumption of sphericity was checked 
using Mauchly’s test. Whenever this assumption was violated, the 
Greenhouse-Geisser correction was applied. Data was analysed 
with intention-to-treat analyses (ITT) using the last-observation-
carried-forward method (LOCF), which included all participants 
for whom complete baseline data was available. We undertook 
sensitivity analyses to test the robustness of the results of the 
mixed design ANCOVAs by repeating all analyses with completers 
only, and no significant differences were found between the two 
approaches. For this reason, main results report the ITT analysis. 
Missing values at baseline (incomplete assessment on daily steps 
and goal progress) were imputed using Multiple Imputation. 
Additional chi-square analyses were conducted for the complete 
dataset to compare the number of patients in each group who a) did 
not meet non-clinical levels of fatigue severity (<35) assessed by the 
subjective experience of fatigue dimension of the CIS20-P, and b) 
who were physically active. Effect sizes were Risk Ratio´s (RR). 
To test mediation, we conducted a bootstrapping procedure 
developed by Preacher and Hayes [53], using the PROCESS macro 
for SPSS. We used simple mediation models, in which separate 
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analyses were conducted to test the indirect effect of  treatment 
condition (independent variable) on changes in subjective 
experience of fatigue at follow-up (dependent variable) through the 
putative mediators: 1) daily steps taken (a more objective physical 
activity measure), 2) perceived physical activity goal progress, 
and 3) use of self-regulation skills. The mediator is assumed to be 
significant at p<0.05 if the corresponding 95% confidence interval 
(CI) for the indirect effect does not include zero. In addition, when 
there were significant indirect effects, the ratio of the indirect 
effect to the total effect was calculated to express the strength 
of the mediation effects (i.e. the amount of the total effect that 
is explained by the indirect effect via the mediator). We used a 
resample procedure of 5000 bootstrap samples (bias corrected), 
controlling for setting (Health care centres vs. Patient association) 
and disease duration.  Data analyses were conducted using the 
statistical software SPSS v22.
Results
Participant flow and patient characteristics 
 The flow of patients through the trial and reasons for exclusions 
and withdrawals are shown in Figure 1. A total of 165 individuals 
were identified as eligible to participate and were informed about 
the study. Of these, 91 patients randomly allocated to either the 
4-STEPS program or the control condition completed baseline 
assessment and received allocated treatment (n=45 and n=46, 
respectively). Sixteen (35%) participants in the intervention group 
and fifteen (32%) participants in the control group were lost to 
follow-up. 
Demographics and clinical characteristics are presented in 
Table 1. No significant differences were found for demographics 
and clinical variables between the intervention and the control 
group at T1. 
Intervention effects
At T3, there was a significant difference of 6.57 points in subjective 
experience of fatigue between the intervention and the control 
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group (t=-3.58, p=0.01 95% CI -10.3 to -2.80, g=0.72). There was a 
near-significant difference in the number of patients presenting 
non-clinical levels of fatigue between the intervention (7/29-
24.1%) and control group (2/31-6.5%; X2=3.68, p=.076, RR= 3.74, 
95% CI 0.85 to 16.52). Mixed-design repeated measures analyses 
of covariance (ANCOVA) revealed a significant time by group 
effect for subjective experience of fatigue (p=.003) and total fatigue 
severity (p=.003), after controlling for the effect of the covariates 
(Table 2). In both analyses, contrasts revealed that significant 
changes occurred between T1 and T3 (p=.004, g= 0.66 and p=.005, 
g= 0.54, respectively). In the intervention group there was a 
significant decrease from T1 to T3 in the subjective experience 
of fatigue (- 4.04; mean change control group = +1.52) as well as 
in total fatigue severity (mean change intervention group= -5.98; 
mean change control group = +4.85). In addition, there was a 
significant effect of the intervention on fatigue impact (p=.018). 
Contrasts revealed a significant time by group interaction when 
comparing impact of fatigue between T2 and T3 (p=.003, g= 0.39). 
Regarding physical activity there was a significant time by group 
interaction for level of leisure-time physical activity (p=.011). 
Statistical contrasts revealed that changes were significant from T1 
to T3 (p=.012, g= 0.21). No significant group x time interaction was 
found for number of daily steps taken (p=.151). Furthermore, there 
was a significantly higher number of physically active participants 
in the intervention group (19/29 – 65.9%) in comparison to the 
control group (11/31 – 35.5 %; X2= 5.41, p=.020; RR=1.84, 95% CI 1.07 
to 2.21) at T3.
There was a significant time by group effect for both physical and 
psychological HrQoL (p=.002). Contrasts revealed that changes 
were significant from T1 to T3 (p=.002, g=0.39 and p=.004, g=057, 
respectively). In the intervention group there was a significant 
increase from T1 to T3 in physical HrQoL (+4.55; vs. mean change 
control group = -3.03) and psychological HrQoL (+8.82; vs. mean 
change control group = -1.32). 
No significant time x group effects were found for somatic 
symptoms (p=.624), depression (p=.605) and anxiety (p=.365). 
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Mediation analysis
Table 3 shows the results of the mediation analysis for each 
proposed mediator. Mediation tests showed that daily steps at 
T2 (objective measure of physical activity) did not mediate the 
effects of treatment on fatigue severity at T3 (95% CI -1.92 to 
1.49). By contrast, physical activity goal progress for which a 
significant time by group effect was found at T2 (F=16.37, p=.000, 
g=0.83), partially mediated the effect of the 4-STEPS program on 
subjective experience of fatigue (point estimate= -1.65, 95% CI 
-4.15 to -0.36). The mediation effect averaged about 26% of the 
total treatment effect.
Regarding self-regulation skills, there was a significant 
difference (t=2.89 p=.006, 95% CI 0.15 to 0.83, g=0.72) between the 
intervention (M=3.68, DP=0.51) and the control group (M=3.19, 
DP=0.82) at T2. Mediation analyses showed a significant indirect 
effect of treatment through the use of self-regulation skills (T2) 
on fatigue at T3 (point estimate= -2.22, 95% CI of -5.41 to -0.56), 
accounting for 32% of the total effect. 
Discussion
This trial tested the medium-term (12-months follow-up) effects 
of a brief self-regulation (SR) based intervention for patients 
with unexplained chronic fatigue (4-STEPS), which combined 
face-to-face motivational interviewing with SR skills training. 
Post-treatment (3-months) results showed beneficial effects of the 
4-STEPS on subjective experience of fatigue (primary outcome) 
and total fatigue severity [33]. At 12-months follow-up, these 
beneficial effects were maintained and a larger difference was 
found for subjective experience of fatigue between groups (6.57). 
Furthermore, we found an increase from baseline for the number of 
patients in the intervention group presenting non-clinical levels of 
fatigue (~21%) in comparison to the control group (0%). In addition, 
the effects of the intervention on fatigue impact in daily life became 
significant. 
Sustained beneficial treatment effects were also found for 
health-related quality of life (HrQoL). In fact, larger effects on 
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psychological HrQoL were found at follow-up in comparison to the 
3 months post-treatment results (g=0.33 vs. g=0.57). Treatment 
effects on additional somatic complaints as well as on psychological 
distress (depression and anxiety) remained non-significant. 
These results are in line with the average effects found in previous 
systematic reviews and meta-analyses of graded exercise and 
psychological interventions in CF(S) [12, 13]. However, few trials 
present medium to long-term follow-up effects and there is 
also heterogeneity in the effects. Two earlier trials with similar 
treatment duration (3-months) that also provided 2 initial face-to-
face sessions and additional self-management manuals focusing 
on educational and behavioural strategies, differ from each other 
with respect to follow-up results. While in the trial conducted by 
Powell et al [19] the authors found large effects of the intervention 
on fatigue, physical functioning and depression, in the trial by 
Friedberg and colleagues [54] beneficial effects were only found for 
fatigue severity. 
The results for physical activity (PA) reveal that the intervention 
has a non-significant effect on number of daily steps. In fact, the 
average difference in daily steps between the two conditions 
at 12 months was only ~383 steps/days. The average number of 
daily steps of participants in each condition met however the 
recommended guidelines for patients with chronic diseases of 
minimum 6500-8000 steps/day [55]. Furthermore, the magnitude 
of the interaction effect between treatment condition and time 
(baseline to follow-up) on leisure-time PA was small. There was 
a decrease in PA levels from post-treatment to follow-up in the 
intervention condition; there was, however, still an increase from 
baseline to follow-up of approximately 30 minutes/week of leisure-
time PA. At the same time, the percentage of physically active 
participants was maintained from post-treatment to follow-up. It 
may be that patients, who were physically active at post-treatment, 
set new personal PA goals that did not focus on increasing PA levels 
but rather on maintaining PA levels or balance between activities 
(e.g. accumulation of leisure-time PA with daily steps taken). Many 
behavioral and psychological trials presenting a graded exercise 
component have found trivial to small beneficial effects on physical 
activity and capacity in CF(S) patients [50, 56]. However, very few 
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studies present follow-up results. These studies also measured 
physical activity mainly in laboratory settings making use of 
functional capacity measures [e.g. 57], an accelerometer [e.g. 50] or 
walking tests [e.g. 58]. 
Since physical activity is a key target in many interventions 
designed for CF patients, it is important to analyse if changes 
in PA actually lead to improved fatigue. In the present study, we 
conducted a mediation analysis to test if the effect of treatment 
on subjective fatigue severity at follow-up could be explained 
by (a) an increase in the number of daily steps (a more objective 
measure of PA) and (b) progress towards a personal PA goal. 
Results showed that an increased number of daily steps did not 
mediate treatment effects on fatigue. A recent study by Wiborg 
and colleagues [59] analysing the mediation effect of PA on fatigue 
severity and including data from two CBT trials targeting PA in 
CFS adult patients [18, 50], did not find a significant mediation 
effect. However, none of the trials included in the analysis had a 
significant impact on PA levels. In the present trial the effect of the 
intervention on daily number of steps at post-treatment was only 
marginally significant. At the same time, we did find that personal 
goal progress partially explained the effects of treatment on 
sustained fatigue improvement. This result suggests that it may not 
be the mere increase in PA that explain fatigue improvement, but 
rather the formulation of self-chosen and personally meaningful 
goals that not only increase the likelihood of goal progress and 
achievement but can also impact positively on disease related 
outcomes. Likewise, it may be that flexible PA related goals that 
take into consideration patients’ own symptoms and capability 
as well as the need to regulate daily activity can also explain the 
beneficial effects of treatment upon sustained fatigue improvement 
[7]. Thus, PA goals can facilitate the increase of PA levels and 
maintain these levels or lead to a more balanced form o PA, taking 
into consideration other daily activities. Future studies could 
further explore this by using daily activities diaries or other remote 
activity monitoring systems. 
One of the main targets of the 4-STEPS intervention was to 
increase patients’ use of SR skills [23]. Although recent trials have 
shown that interventions using a combination of theoretically 
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derived SR-skills [23, 24] were more effective than other 
interventions [27, 28], only few studies analyzed the mediation 
effect of SR-skills on health behavior changes and disease related 
outcomes [20, 21]. Mediation analysis showed that the effect of 
treatment on fatigue at follow-up could be partly explained by 
a treatment effect on SR-skills at post-treatment. Encouraging 
patients to set personal active goals and providing them with skills 
to attain these goals seems to explain part of the intervention effect 
on fatigue severity.  
Study limitations 
The present study has a number of limitations. First, the small 
sample size limits the generalizability of our findings. Employing 
complex moderated mediation models with larger samples can 
provide more insight in differential effects of SR skills (e.g. self-
monitoring) and other proximal targets and explore for which 
subgroups and in which phases of health behaviour change these 
interventions works best. Furthermore, the intervention combined 
motivational interviewing, the use of self-regulation techniques 
and motivational tools (e.g. pedometer), but the effect of each 
components could not be separated out in present study. Future 
studies should address this issue by using a full-factorial design. 
Second, this trial was carried out in health care centres and in a 
patient association. To deal with potential bias the randomisation 
procedure was stratified by sample, and statistical analyses were 
conducted controlling for setting. Differences in recruitment 
strategy within these settings may, however, have led to a selection 
bias. Third, confirmation of CF(S) inclusion and exclusion criteria 
was based on self-reported CDC criteria and it can therefore not 
be excluded that some patients did not fulfill the criteria. Ideally, 
the diagnosis should also rule out other somatic and psychiatric 
causes of the symptoms, by means of a full clinical assessment 
and standardised psychiatric interview. Fourth, men were largely 
underrepresented in the sample; more studies are therefore needed 
to determine the effects of this program in men suffering from 
CF(S). Fifth, due to the fact that there are no normative data for 
the Portuguese CIS20, comparisons made regarding (non-) clinical 
levels of fatigue severity should be interpreted with care.
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Furthermore, future trials should investigate the benefits of 
self-regulation based interventions in a design that includes an 
active control condition, e.g. a treatment such as GET. Finally, we 
expected a brief intervention with less direct contact to have a 
lower dropout rate than more lengthy interventions, but this was 
not the case. Attrition from baseline to 12-months follow-up was 
however lower in this study than what was recently found in other 
randomized controlled trials of brief interventions [54, 60]. 
Conclusion
Despite its limitations, this study found that a brief intervention 
has sustained small to medium effects on fatigue severity and 
impact, health-related quality of life, and leisure-time PA. Minimal 
direct contact interventions that can be easily implemented 
in standard health care can be useful for patients presenting 
difficulties in attending regular health care facilities [60] and/or for 
patients who do not need more intensive forms of treatments [61]. 
Furthermore, our results suggest that using motivational and self-
regulation principles and techniques can lead to improved fatigue 
in CF(S) patients. Self-chosen, personally meaningful goals appear 
to motivate these patients, while SR-skills training facilitate the 
attainment of their goals. By providing continued remote contact 
with patients, making use of e.g. e-health and m-health in order to 
provide maintained tailored feedback, intervention effects could be 
sustained over a longer period of time.   
212
Other information
The trial is registered at http://www.controlled-trials.com, number 
ISRCTN70763996 and we have previously published the protocol 
of our trial [32]. This report followed the revised CONSORT 
guidelines for reporting randomized trials [62].
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Figure 1   Flow diagram of participants through the intervention.









·Not meeting inclusion criteria (n= 19) 
·Not interested (n=47)
·Allocated to control condition (n=50)
·Did not complete baseline assessment (n=4)
Not feeling well enough (n=3)
Lack of time (n=1)
·Received allocated intervention (n=46)
Allocated to intervention condition (n=49)
·Did not complete baseline assessment (n=4)
Not feeling well enough (n=2)
Lack of time (n=2)
·Received allocated intervention (n=45)
·Discontinued intervention (n=5)
 Lack of time (n=5)
Lost to follow-up (n=5) 
Couldn’t contact (n=2)
Failing to provide a reason (n=2) 
Not feeling well enough (n=1)
· Lost to follow-up at T3 (n=6) 
Couldn’t contact (n=3)
Failing to provide a reason (n=2)
Lack of time (n=1)
·Lost to follow-up at T2, re-included at T3(n=0)
Analyzed in intention to-treat analysis (n=45)
Per-protocol analysis (n=29)
· Excluded from analysis (n=0)
·Discontinued intervention (n=0) 
·Lost to follow-up (n=13)
Couldn’t contact (n=4)
Failing to provide a reason (n=3)
 Lack of interest (n=3)
Lack of time (n=3)
·Lost to follow-up at T3 (n=6) 
Couldn’t contact (n=4)
Failing to provide a reason (n=1) 
Lack of interest (n=1)
·Lost to follow-up at T2, re-included at T3(n=4)
Analyzed in intention to-treat analysis(n=46) 
Per-protocol analysis (n=31)







Age 46.96±10.39 49.20±11.49 0.33
Gender (women) 44 (97.8) 45 (97.8) 1.00
Education
Primary 12 (26.7) 16 (34.8)
0.65Secondary 17 (37.8) 17 (37.0)
Higher 16 (35.6) 13 (28.3)
Employed 24 (54.3) 25 (54.3) 1.00
Not working due to fatigue 1 10 (45.5) 11 (47.8) 1.00
Abseentism (n. days) 2 6.20 ± 10.44 14.36 ± 22.61 0.14
Physically active3 15 (33.3) 17 (37) 0.82
Disease duration (years) 9.81 ± 8.02 10.96 ± 9.06 0.53
Number of medical consultations 4.03± 2.88 5.10 ± 4.43 0.20
Number of major CDC CFS symptoms  6.42 ± 1.29 6.70 ± 1.38 0.33
Diagnostic criteria
ICF 5 (11.1) 3 (6.5) 0.49
CFS 40 (88.9) 43 (93.5)
Clinical Levels of Fatigue4,5
Yes 42 (93.3) 43 (93.5) 1.00
No 3 (6.7) 3 (6.5)
Setting
1.00
Health Care Centres 24 (53.3) 25 (54.3)
Patient Association 21 (46.7) 21 (45.7)
Table 1 Baseline demographics and patient characteristics
Note. Values are presented as Mean ± Standard Deviation or Frequencies (%). 1 n=21 in each condition. 2 n=20 (Intervention condition); 
n=22 (Control condition). 3Results for completers [Physically active: Intervention group = 11/29 (37.9%); Control condition= 
13/31 (41%); p= 0.75]. 4Cut-off score of 35 on the Subjective Fatigue sub-scale of the CIS20. 5Results for completers [clinical levels: 
Intervention group= 28/29(96.6%) and 29/31 (93.5%); p=01.00]. CDC = Centres for Disease Control and Prevention; ICF = Idiopathic 
Chronic Fatigue; CFS = Chronic Fatigue Syndrome.
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Table 2 Changes in outcomes between baseline (T1), post-treatment (T2) and follow-up (T3)




Group x Time interactionª





T1 46.00±6.30 47.00±7.66 6.70 .003
T2 42.62±9.93 47.35±8.31 T1-T3 .004
T3 41.96±10.08 48.53±7.92 T2-T3 .140
Fatigue 
severity1 
T1 98.40±16.43 103.54±19.07 6.14 .003
T2 93.73±22.37 106.76 ±20.32 T1-T3 .003
T3 92.42±22.30 108.39±20.07 T2-T3 .282
Fatigue 
impact
T1 6.25±1.89 6.88±1.90 4.12 .018
T2 5.89±2.38 6.33±2.21 T1-T3 .436
T3 5.13±2.52 6.49±2.23 T2-T3 .003
Leisure-
time PA2 
T1 41.56±70.59 58.37 ±106.28 4.83 .011
T2 120.67±146.19 57.39± 152.00 T1-T3 .012
T3 71.67±110.36 66.08±121.17 T2-T3 .054
PA (steps/
day)





T1 38.22±17.78 31.30±18.90 7.06 .002
T2 43.33±21.87 28.15±20.23 T1-T3 .002
T3 42.78±21.20 28.27±19.68 T2-T3 .790
Mental 
HRQoL 
T1 41.57± 16.13 37.59 ±17.62 6.39 .002
T2 46.85±19.71 36.79±19.15 T1-T3 .004
T3 50.39±18.80 36.27±18.35 T2-T3 .063
Somatic 
distress
T1 14.02±4.04 16.20 ±4.47 0.43 .624
T2 13.05±4.72 15.76±4.48
T3 13.40±5.50 15.59±4.61
Depression T1 1.49±0.88 1.89±0.91 0.48 .605
T2 1.55±0.95 1.91±0.93
T3 1.39±0.97 1.88±0.98




 (Note. Values are presented as mean ± standard deviation. ªMixed design repeated measures using intention to treat analysis, adjusted 
for disease duration and setting (Health care centres vs. Patient association).1CIS20 total score. 2Descriptives are presented in raw form. 
PA= physical activity. HRQoL= Health-related quality of life. 
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Table 3  Summary of mediation analyses predicting levels of fatigue severity at 
follow-up
Mediators
Daily steps Goal progress Self-regulation skillsª
Paths a (IV →M) 666.47 1.65* 0.49**
Paths b  (M→DV) -0.00 -4.65* -4.55*
Path c (total effect IV→DV ) -6.31** -6.31** -7.02**
Paths c’ (direct effect IV→DV 
after controlling for M-
-5.83** -4.63** -4.80*
Estimate of indirect effect 
(axb paths)
-0.47 -1.65 -2.22
95% CI of indirect effect -1.92 to 1.49 -4.15 to -0.36 -5.41 to -0.56
Effect ratio of  indirect effect 0.07 0.26 0.32
Note . * p < 0.05, ** p<0.01 CI=Confidence Interval;  IV Independent Variable (treatment condition); DV  Dependent Variable (subjective 
fatigue severity); M Mediator . ª Sample size corresponds to completers dataset, as SR skills was only assessed at T2 (n=35 in intervention 









The focus of this thesis was on the role of self-regulation and 
physical activity in chronic fatigue management. Idiopathic 
Chronic Fatigue (ICF) and Chronic Fatigue Syndrome (CFS) 
are of unknown aetiology, but research suggests a multifactorial 
nature in which biological/physical, psychological and social 
factors interact [1, 2]. 
Treatment approaches target mainly perpetuating factors of 
fatigue chronicity, such as lack of physical activity (PA). Adopting 
a health behaviour change framework can thus contribute to the 
understanding and promotion of PA in CF(S) patients. One of 
the theoretical perspectives on health behaviour change is Self-
regulation (SR), which postulates that behaviour is a goal driven 
process, in which motivational and volitional aspects interact 
[3]. SR based interventions have demonstrated to be effective 
in promoting long-lasting health behaviour change in chronic 
disease populations [4-7]. 
The main purpose of this thesis was to develop, implement 
and evaluate the effects of a SR-based intervention targeting PA, 
the “4-STEPS to control your fatigue” trial on chronic fatigue 
management among patients with CF(S). We also intended 
to examine whether changes in the intermediate targets of the 
intervention (self-regulation skills and physical activity) explained 
subsequent changes in fatigue severity. 
Prior to this intervention study we conducted a series of studies 
that were important for the development and evaluation of the 
4-STEPS Randomized Controlled Trial (RCT): (1) a validation of a 
measure of fatigue severity (primary endpoint) for the language and 
population in which we intended to implement the intervention 
(Portugal),(2) a comparison of clinical characteristics and 
behavioural and cognitive determinants of CFS in a Dutch and a 
Portuguese patient sample, and (3) a systematic review and meta-
analysis of behavioural and psychological interventions with a 
graded PA component conducted with CF(S) patients.
In this chapter, we first present a summary of each empirical 
study. Next, we present a theoretical integration of findings and 
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implications for practice, followed by a number of methodological 
considerations with a focus on the strengths and limitations of the 
4-STEPS trial. Finally, possible avenues for future research and 
concluding remarks are addressed.
Summary of Studies
Assessment of Fatigue
The first empirical study (Chapter 2) described the psychometric 
properties of the Portuguese Version of the Checklist of Individual 
Strength (CIS20-P; [8]). The main reason for conducting this 
empirical study is that fatigue severity is the primary endpoint 
of the 4-STEPS trial. Therefore, we intended to use a measure 
with adequate psychometric properties for the language and 
population of interest, allowing at the same time the assessment 
of fatigue according to international standards. The CIS20 [9, 10], 
a multidimensional self-report instrument incorporating both 
physical and mental fatigue, is a well validated measure developed 
for CFS patients that has been widely used within this (e.g. [11, 12]) 
and other populations (e.g. working population; [13]), especially in 
the Netherlands. For the purpose of this study, data was collected 
from a large sample of healthy adults (N= 430) and a sample of 
CF(S) patients (N=89). 
Our findings were similar to what was found in previous 
research [14], although studies examining the factorial structure 
of the CIS20 are scarce. Convergent validity of the CIS20-P with 
the Vitality Scale and Physical and Psychological Functioning 
(assessed by the SF-12v2 [15]) was good. The CIS20-P was also 
able to adequately discriminate between matched healthy and 
CF(S) samples. Patients with CF(S) presented significantly higher 
levels of fatigue on all subscales and on total fatigue severity (Total 
CIS20-P). Internal consistency estimates of each subscale and 
total CIS20-P were satisfactory, with the exception of Motivation. 
Furthermore, results supported a multidimensional (four-factor) 
structure of the CIS20-P, but some of the adjustment indices 
of fit to the model were unsatisfactory, especially in the CF(S) 
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sample. The small sample size of the CF(S) group may explain why 
estimates were in general poorer within this group.  
In the subsequent studies presented in this thesis, only the 
Subjective Experience of Fatigue subscale measuring general 
fatigue severity (e.g. “I feel weak”) and the total CIS20-P were 
considered. The choice for selecting the subscale Subjective Fatigue 
as the primary outcome in the 4-STEPS trial was based on the fact 
that most trials using the CIS20 typically use this subscale as their 
primary endpoint.  
From Determinants...
Chapter 3 focused on the cross-cultural comparison of clinical 
characteristics as well as on the behavioural and psychological 
determinants of CFS between a Portuguese and a Dutch CFS 
patient sample. Due to the fact that there was no published 
research conducted in CFS patients in Portugal, and that most 
trials targeting these patients are conducted in Northern European 
countries this comparison was important in view of culturally 
adapting existing CFS models and developing tailored treatment 
strategies. 
We conducted a comparative survey based study with matched 
samples (female patients with CFS) from the Netherlands (N=167) 
and Portugal (N=85). The objective of this study was threefold. 
First, it compared fatigue impairment and severity, somatic 
distress, psychological distress (depression and anxiety) and 
physical and psychological Health-Related Quality of Life (HrQoL) 
in Portuguese and Dutch CFS samples. Second, it examined 
the contribution of fatigue severity and somatic complaints to 
HrQoL in Portuguese and Dutch CFS patients. Third, it explored 
differential effects of self-regulation cognitions (illness beliefs) 
and behaviours (physical activity and erratic behaviour regulation 
patterns – limiting behaviour and all-or-nothing) on fatigue 
severity. 
As expected, there were similar levels of fatigue severity in both 
samples, which supports the validity of the CIS20 to assess fatigue 
across different CFS samples. The levels of somatic distress, the 
poor physical and mental HrQoL and the high rate of patients not 
working in both samples, reflect the disability commonly found 
230
in CFS patients [1]. Furthermore, we found that higher levels of 
fatigue and additional somatic symptoms were related to poor 
HrQoL. In addition, the Portuguese sample demonstrated worst 
psychological functioning, and higher levels of depression and 
anxiety. In fact, more than half of the Portuguese CFS patients met 
clinical levels of psychological distress. 
Regarding the third objective of this study, we found that both 
self-regulation cognitions (illness beliefs) and behavioural factors 
(physical activity or certain behaviour regulation patterns) were 
significantly associated with fatigue severity in both samples. 
Regarding self-regulation cognitions, which according to 
Leventhal’s illness cognition model [16] trigger subsequent (un-)
adjusted coping behaviours, our findings are in line with previous 
research showing that positive illness beliefs are associated with 
lower fatigue severity and negative beliefs with higher fatigue 
severity [17]. However, there were differences in specific beliefs. For 
the Portuguese sample we found that attributing more symptoms 
to the illness (seriousness of CFS) and reporting a higher emotional 
impact of the experience of CFS was associated with worse fatigue 
severity. In relation to the behavioural determinants in the 
Portuguese sample, higher levels of physical activity were positively 
associated with fatigue improvement and, on the contrary, limiting 
behaviour (i.e. excessive resting and marked decrease in daily 
activities) [18] was associated with worst fatigue levels. This is 
in line with previous research and current recommendations 
for CFS patients [19]. In the Dutch population, in which levels of 
physical activity were higher, adopting an erratic all-or-nothing 
behaviour regulation pattern (i.e. systematic alternation between 
periods of over activity and excessive resting as a consequence) was 
significantly associated with worse fatigue severity. These findings 
show similarities and differences in clinical characteristics and 
cognitive and behavioral determinants of CFS that are important 
for treatment.
...to Interventions
Next, Chapter 4 presented a systematic review and meta-analysis 
on the efficacy of behavioral and psychological treatments for 
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patients with CF(S) focusing on graded PA. Physical activity is 
considered a key factor in chronic fatigue management, and is 
therefore targeted in current recommended non-pharmacological 
treatments for CFS, such as Graded Exercise Therapy (GET) and 
Cognitive-behavioral Therapy (CBT). None of the published meta-
analysis [20, 21] assessed so far the efficacy of these treatment 
approaches upon physical activity. The first objective of this meta-
analysis was to evaluate the overall effect of interventions on PA as 
well as on fatigue severity, physical functioning and psychological 
distress (anxiety and depression), among CF(S) patients. Only RCTs 
were included, in which intervention conditions were compared 
with either passive control conditions (e.g. waiting list) or active 
controls (e.g. flexibility/ relaxation).
Overall, results showed that interventions (k=16) had beneficial 
medium effects on fatigue improvement, and small effects on 
physical functioning/impairment, physical activity/capacity and 
psychological distress (depression and anxiety), at post-treatment 
and at follow-up (up to 17 months). There was an exception for 
PA at post-treatment for which only a near-significant effect was 
found.
As treatment effects varied widely between trials, potential 
moderators of interventions effect were also examined in the 
meta-analysis. These included the type of care provided to the 
control condition, treatment setting, length of the intervention, 
provider of treatment, presence of a psychological (cognitive) 
component (vs. only behavioural), minimal direct contact between 
patient and provider (vs. more intensive interventions), and a 
flexible approach to physical activity (adjustment in PA levels/
goals according to individual tolerance level). Although the small 
number of studies somewhat limit the conclusions that can be 
drawn from these subgroup analyses, results showed that some 
of the variables were moderators of interventions effect but only 
for Fatigue Severity and Depression. Interventions provided by 
psychologists/psychotherapists and interventions conducted 
at secondary or tertiary settings presented larger benefits. In 
addition, interventions providing minimal direct contact with 
patients had additional beneficial effects upon fatigue severity and 
depression. Furthermore, we found that interventions allowing 
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flexibility in physical activity levels and goals, presented higher 
effects on depression. We did not find a significant difference in 
effects between interventions focusing on physical activity only or 
also targeting psychological factors (e.g. CBT approach), though 
results point towards a greater effect of this last treatment modality 
on both fatigue and depression. These results provide valuable 
indications for the targets and format of future interventions for 
chronic fatigue management. 
Informed by the previous studies, Chapter 5 presented the 
protocol of the “4-STEPS to control you fatigue” trial. In the study 
protocol we presented the theoretical and empirical rationale for 
developing and implementing the 4-STEPS with CF(S) patients, 
the aims of the RCT, and a detailed description of the methods 
and procedures (study design, recruitment and randomization 
procedures, intervention content and materials, outcomes assessed 
and data analysis plan). 
The 4-STEPS trial was tested in several Primary care centres 
and in the Portuguese Patient Association. Eligible patients 
who were willing to participate in the RCT were randomly 
allocated to either the control (usual care + leaflet with PA-
related information) or the intervention condition (usual care + 
4-STEPS). The treatment condition received a brief intervention 
(12 weeks) with minimal direct contact (up to 3 hours of total 
contact time). The 4-STEPS consisted of a combination of 
Motivational Interviewing [22], with SR-skills based training. 
Participants set and planned a relevant PA goal, and were advised 
to gradually increase PA according to a personal flexible scheme 
[23]. Patients received manuals with information about CF(S) 
and physical (in-)activity and received SR based manuals which 
incorporated SR cognitions and skills for each phase of the 
goal-related process (goal selection/setting, active goal pursuit 
and goal attainment/maintenance). To support patients during 
this process, patients received additional telephone SR-based 
counselling, as well as a pedometer and daily activities diaries, 
which could be used to monitor daily activity patterns during 
the intervention period. Finally, participants received a leaflet 
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with information of CF(S) to give to their partners of significant 
other. 
 Assessments were conducted at baseline, post-treatment 
(3-months) and at follow-up (12-months). Primary outcome was 
subjective experience of fatigue (CIS20-P Subjective Experience 
of Fatigue subscale). Secondary outcomes analyzed in the articles 
presented in this thesis were fatigue severity (Total CIS20-P), 
fatigue impact, Health-related Quality of Life (HrQoL; dimensions 
of physical and psychological functioning), somatic distress 
and psychological distress (depression and anxiety). To capture 
different forms of PA in which CF(S) patients may engage in, 
we assessed (1) daily steps taken (pedometer), (2) Leisure-time 
PA (Moderate to vigorous PA), and (3) personal elicited PA goal 
progress and achievement. In addition, we assessed at post-
treatment the use of Self-regulation (SR) skills to achieve personal 
elicited goals.
Post-treatment results of the 4-STEPS trial were reported in the 
empirical study presented in Chapter 6 and follow-up results were 
reported in Chapter 7.
Data from eighty-four patients who were equally randomized 
to treatment conditions and completed baseline assessment was 
analyzed. Most patients were middle-age (~48 ys.) women (97.8%), 
and about half of the sample was unemployed. At baseline, only a 
third of the participants were physically active, doing an average of 
~50 minutes per week of leisure-time PA and ~6700 steps/day. Only 
two participants discontinued the intervention, and total attrition 
was 25% to post-treatment and 33% to follow-up.  
In general, results are in line with what is reported in previous 
reviews and meta-analysis of trials conducted with CF(S) patients 
[20, 21, 24, 25], including the meta-analysis presented in this thesis. 
At post-treatment, there was a significant difference between the 
intervention and control group of medium magnitude. Likewise, 
mixed design analysis, controlling for disease duration and setting, 
showed a significant time by group effect on fatigue severity 
improvement (Subjective Experience of Fatigue and Total CIS20). 
In addition, patients who received the 4-STEPS program 
showed a significant improvement in physical and psychological 
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HrQoL. In contrast, we did not find significant effects of the 
4-STEPS in reducing psychological distress (depression and 
anxiety) nor somatic distress (additional somatic complaints). 
Physical activity was one the main targets of the 4-STEPS trial. 
At post-treatment, we only found a near-significant effect of the 
intervention on the average number of daily steps. Regarding 
leisure-time PA there was a marked increase from baseline to 
post-treatment in the intervention group, by an average of ~80 
minutes per week. In addition, there was a significantly greater 
number of physically active participants in the intervention 
group (74%; vs. 33% in the control group). Furthermore, a 
large effect of the 4-STEPS was found on patients’ progress in 
attaining a personal elicited PA goal. 
At follow-up (Chapter 7), a larger difference in subjective 
experience of fatigue between treatment and control conditions 
was reached (6.6 points; g= 0.72), and there was a marked increase 
by approximately 21% in the number of patients presenting 
non-clinical levels of fatigue in the intervention group compared 
to none in the control group. From post-treatment to follow-
up, beneficial effects of the 4-STEPS upon fatigue severity were 
maintained with larger effects from baseline, and there was 
an additional significant effect for fatigue impact in daily life. 
Similarly, we found sustained beneficial effects for physical 
functioning and larger effects on psychological HrQoL. Treatment 
effects on somatic complaints and psychological distress 
(depression and anxiety) remained non-significant. Regarding 
physical activity, differences between groups on daily steps 
became meaningless at follow-up. Nevertheless, average of daily 
steps in each condition met minimal guidelines for patients with 
chronic diseases [26]. Regarding leisure-time PA, there was no 
significant time by group effect from post-treatment to follow-
up. Although there was a decrease in physical activity levels in 
the intervention condition, it was still higher than the levels 
presented at baseline (+ 30 minutes/week). Similarly to what 
was observed at post-treatment, there was a significantly greater 
number of physically active participants in the intervention 
condition (66%; vs. 36% in the control group).
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The last objective of this thesis, presented in Chapter 7, was to 
analyze the mechanisms by which the intervention produced 
sustained effects on the primary endpoint of the 4-STEPS trial 
(subjective experience of fatigue). For this purpose, we conducted 
simple mediation analyses investigating the contribution of the 
empirically and theoretically derived intermediate targets of the 
4-STEPS - physical activity and self-regulation skills -, to fatigue 
improvement.
Regarding PA, we conducted mediation analysis with daily 
steps taken assessed by a pedometer (near-objective measure 
of PA) and perceived PA goal progress. Our results showed that 
fatigue improvement at follow-up could be partially explained 
by participants’ progress and achievement of personal PA goals 
at post-treatment. In relation to the use of SR skills in pursuing 
personal behavior change goals, at post-treatment, participants 
in the intervention group reported a greater overall use of SR-
skills (action planning, self-monitoring, seeking feedback, focus 
attention of goal, emotion regulation, coping with problems and 
goal persistence) in comparison to those in the control condition. 
Mediation analysis revealed that increased use of SR strategies 
to achieve personal behavior change goals (at post-treatment) 
contributed to improved fatigue reported at follow-up. 
The results from the 4-STEPS trial show that a brief self-
regulation based intervention can have a beneficial and sustained 
impact in chronic fatigue management and that progress and 
achievement of personal PA goals and increase use of SR-skills 




Theoretical Integration and Translation into Practice 
In this thesis we intended to examine if a self-regulation based 
approach would add to the current psychological and behavioral 
models and treatments for chronic fatigue management. 
Is a Self-regulation Framework Useful for CF(S) Management?
Central in self-regulation theories is the assumption that human 
actions are goal-oriented and that self-regulation concerns 
cognitions, emotions, and skills that guide the achievement 
of personally relevant goals [3, 27]. Thus, behavior change is a 
dynamic goal-guidance process consisting of a goal selection and 
setting phase, active goal pursuit and goal attainment phase, in 
which motivational and volitional aspects interact [3]. By using the 
Motivational Interviewing method and Self-regulation skills based 
manuals, the 4-STEPS trial targeted all phases of the goal-guidance 
process, based on the set of guidelines for interventions formulated 
by Maes & Karoly [3]. In Chapter 3, we examined how illness beliefs 
derived from Leventhal’s illness cognition model [16], contribute 
to fatigue severity in two patient samples. In line with previous 
research [17, 28], we found that negative illness beliefs, such as 
the belief that one has a severe illness with serious consequences, 
as well negative emotional responses, were associated with 
worst fatigue severity. If patients experience many symptoms, 
which may even be misattributed to the disease, this can lead to a 
hypersensitivity and hypervigilance to somatic symptoms that will 
confirm illness identity and perceived consequences [17]. On the 
other hand, positive illness beliefs such as believing that one is in 
control of CFS were associated with improved fatigue severity. 
For this reason, providing patients with clear information on the 
symptoms associated with CF(S) and how self-regulation strategies 
can positively impact chronic fatigue was an important first step in 
view of intervention [3]. In the 4-STEPS intervention (Chapters 5, 6 
and 7), patients were initially provided with information regarding 
CF(S) symptoms, perpetuating factors, and self-management of 
CFS, to clarify maladaptive illness perceptions in order to facilitate 
the formulation of more adaptive and positive goals.
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Goal setting is a central component of interventions based on a 
self-regulation framework [3]. Several theoretical considerations 
should be made in this respect. First, according to self-regulation 
theories (e.g. Carver and Scheier’s Control Theory [27]) goals are 
hierarchically organized and interconnected; from lower-order 
concrete goals (so-called “do” goals, e.g. do physical activity) to 
higher-order abstract goals (so-called “be” goals, e.g. be loved). This 
means that the formulation of and commitment to particular health 
behavior goals will depend on the degree to which lower-order goals 
facilitate or conflict with the achievement of higher-order goals, as 
well as with other personal goals, at the same hierarchical level, that 
are valued by the individual (multiple goal pursuit). Goal conflict 
and goal facilitation are therefore considered to be of importance 
in all goal-related phases. In the 4-STEPS trial, through the use of 
Motivational interviewing, the link between physical activity and 
core values for patients was explored and established by the 
patients themselves, i.e. how being physically active could 
fulfil other important goals such as recovering from CF(S), 
or even more broader goals such as being cared. By doing this 
exercise, an increase in the personal relevance of health goals 
and motivation to change was expected. Likewise, during the MI 
sessions and in the self-regulation skills manual, patients were 
prompted to identify and prioritize conflicting goals with PA. 
Second, choosing and setting personally salient goals (goal 
ownership), rather than assigned goals, increases the likelihood 
of goal achievement as patients will be more committed and 
engaged in the process of goal striving [3, 27, 29]. Moreover, 
research derived from Self-Determination theory [29, 30], 
has shown a relation between autonomous motives for goal 
pursuit and goal attainment [31], as well as with the adoption 
and maintenance of physical activity in healthy and chronic 
disease populations [32]. By evoking patients’ motives and 
strengthening confidence to change in an autonomy-supportive 
environment, we could prompt the formulation of personally 
salient and self-chosen goals.  In the 4-STEPS trial we found 
that progress and achievement of personal physical activity 
goals contributed to sustained improved fatigue (Chapter 7). 
Third, according to a Self-regulation perspective [27], one of the 
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triggers of motivation to change and selection of behaviour change 
goals is the perceived discrepancy between an individual current 
state (input value) and a desired state (reference value), through 
a comparator (e.g. self-monitoring). By identifying discrepancy 
it will prompt individuals to seek a reduction in the discrepancy 
towards the desired state. CF(S) patients tend however to adopt 
a discrepancy system that reinforces their status quo as their 
reference value is frequently based on symptom avoidance (e.g. 
activity avoidance) [33]. One way in which we targeted discrepancy 
during MI was by eliciting the association between the current 
behaviour and important life goals/values (aforementioned 
activity) and by resolving the ambivalence that can contribute to 
moving from keeping the status quo to engage in behavior change, 
which, in turn, can lead to improved fatigue and well-being. In 
addition, from the first to the second MI session patients monitored 
their daily activity levels by means of pedometer and daily 
activities records, which provided the necessary feedback to trigger 
discrepancy reduction (i.e. behaviour change goal). By experiencing 
a gradual increase in physical activity without exacerbation 
patients are expected to adopt more positive reference values that 
will encourage them to formulate active and positive goals instead 
of avoidance behaviours [33]. 
To enhance the process of formulating health-related goals 
(e.g. physical activity) and pursuing them, several self-regulation 
skills are considered to play an important role [3, 34]. First, action 
planning (i.e. detailed plans of what, how, when, where, and with 
whom) is consider to promote a transition from intention to action. 
Research has shown the beneficial effects of action planning and 
implementation intentions for health behaviour change [35] and 
goal achievement [36]. In the 4-STEPS trial, only patients in the 
intervention group were supported to formulate such a detailed 
plan to achieve a physical activity goal, resulting in a significantly 
higher level of goal progress and achievement in the treatment 
group (Chapter 6).
Second, prompting self-monitoring of behaviour and obtaining 
progress-related feedback is a critical component of successful self-
regulation [3, 34], as it serves to focus one’s attention on behaviour/
goal progress and make the necessary adjustments in accordance. 
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To facilitate self-monitoring and progress-related feedback, we 
used several strategies: (1) patients were offered pedometers, which 
promoted sustained monitoring of physical activity and immediate 
feedback, (2) we provided daily activities records (to identify 
and monitor behaviour regulation patterns), (3) participants 
set incremental goals (goal laddering), which allowed patients 
to check their progress for each goal step, and (4) we provided 
subsequently brief telephone counselling, which was also a form of 
providing feedback by revisiting goals that patients had previously 
formulated. 
Finally, participants were prompted to plan how to cope with 
anticipated barriers to behaviour change. A recent systematic 
review [37] shows that interventions combining action and 
coping plans were more effective than interventions targeting 
action planning alone, and that supporting participants in the 
process of forming plans to prevent relapse increases intervention 
effectiveness. A coping planning or problem solving activity was 
presented in the self-regulation skills manual and it was the main 
focus of the telephone counselling sessions.
The results of the 4-STEPS trial (Chapters 6 and 7) demonstrated 
that the strategies employed lead to a higher use of SR-skills 
to regulate one’s own behaviour in the treatment condition in 
comparison to the control condition leading to an increase in 
physical activity in the intervention group. Furthermore, the use 
of these skills significantly contributed to sustained improved 
fatigue. These results are in line with previous research showing 
the beneficial sustained effects of targeting SR-interventions in 
patients with chronic diseases [4, 5, 38]. Likewise, recent meta-
analyses found that interventions combining SR-skills derived 
from Self-regulation theory (e.g. Control Theory [27]), were more 
effective than other interventions in the general population [34] 
and in patients with chronic disease [39, 40]. Unfortunately, the 
limited information regarding the content of the interventions 
included in the meta-analysis (Chapter 4), did not allow the coding 
and examination of potential moderation effects of specific self-
regulation principles as a moderator of intervention effects (e.g. 
goal setting).
Why and How to Target Physical Activity for CF(S) 
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Management?
Extensive literature has demonstrated that physical inactivity 
and excessive resting are perpetuating factors of fatigue 
chronicity in CF(S) patients and that PA based on a graded 
activity approach can lead to improved health-related outcomes 
in CF(S) patients [1, 41]. 
In this thesis our aims regarding PA were to (1) examine physical 
(in-)activity behaviour in a Portuguese sample of CF(S) patients 
in order to inform key targets of the 4-STEPS trial, (2) to analyze 
whether available interventions had a positive effect on PA, (3) 
whether a self-regulation approach would have a beneficial impact 
in improving PA among CF(S) patients, and (4) whether PA was in 
fact related to improved outcomes in CF(S).
In Chapter 3, we found that Portuguese CFS patients were 
characterized by low levels of PA, and that these levels as well as 
limiting behaviour were associated with fatigue severity, pointing 
at the need to address PA in interventions for chronic fatigue 
management in this population.
In Chapter 4 we analyzed the effects of behavioral and 
psychological interventions with a graded activity component in 
increasing PA. Although there were few studies including PA as an 
outcome, our results showed that the overall effect of interventions 
on physical activity/capacity was either non-significant or small. 
None of the moderators analysed explained the heterogeneity 
found between studies. The fact that physical activity interventions 
had only limited impact on PA is worth addressing. This could be 
due to variability in assessment methods of PA used in the trials 
(walking tests, accelerometers or physiological measures) or to 
other potential moderators that were not included in this meta-
analysis (e.g. type of PA). It also points at the need of testing other 
forms of interventions that may be more successful in promoting 
physical activity (e.g. motivational and self-regulation approaches), 
as we did in the 4-STEPS trial. 
The fact that Portuguese patients presented with low levels 
of physical activity justified the adoption of an intervention 
combining motivational interviewing, aiming at strengthening 
patients own motivation and confidence to engage in personal 
relevant health-behaviour goals, with self-regulation skills training 
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to support the process of goal setting and pursuit. 
Recent literature suggests that graded activity approaches rather 
than adopting a rigid model of gradual increases in the frequency 
and intensity of physical activity, independently of symptoms 
experienced, should promote flexibility in PA levels and goals that 
patients adopt on a daily basis with a personal balance between 
daily activities and with rest (pacing) [23]. This approach can 
prevent overexertion, a major symptom in CFS that contributes 
a boom-and-bust pattern of activity and thus to the perpetuation 
of fatigue, [19, 23]. In the meta-analysis presented in Chapter 4 we 
found that interventions incorporating a flexible approach to PA 
levels or goals had also beneficial effects on depression (p<.10) and 
a slightly larger effect on fatigue severity. In the 4-STEPS trial, we 
adopted this approach to PA. 
Results of the 4-STEPS trial showed variability between different 
PA-related outcomes. Effects on increase daily steps were trival, 
but moderate to large effects were found for leisure-time PA and 
progress towards a personal PA goal at post-treatment. The fact 
that the percentage of active patients in the intervention group 
remained stable from post-treatment to follow-up in spite of a 
decrease in leisure-time PA, points at the possibility that patients 
may have set new goals not targeting an increase in PA levels, but 
focusing on e.g. flexibility in PA levels or on a balance between 
different forms of PA or daily activities.
Furthermore, we found that progress toward a self-chosen PA 
goal contributed to the explanation of the effects of the 4-STEPS 
on fatigue improvement, contrarily to what we found for daily 
steps taken. Previous research analyzing the mediation effect of 
PA (assessed by means of accelerometer), using data from three 
RCTs, did not find significant mediation effects nor significant 
intervention effects on increasing PA [42]. In addition, a recent 
study found that perceived activity (assessed with a modified 
version of the subscale Daily Activities of the CIS20) and not 
objective activity (also assessed by means of accelerometer) 
explained the variance in fatigue during a CBT based treatment 
[43]. Our findings point at the benefits of setting personally 
meaningful PA goals on physical activity and, as a result, improved 
fatigue. Possible explanations for this mediation effect, are that 
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patients by identifying that they are progressing towards their own 
physical activity goal, may experience a change in other cognitive 
factors such as focus less on symptoms and negative consequences, 
get a higher sense of control over fatigue, feel more confident 
in their ability to continue on making the necessary efforts and 
changes to recover from fatigue, feel more satisfied with their 
progress, and/or increase their sense of goal ownership, leading to 
better disease management and improvement  [3, 33, 44-46]. 
Implications for Practice
Findings from the studies reported in this thesis show that 
focusing on identifying self-regulation factors that influence 
CF(S) outcomes, can lead to better care for patients with CF(S). 
The mediation effects found for self-regulation skills and personal 
goal progress (Chapter 7) indicate that assessing and targeting 
SR mechanisms can indeed lead to disease improvement. It is 
however important that health care professionals have access to 
guidelines that best inform on how to target these mechanisms. 
To translate SR theory to practice, Maes and Karoly [3] developed 
a set of principles to guide interventions targeting illness self-
regulation, from which the 4-STEPS trial was derived. By providing 
these guidelines, self-help materials, and adequate training, we 
can support health professionals in increasing patients’ skills to 
regulate their own behaviours and implement strategies for CF(S) 
management. Likewise, health care professionals can be trained on 
how to prompt health behaviour change by applying Motivational 
Interviewing principles in routine practice. In fact, there has been 
an increase in Motivational Interview interventions conducted in 
primary care [47]. Nonetheless, the results from our meta-analysis 
(Chapter 4) point at additional benefits of treatments provided 
by psychologists or psychotherapists and the 4-STEPS trial was 
also conducted by a health psychologist. This finding and the fact 
that CF(S) seems to result from a multiplicity of determinants, 
including cognitive, emotional and behavioural factors, reinforces 
the importance of a multidisciplinary approach in the treatment of 
CF(S) including psychologists.
The fact that the 4-STEPS is a brief intervention, consisting 
of a combination of minimal personal contact with health care 
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professionals, brief telephone counselling and self-regulation based 
manuals to support CF(S) patients in changing their physical (in-)
activity behavior, can be seen as an advantage as it can be offered 
as an adjunctive treatment for CF(S) in outpatient care. In fact, 
interventions with minimal direct contact that also allowed for 
flexibility in PA, provided continuous remote contact to support 
patients and provided patients with self-management strategies 
have larger effects on fatigue severity and depression (Chapter 4). 
Supporting patients’ autonomy over their own process of behavior 
change and providing them with the resources and skills to self-
regulate and achieve personal goals seems to be crucial in this 
respect. 
Notwithstanding its potential, the 4-STEPS needs to be assessed 
for cost-effectiveness and standardized treatments for CF(S) 
patients in Portugal are yet to be implemented. Several barriers 
can be identified to the implementation of evidence-based 
treatments and standardized procedures for the diagnostic and 
managements of CF(S) in the Portuguese health care system. 
The first of which is the fact that CF(S) is not recognized as a 
discrete disorder by primary health care professionals and when 
referred to secondary-tertiary care, these patients are followed 
in different medical specialities based on the main symptoms 
presented  by patients to their medical doctor (e.g. rheumatology, 
internal medicine, neurology or psychiatry). Second, the lack 
of psychologists in the Portuguese National Health care system 
that was recently reported by the Portuguese Association of 
Psychologists can be a major obstacle to the implementation of self-
regulation based interventions in health care [48]. Furthermore, 
the implementation of psychological and self-regulation based 
treatments for CF(S) patients will depend on the funds available, 
and the financial constraints that the health care system currently 
face can also be an obstacle to its implementation. At the same 
time, due to these financial and human resources constraints the 
development of brief interventions with minimal direct contact can 
also been seen as an advantage.
The examination of self-regulation and behavioral determinants 
of fatigue improvement can contribute to develop predictive 
models that have good validity and that can be cross-culturally 
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applied, guiding the development of more effective interventions. 
Developing a diagnostic tool that explores various mechanisms 
of fatigue perpetuation or improvement, could lead to the 
development of tailored intervention strategies from which 
patients can benefit the most. 
Methodological Considerations
Several methodological considerations were already made in the 
different chapters of the thesis. The aim of this section is to outline 
the main methodological issues of the 4-STEPS randomized 
controlled trial, and to formulate methodological considerations 
that should be taken into consideration in future research.
Strengths and Limitations of the 4-STEPS Trial 
The 4-STEPS trial was based on previous studies and is 
characterized by (1) a randomised controlled designed, (2) 
inclusion of a 1-year follow-up assessment point, (3) current 
recommendations for CF(S) management, (4) consideration for 
the specificities of the Portuguese CF(S) population and context, 
(5) a theoretical perspective (self-regulation theory) and (6) 
intervention briefness with low participant burden. With this 
RCT we evaluated the efficacy of a complex behavior change 
intervention, and potential mechanisms of change (i.e. PA and 
SR-skills).  
Notwithstanding its strengths, this trial has several limitations 
that were addressed in detail in Chapters 6 and 7. A first limitation 
is the basis for the power calculation that was used, the difference 
in subjective experience of fatigue between the intervention and 
control condition, which does not necessarily correspond to a 
clinically significant improvement in fatigue. At present, we believe 
that there are more appropriate approaches for power calculation, 
such as a difference of 0.5 SD in fatigue severity from baseline in the 
intervention group [49], the overall effect size obtained in previous 
meta-analysis of CBT and GET trials [21], or the change in the mean 
scores within the intervention group [50].
Second, patients were recruited from several Primary Care 
centres and from a Patient Association. Although recruitment 
of participants was stratified by setting, there were differences 
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in recruitment procedures in each setting that may have caused 
selection bias. While statistical analyses used to evaluate the effects 
of the 4-STEPS trial, controlled for potential confounding effects 
of the type of setting (Health care centres vs. Patient Association). 
On the other hand, one of the strengths of this trial is that it was a 
multi-centre RCT, which allowed the inclusion of a larger number 
of participants from different locations and targeted a more 
heterogeneous population, therefore contributing for the external 
validity and generalizability of the findings. In fact, recent reviews 
suggest that single-centre trials tend to overestimate effects of trials 
[51, 52]. Unfortunately, due to the limited sample size recruited 
in each health care centre, we could not control for the potential 
differential effects of each centre.
Third, attrition rate to the 4-STEPS trial was higher than what 
was initially anticipated for a brief intervention, in particular to the 
follow-up assessment point. The reasons for this attrition rate were 
not further analysed, although patients were followed and some 
of the patients that were lost to the post-treatment assessment 
were re-included at the 12-months period of assessment. Other 
brief and remote contact interventions have also found high drop-
out rates [53, 54]. It should be further explore if e.g. other forms 
of recruitment and contact with patients, between the end of the 
intervention and assessment points (e.g. booster sessions) could 
prevent the high attrition rate found. 
Fourth, the fact that the intervention was conducted only by one 
therapist is a clear limitation of the 4-STEPS trial, as we could not 
assess the effect of the therapist on the intervention. In addition, 
due to constraints in available resources we could not assess 
treatment integrity. In clinical trials using MI it is recommended 
to assess therapist fidelity to the treatment, as it is the consistent 
use of MI principles and skills as well as the interpersonal style of 
the therapist that is thought to influence behaviour change and 
health-related outcomes [22, 47]. For this purpose, several scales 
such as the Motivational Interviewing Treatment Integrity [55] 
have been created. Likewise, we did not assess adherence to the full 
treatment protocol. Although all participants who completed the 
4-STEPS intervention received the two MI sessions and telephone 
counselling, we do not know how many patients were fully adherent 
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to the content of the SR-skills manual.
Fifth, as the intervention combined several behavior change 
methods and techniques, such as the use of pedometers, 
motivational interviewing and SR-skills training, the effects 
of the different components of the 4-STEPS trial cannot be 
disentangled nor could we assess whether this specific combination 
of techniques was responsible for the intervention effects. Future 
research should consider using a full factorial design to determine 
the individual contribution of each component.
Finally, in this controlled trial the 4-STEPS program was 
compared against a passive control group whose participants 
only received general information about physical activity and 
formulated a personal physical activity goal without additional 
guidelines. Comparing the 4-STEPS with other active treatments 
(such as GET alone, or educational approaches), is an important 
target for future research.
Sample and Recruitment Considerations 
One of the main limitations of the studies presented in this thesis 
is the small size of the Portuguese CF(S) sample. There were also 
large differences between samples sizes in the studies presented in 
Chapter 2 (Portuguese CF(S) vs. healthy sample) and in Chapter 3 
(Portuguese CFS vs. Dutch samples), which limits the conclusions 
that can be drawn from these comparisons. Furthermore, the 
sample size lacks power to detect changes in secondary outcomes 
and mediation effects, limiting not only conclusions that can be 
drawn from the analysis conducted in the RCT (Chapters 6 and 7) 
but also the type of statistical models that could be employed. 
A second limitation is that only two men with CF(S) participated 
in the 4-STEPS trial and only women were included in the 
international comparative study (Chapter 3). Studies have 
shown that CF(S) is more common among women [56], but 
report a considerable higher percentage of men suffering from 
CF(S). Future studies should test for differential behavioral and 
psychological explanatory models of CF(S) concerning gender and 
explore the effects of the 4-STEPS in male CF(S) patients. 
Another important remark is that the empirical studies presented 
in this thesis targeted only adult patients with CF(S). More studies 
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are needed to test differential effects of interventions and the 
application of a self-regulation perspective on CF(S) between 
adolescents and adults.   
The fact that samples were recruited via Health Care Centres 
and a Patient Association does not allow to generalize results to 
the general population nor to attribute differences with the Dutch 
population only to cross-cultural differences in the international 
comparative study (Chapter 3). In addition, as aforementioned, 
differences between settings in the recruitment strategy may have 
led to selection bias. To overcome this bias, not only recruitment 
for the RCT was stratified by setting, but also statistical analyses on 
the effects of the 4-STEPS trial were conducted controlling for the 
effects of the type of setting (Chapters 6 and 7). 
The fact that inclusion/exclusion criteria were not verified 
by means of full laboratory examination and a structured 
psychiatric interview, may have led to the inclusion of patients 
with misdiagnosis and/or co-morbidity with other psychiatric 
and physical clinical conditions, such as Fibromyalgia, as there is 
a considerable proportion of patients presenting with both CF(S) 
and Fibromyalgia [1]. This possible co-morbidity with undiagnosed 
psychiatric disorders may in part explain the difference in 
psychological distress and psychological HrQoL found between the 
two cohorts in the cross-cultural study (Chapter 3) as well as the 
trivial impact of the 4-STEPS upon psychological distress (Chapters 
6 and 7). Furthermore, both patients with Idiopathic Chronic 
Fatigue or Chronic Fatigue Syndrome were included, which 
means that our sample is constituted by patients presenting with 
different levels of disability and number of major CFS symptoms 
experienced. Future studies should examine the contribution of 
Self-regulation models and the efficacy of the 4-STEPS intervention 
for different levels of disease severity.
Assessment Considerations  
In the studies presented in this thesis, we made extensive use 
of self-report measures, which are susceptible to response bias. 
Nevertheless, many of the questionnaires used in this thesis are 
well validated and reliable. In the case of physical activity, although 
we used a more objective measure to assess physical activity 
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(pedometers), it was still the individual that registered and provided 
written information on daily steps taken. As an alternative, future 
studies could use accelerometers, in which scores are stored 
into the internal memory of the device and afterwards fed into 
an external computer. In addition, accelerometers also provide 
information on physical activities performed at different levels of 
intensity and sedentary periods, which allows the assessment of 
daily activity patterns and fluctuations. In this respect, although 
we provided patients with diaries to register daily activities, we 
did not use them as an additional assessment measure. Future 
studies could use these daily records to assess behaviour regulation 
patterns (e.g. all-or-nothing behaviors). 
Moreover, for the assessment of fatigue severity we were not able 
to establish normative data for the CIS20-P, as we did not have 
a representative sample of the Portuguese population. As such, 
comparisons made in the empirical studies regarding (non-)clinical 
levels of fatigue severity were based on cut-off scores established 
for the Dutch population, and should thus be interpreted with care. 
Future studies should examine normative scores and thresholds for 
clinical levels in representative samples of the general Portuguese 
population and populations with chronic diseases, so that the 
CIS20-P can be used as a complementary diagnostic tool of 
prolonged fatigue severity in both research and clinical practice 
in Portugal. Likewise, because there is no normative data for the 
Portuguese population of the measure used to assess depression 
and anxiety (Brief Symptom Inventory; BSI [57, 58]), cut-off points 
for (non-)clinical levels of psychological distress in the cross-
cultural study (Chapter 3) were also based on normative data from 
the Netherlands. 
Finally, some of the measures used lack a full comprehensive 
quality assessment for the Portuguese population (e.g. the Self-
regulation Skills Battery), or validation of modified versions (e.g. 
the Fatigue impact scale).  
Future Directions
The studies presented in this thesis showed promising findings 
indicating that a self-regulation framework can add to existing 
models and treatments for chronic fatigue management. 
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However, some questions remained unanswered while others 
were raised throughout the conduction of these studies. In this 
section we present some avenues for future research focusing 
on this thesis as a whole. 
In the comparison study presented in Chapter 3, we found 
that a psychological model of CFS is common to patients 
from different countries, which is an important finding 
for the development of treatment modalities that can be 
internationally implemented, but we also found differences 
between the patient samples. While this first exploratory study 
has its merits, more research is needed to fully understand 
cross-cultural patterns of behaviour and self-regulatory factors 
in CFS. For example, the large difference in psychological 
distress found between Portuguese and the Dutch CFS patients 
may in part have to do with the fact that, in contrast to the 
situation in the Netherlands, CFS is not recognized as a discrete 
disorder by primary health care practitioners in Portugal. 
Difficulties in the diagnosis and lack of legitimization of the 
disease may therefore lead to higher levels of psychological 
distress [59].  We are currently conducting a longitudinal survey 
study comparing clinical characteristics, behaviours and self-
regulation factors of CFS between patient samples from several 
European Countries (France, Italy, Netherlands, Rumania and 
the United Kingdom).
Our RCT (Chapters 5, 6 and 7) showed that using motivational 
interviewing principles and SR skills training targeting 
physical activity and CF(S) management leads to beneficial 
improvements in fatigue, but sustained effects were assessed 
only at one year follow-up after baseline assessment. 
Future studies should analyze longer-term effects of brief 
interventions. So far, only one study using a brief intervention 
targeting physical activity in CF(S), analyzed its effects at a 
longer period of time (2 years) [60], but there was crossover 
between the conditions. In the meta-analysis conducted 
within this thesis (Chapter 4), the average follow-up period of 
assessment in the trials included was 13 months. Although we 
found that the main effects of the 4-STEPS were maintained 
at follow-up, for some secondary outcomes the impact of the 
250
intervention decreased. To increase the sustained use of self-
regulation skills and to optimize long-term effects of brief 
interventions, other forms of remote contact using m-health 
and e-health are worth exploring. Using remote technology 
can for e.g. prompt continuous self-monitoring of behavior and 
provide tailored feedback. 
Identifying psychological and behavioural perpetuating factors 
of CF(S), can contribute to the development of diagnostic tools 
and tailored interventions. While we identified important SR 
cognitions and skills as well as behaviours that are related to 
fatigue severity, these only explain a part of the variation in 
this outcome. Other potential determinants and mechanisms 
of change have been described in the literature that should be 
explored, such as social factors (e.g. social support), focusing on 
bodily symptoms, (in-) avoidance behaviour, or balance in daily 
activity patterns [1, 44, 61]. Future research should use more 
complex mediation models to explore how changes in physical 
activity impact on fatigue improvement from a psychological 
point of view. As previously mentioned in this chapter, from 
a self-regulation perspective, feeling capable to engage and 
progress in some form of physical activity (without exacerbating 
symptoms), cognitive changes (e.g. focus less on fatigue) and 
feelings of satisfaction with achievements, can positively impact 
disease management and improvement [3, 44, 45].
Likewise, examining predictive models and effects of this 
brief treatment for CF(S) on other important outcomes related 
to CF(S) is necessary, such as recovery from fatigue  as well 
severity of disability and impairment associated with CF(S) (e.g. 
work, social life).
More research is clearly needed to identify moderators 
of explanatory models and intervention effects, so that 
we can better understand under which conditions (i.e. 
intervention design) and for whom SR based approaches are 
most effective. Previous moderator analyses on the effects 
of brief interventions for CFS found that patients with 
substantial depressive symptoms benefit less from these 
types of interventions [50, 62]. In the 4-STEPS trial we did 
find a lower effect than initially anticipated for psychological 
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distress (especially for depression). The fact that Portuguese 
CF(S) patients presented with high levels of psychological 
distress may explain this finding. At the same time, in meta-
analyses that also included more intensive CBT interventions 
for CFS, the magnitude of treatments effect upon anxiety and 
depression were small ([21], Chapter), and in our meta-analysis 
we even found that brief interventions had a larger effect on 
depression improvement (Chapter 4).  Although we attempted 
to target emotional regulation in the 4-STEPS intervention, 
this component was directed only to the regulation of emotions 
to achieve personal elicited goals. Thus, patients presenting 
with clinical psychological distress may need additional forms 
of treatments for depressive or anxiety disorders.
Other moderators are worth addressing in future research, 
such as severity of fatigue, co-morbidity with other Functional 
Somatic Syndromes (e.g. Fibromyalgia), level of physical 
activity (passive vs. more active patients), mastery in the use 
of self-regulation skills (high vs. low), combination of SR-
skills, or how SR strategies are prompted (e.g. self-chosen 
elicited goals vs. goals assigned by practitioners; autonomy-
supportive or controlled environment). Furthermore, other 
methodologies such as N-of-1 RCT design can be used to analyse 
intraindividual effects of interventions, which can be particular 
useful to better understand who benefits from treatment 
techniques and to tailor interventions to each individual [63]. 
Finally, although this intervention was partially conducted in 
primary care, a health psychologist delivered it. Due to the fact 
that motivational and self-regulation based interventions as 
well as interventions for CF(S) management in primary care are 
usually delivered by other health professionals (e.g. a general 
practitioner) in brief consultations, more research is needed 
to optimize existing  interventions for CF(S) management in a 
primary care setting [21, 47, 64].
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Concluding Remarks
The scope of this thesis was on the behavioral and self-
regulatory factors associated with health behavior change 
and chronic fatigue management. Informed by preliminary 
investigations, we developed and implemented a self-regulation 
based intervention targeting physical activity for CF(S) 
patients, the “4-STEPS to control your Fatigue”.
The 4-STEPS program, which was tested in a multicentre 
randomised controlled trial, lead to significant and sustained 
improvements in fatigue and in patients’ functioning and 
quality of life. The 4-STEPS also produced significant effects 
on the use of self-regulation skills and physical activity, 
especially progress towards a personal physical activity goal, 
partially explaining the sustained effects of the intervention 
upon fatigue severity. Nonetheless, the 4-STEPS also presented 
limited effects for some of the outcomes assessed.
 The limitations of each of the six empirical studies that were 
reviewed in this chapter point at the need to conduct more 
research on the behavioural and psychological mechanisms 
involved in CF(S) management. In spite of these limitations, we 
believe that this thesis positively contributes to the advance of 
disease management in CF(S) patients.
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De focus van dit proefschrift ligt op de rol van zelfregulatie en 
lichaamsbeweging bij het omgaan met chronische vermoeidheid. 
Wij hebben een op zelfregulatie gebaseerde interventie die zich 
richt op lichaamsbeweging (LB) bij patiënten met (het) chronische 
vermoeidheid(ssyndroom) (CV(S)) ontwikkeld, geïmplementeerd 
en geëvalueerd. Deze interventie is genaamd ’de 4 STAPPEN naar 
controle over je vermoeidheid’[1]. Bij de evaluatie zijn we ook 
nagegaan of veranderingen in de intermediaire doelen van de 
interventie (zelfregulatie vaardigheden en lichaamsbeweging) de 
veranderingen in de ernst van de vermoeidheid verklaarden. 
Voorafgaand aan deze interventie studie hebben we een serie 
onderzoeken uitgevoerd die van belang waren voor de ontwikkeling 
van de interventie en de evaluatie van de effecten middels een 
gecontroleerde studie (Randomized Controlled Trial (RCT)): 
(1) de validatie van een meetinstrument voor het bepalen van 
de ernst van de vermoeidheid (primair einddoel) in de taal en 
voor de doelgroep waar we de interventie wilden implementeren 
(Portugal), (2) een vergelijking van klinische kenmerken en 
gedragsmatige en cognitieve determinanten van CV(S) in een 
Nederlandse en Portugese patiëntengroep, en (3) een systematische 
review en meta-analyse van de gedragsmatige en psychologische 
interventies met een component gericht op het gradueel opvoeren 
van lichaamsbeweging uitgevoerd bij CV(S) patiënten. 
De meting van vermoeidheid
De eerste empirische studie (Hoofdstuk 2) beschrijft de 
psychometrische kenmerken van de Portugese versie van de 
Checklist Individuele Spankracht (Checklist of Individual 
Strength (CIS20-P; [2]). De CIS20 [3], een multidimensionaal 
zelf-rapportage instrument dat zowel de fysieke als de mentale 
vermoeidheid omvat, is een gevalideerde maat ontwikkeld voor 
CVS patiënten en is breed gebruikt binnen deze (bijv. [4]) en andere 
populaties (bijv. beroepspopulatie; [5]).  Voor deze studie zijn 
gegevens verzameld van een grote steekproef gezonde volwassenen 
(N= 430) en van een steekproef CV(S) patiënten (N=89). 
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Onze resultaten lieten een goede convergente validiteit van de 
CIS20-P zien met een maat voor Vitaliteit en een maat voor Fysiek 
en Psychologisch Functioneren, bepaald met de SF-12v2 [6]. De 
CIS20-P kon ook adequaat onderscheid maken tussen gematchte 
gezonde en CV(S) onderzoeksgroepen. Patienten met CV(S) 
lieten significant hogere niveau’s van vermoeidheid zien op alle 
subschalen en op de totale vermoeidheidsscore (Total CIS20-P). 
Interne consistentie indicatoren van alle subschalen en de totale 
vermoeidsheidsscore waren voldoende, met uitzondering van 
de schaal Motivatie. Daarnaast ondersteunden de resultaten de 
multidimensionale (vier-factor) structuur van de CIS20-P, maar 
enkele van de adjustment indices of fit van het model waren 
onvoldoende, met name in de CV(S) groep. Het geringe aantal 
participanten in de CV(S) groep kan een rol hebben gespeeld bij de 
meer matige indicatoren in deze groep.  
Van Determinanten ...
Hoofdstuk 3 richt zich op een cross-culturele vergelijking 
van klinische karakteristieken en gedragsmatige en 
psychologische determinanten van CVS tussen een Portugese 
en een Nederlandse CV(S) patiëntengroep. We hebben een 
gelijksoortig vragenlijstonderzoek uitgevoerd met vergelijkbare 
onderzoeksgroepen (vrouwelijke patiënten met CVS) in Nederland 
(N=167) en Portugal (N=85). Het doel van de studie was om de 
ernst van de vermoeidheid, somatische klachten, psychologische 
klachten (depressie en angst) en gezondheidsgerelateerde Kwaliteit 
van Leven (Health-related Quality of Life (HrQoL)) in Portugese 
en Nederlandse CVS patiënten te vergelijken, en de differentiële 
effecten van zelfregulatie cognities (ziekte cognities) en gedrag 
(lichaamsbeweging en ongunstige gedragsregulatie patronen – zich 
(overmatig) beperkend gedrag en ’alles of niets’ gedrag) op ernst 
van de vermoeidheid te exploreren. 
In lijn met de verwachtingen, was de ernst van de vermoeidheid 
vergelijkbaar in de twee onderzoeksgroepen. Het hoge niveau van 
somatische klachten, de ongunstige fysieke en mentale Kwaliteit 
van Leven, en het hoge percentage patiënten dat niet werkzaam 
was in beide groepen, reflecteren de beperkingen die algemeen 
gevonden worden in CVS patiënten [7]. Verder vonden we dat hoge 
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niveaus van vermoeidheid en bijkomende somatische klachten 
waren gerelateerd aan een lage Kwaliteit van Leven. Daarnaast liet 
de Portugese onderzoeksgroep de meest ongunstige scores zien 
op psychologisch functioneren, en had hogere depressie en angst 
scores.
Ziekte cognities en gedragsmatige factoren waren in beide 
onderzoeksgroepen significant geassocieerd met ernst van 
vermoeidheid. Met betrekking tot ziekte cognities, waren onze 
resultaten in lijn met eerder onderzoek dat liet zien dat positieve 
ziekte cognities gepaard gaan met lagere ernst van de vermoeidheid, 
en negatieve ziekte cognities gepaard gaan met sterkere ernst van 
de vermoeidheid. [8]. Echter, er waren verschillen in de specifieke 
cognities. Bij de Portugese patiënten zagen we dat het toeschrijven 
van meer symptomen aan de ziekte en het rapporteren van een 
sterkere emotionele impact van het hebben van CVS gerelateerd 
was aan sterkere vermoeidheid. Wat betreft de gedragsmatige 
determinanten in de Portugese patiëntengroep bleek dat 
hogere niveaus van lichaamsbeweging positief samenhingen 
met verbetering in vermoeidheid, en dat zich beperkend gedrag 
daarentegen verband hield met ernstigere vermoeidheid. In de 
Nederlandse patiëntengroep, die meer aan lichaamsbeweging 
deed, bleek het hanteren van een alles-of-niets gedragsregulatie 
patroon significant samen te hangen met een hogere ernst van de 
vermoeidheid. Deze onderzoeksresultaten laten overeenkomsten 
en verschillen zien in de klinische kenmerken en cognitieve 
en gedragsdeterminanten van CVS die van belang zijn voor de 
behandelingsmogelijkheden.
...naar Interventies
Vervolgens, wordt in Hoofdstuk 4 een systematische review en 
meta-analyse gepresenteerd over de effectiviteit van gedragsmatige 
en psychologische behandelingen voor patiënten met CV(S) die 
focussen op een geleidelijke opbouw van lichaamsbeweging. Het 
eerste doel van deze meta-analyse was om het algehele effect 
van interventies op zowel lichaamsbeweging als op ernst van de 
vermoeidheid, fysiek functioneren en psychologische klachten van 
CV(S) patiënten vast te stellen. Uitsluitend gecontroleerde (RCT) 
studies werden hierbij meegenomen, waarbij een of meerdere 
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interventie condities werden vergeleken met (een) controle 
conditie(s).
In totaliteit laten de resultaten zien dat interventies (k=16) een 
gunstig medium effect hadden op verbetering van vermoeidheid, en 
kleine effecten hadden op fysiek functioneren, lichaamsbeweging, 
en psychologische klachten, bij de nameting na interventie, en bij 
lange-termijn follow-up (tot 17 maanden). Een uitzondering was 
zichtbaar voor lichaamsbeweging bij de nameting – hierbij was 
uitsluitend een tendens in de gunstige richting zichtbaar. 
Aangezien de interventie effecten sterk verschilden tussen de 
verschillende studies, werden in deze meta-analyse ook mogelijke 
moderatoren van het interventie effect onderzocht. Deze potentiele 
moderatoren betroffen het type zorg dat aangeboden werd in de 
controle conditie, de behandelsetting, de duur van de interventie, 
de behandelaar / uitvoerder van de interventie, de aanwezigheid 
van een psychologische (cognitieve) component (versus uitsluitend 
gedragsgerichte interventies), minimale vormen van direct 
behandelaar-patiënt contact  (versus meer intensieve interventies), 
en een flexibele aanpak van lichaamsbeweging (aanpassing van 
lichaamsbewegingsniveaus of doelen aan individuele grenzen). 
Hoewel de conclusies die van deze subgroep analyses getrokken 
kunnen worden enigszins beperkt worden door het geringe aantal 
studies, laten de resultaten zien dat een aantal van de genoemde 
variabelen moderatoren waren van het interventie effect. Dit was 
echter uitsluitend het geval voor de effecten op  vermoeidheid 
en depressieve klachten. Interventies die aangeboden werden 
door psychologen of psychotherapeuten en interventies die in 
secundaire of tertiaire zorg instellingen uitgevoerd werden lieten 
sterkere gunstige effecten zien. Daarnaast, interventies met 
minimaal direct contact met patiënten lieten gunstige effecten 
zien op ernst van de vermoeidheid en depressieve klachten. Verder 
vonden we dat interventies die flexibiliteit toestonden in het niveau 
van lichaamsbeweging en het te stellen doel sterkere effecten 
hadden op depressieve klachten. We vonden geen significante 
verschillen in de effecten van interventies die zich uitsluitend 
richtten op lichaamsbeweging of degenen die zich ook richtten op 
psychologische factoren, hoewel de resultaten in de richting lijken 
te wijzen van een groter effect van de laatste groep interventies daar 
waar het gaat om vermoeidheid en depressieve klachten.
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Deze resultaten leveren waardevolle aanknopingspunten voor de 
focus en vorm van toekomstige interventies voor het omgaan met 
chronische vermoeidheid.
Gebaseerd op de eerdere studies, geeft Hoofdstuk 5 het protocol 
van de ‘4 STAPPEN naar controle over je vermoeidheid’ trial. In het 
onderzoeksprotocol presenteren we de theoretische en empirische 
onderbouwing voor de ontwikkeling en implementatie van de 
4 STAPPEN bij CV(S) patiënten, de doelen van de RCT, en een 
gedetailleerde beschrijving van de methoden en procedures. 
De ‘4 STAPPEN’ trial werd onderzocht in diverse eerstelijns 
gezondheidscentra en in de Portugese Patiënten Associatie. 
Patiënten die bereid waren te participeren in de RCT werden 
random toegewezen aan de controle conditie (standaard 
zorg + een brochure met informatie over lichaamsbeweging) 
of de interventie conditie (standaard zorg + 4 STAPPEN 
programma). Patiënten in deze experimentele conditie kregen 
een kortdurende interventie (12 weken) met minimaal direct 
contact (maximaal 3 uur totale contact tijd). De 4 stappen 
bestond uit een combinatie van Motiverende Gespreksvoering 
(Motivational Interviewing) [9], met training in zelfregulatie 
vaardigheden [1]. Deelnemers stelden en planden een 
relevant lichaamsbewegingsdoel, en werden geadviseerd om 
geleidelijk hun lichaamsbeweging op te bouwen op basis van 
een persoonlijk flexibel schema [10]. Patiënten ontvingen 
handleidingen met informatie over CV(S) en (gebrek aan) 
lichaamsbeweging en ontvingen op zelfregulatie gebaseerde 
handleidingen die ingingen op zelfregulatie cognities en 
vaardigheden voor iedere fase van het proces op weg naar het 
doel. Om patiënten te ondersteunen bij dit proces, ontvingen 
zij in aanvulling hierop telefonische op zelfregulatie gebaseerde 
begeleiding, als ook een stappenteller en een dagelijkse 
activiteiten dagboek, dat gebruikt kon worden om de dagelijkse 
bewegingsactiviteit te monitoren tijdens de interventie periode.
 Metingen werden uitgevoerd bij de nulmeting, na de 
interventie (3 maanden), en bij de follow-up (12 maanden). 
De primaire uitkomstmaat was de subjectief ervaren 
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vermoeidheid (CIS20-P Subjective Experience of Fatigue 
subschaal). Secondaire uitkomstmaten die werden onderzocht in 
de diverse hoofdstukken van dit proefschrift betroffen Ernst van de 
vermoeidheid (Totaalscore CIS20-P), Impact van de vermoeidheid, 
gezondheidsgerelateerde Kwaliteit van leven, somatische klachten 
en psychologische klachten (depressie en angst). Om zicht te 
krijgen op de verschillende vormen van lichaamsbeweging die de 
CV(S) patiënten ondernamen, bepaalden we (1) aantal stappen per 
dag (stappenteller), (2) Lichaamsbeweging in de vrije tijd (Matig 
tot intensieve lichaamsbeweging), en (3) progressie t.a.v. c.q. het 
bereiken van het lichaamsbewegingsdoel. Daarnaast hebben we 
na afloop van de interventie gemeten in hoeverre zelfregulatie 
vaardigheden toegepast werden om persoonlijke doelen te bereiken 
De nametingresultaten van de 4 STAPPEN trial zijn besproken in 
de empirische studie weergegeven in Hoofdstuk 6 en de lange-
termijn resultaten zijn terug te vinden in Hoofdstuk 7.
Gegevens van 84 patiënten die random toegewezen waren aan de 
condities en de nulmeting hadden ingevuld werden meegenomen 
in de analyse. De meeste patiënten waren van middelbare leeftijd 
(~48 jaar), van het vrouwelijke geslacht (97.8%), en ongeveer de 
helft van de onderzoeksgroep had geen betaald werk. Slechts twee 
deelnemers stopten tijdens de interventie-periode, en de gehele 
uitval was 25% bij de nameting en 33% bij de follow-up.  
Bij de nameting verschilden de interventie en de controle groep 
significant, met een medium effect, op Ernst van de vermoeidheid. 
Een mixed design analyse, waarbij werd gecontroleerd voor 
duur van de ziekte en setting, liet eveneens een significant tijd x 
groep effect zien in de verbetering in ernst van de vermoeidheid. 
Daarnaast lieten de patiënten die het 4 STAPPEN programma 
hadden ontvangen een significante verbetering in fysiek en 
psychologisch Kwaliteit van Leven zien. Daarentegen vonden 
we geen significant effect van het 4 STAPPEN programma in het 
reduceren van psychologische klachten of somatische klachten. 
Lichaamsbeweging was een van de hoofddoelen van het 4 
STAPPEN programma. Bij de nameting vonden we alleen een 
tendens in de richting van een gemiddeld hoger aantal stappen per 
dag in de interventie groep. Met betrekking tot lichaamsbeweging 
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in de vrijetijd was een duidelijke toename tussen nulmeting en 
nameting zichtbaar in de interventie groep. Daarnaast was in de 
interventie groep een significant hoger percentage deelnemers 
fysiek actief. Tenslotte bleek het 4 STAPPEN programma een 
sterk effect te hebben op de progressie van patiënten richting hun 
persoonlijke lichaamsbewegingsdoel. 
Bij de follow-up (Hoofdstuk 7), werd een groter verschil in 
de subjectief ervaren Ernst van de vermoeidheid tussen de 
interventie en de controle conditie gevonden, en was er sprake 
van een aanzienlijke toename, met circa 21%, in het percentage 
patiënten die niet-klinische niveaus van vermoeidheid lieten 
zien in de interventiegroep ten opzichte van het ontbreken van 
dergelijke subklinische niveaus in de controle groep patiënten. 
Tussen de nameting en de follow-up werden de gunstige effecten 
van het 4 STAPPEN programma gehandhaafd met sterkere 
effecten ten opzichte van de nulmeting, en er was daarnaast een 
significant effect zichtbaar op de impact van vermoeidheid in het 
dagelijkse leven. In dezelfde lijn vonden we zich doorzettende 
gunstige effecten op fysiek functioneren en sterkere effecten 
op psychologische Kwaliteit van Leven. Significante interventie 
effecten op somatische klachten en psychologische klachten 
bleven uit. Met betrekking tot lichaamsbeweging werden de 
verschillen tussen de groepen in dagelijkse aantal stappen gering. 
Desalniettemin, het gemiddeld aantal stappen per dag voldeed aan 
de minimale richtlijnen voor patiënten met een chronische ziekte 
[11]. Ten aanzien van lichaamsbeweging in de vrije tijd was geen 
significant tijd x groep effect zichtbaar tussen nameting en follow-
up. In lijn met hetgeen dat bij de nameting zichtbaar was, was er in 
de interventie groep sprake van een significant hoger percentage 
lichamelijk actieve deelnemers (66%; vs. 36% in de controle groep).
Het laatste doel van dit proefschrift, dat aan de orde komt in 
Hoofdstuk 7, was het onderzoek naar het mechanisme via welke 
de interventie de blijvende effecten liet zien op de primaire 
uitkomst van het 4 STAPPEN programma: de subjectieve ervaring 
van vermoeidheid. Met oog op dit doel hebben we mediatie-
analyses uitgevoerd waarbij werd nagegaan in hoeverre de op 
basis van empirie en theorie gestelde intermediaire doelen – 
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lichaamsbeweging en zelfregulatie vaardigheden – bijdroegen aan 
de vermindering van vermoeidheid. 
Met betrekking tot lichaamsbeweging, hebben we een mediatie 
analyse uitgevoerd met dagelijkse aantal stappen vastgesteld met 
de stappenteller (een vrij objectieve maat voor lichaamsbeweging) 
en ervaren progressie t.a.v. het lichaamsbewegingsdoel. De 
resultaten lieten zien dat verbetering in vermoeidheid bij de 
follow-up deels verklaard kan worden door de progressie en het 
bereiken van het persoonlijke lichaamsbewegingsdoel bij de 
nameting. Wat betreft het gebruik van zelfregulatie vaardigheden 
in het streven naar een persoonlijk gedragsveranderingsdoel, 
gaven de deelnemers in de interventie conditie bij de nameting 
aan vaker gebruik te maken van zelfregulatie vaardigheden 
(bijv. actie plannen maken) in vergelijking met deelnemers in 
de controle conditie. Mediatie analyse liet zien dat het vaker 
gebruik maken van zelfregulatie strategieën om persoonlijke 
gedragsveranderingsdoelen te bereiken (bij de nameting) bijdroeg 
aan een verbetering in vermoeidheid bij de follow-up.
De resultaten van de 4 STAPPEN trial laten zien dat een 
kortdurende op zelfregulatie gebaseerde interventie een gunstig 
en blijvend effect kan hebben in het omgaan met chronische 
vermoeidheid en dat progressie in de richting van en het bereiken 
van persoonlijke lichaamsbewegingsdoelen en een toename in het 
gebruik van zelfregulatie vaardigheden deels verantwoordelijk zijn 
voor deze blijvende verbetering in vermoeidheid.
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